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Abstract 
 Staphylococci commonly form a part of the normal micro-flora for humans and a wide variety of 
animals but also represent a group of clinically significantly pathogens. However, it has also been 
recognised that for bacteria to become pathogens, they must have the ability to accomplish infection and 
consequently cause disease in the host. This is known as pathogenicity and virulence is a degree of the 
pathogenicity observed. Virulence factors are proteins made through the expression of virulence factor 
genes produced by a pathogen which contribute to the pathogenicity, and literature research identified a 
variety of virulence factor genes. The predominant pathogenic staphylococcal species is Staphylococcus 
aureus, with methicillin-resistant Staphylococcus aureus (MRSA) recognised as significant in both 
veterinary and medical contexts. The role of the S. aureus in human disease is clear; however, the 
organism is also well recognised as a cause of animal disease with animal specific strains such as ST398 
becoming increasingly common. The approach taken to determine how similar or different the S. aureus 
strains are at genomic level as well as investigate the virulence factors that may be under positive 
selection was undertaken by employing the wealth of nucleotide sequences data available for a number 
methicillin-resistant and methicillin-sensitive S. aureus strains. This helped to establish if there was 
genomic variation between strains and investigate the potential relationship of these alterations in host/ 
niche preferences. In total, 53 strains of S. aureus were investigated; including, three novel isolates of S. 
aureus from human patients that were provided by Prof. Valerie Edward-Jones (Manchester Metropolitan 
University) and 3 novel isolates from various farm animals (cattle, chicken & swine) provided by Dr Patrick 
Butaye (The Veterinary & Agrochemical Research Centre, Belgium). The novel isolates were sequenced 
with Ion Torrent Next-Generation sequencing methodologies. Literature research has classified the 
strains of S. aureus as either hospital-associated (HA), community-associated (CA) or livestock-
associated (LA); these classifications were further investigated. Virulence factor gene sequences, if 
present, were isolated from the S. aureus strains and a comparative analysis was carried out; this 
includes initial MAUVE analysis and more detailed maximum-likelihood phylogenetic analysis, using 
	 III	
MEGA. A bioinformatics software called DnaSP was used for the analysis of polymorphism from aligned 
virulence factor nucleotide sequences and the dN/dS (synonymous vs nonsynonymous mutations) ratio 
(ω) was investigated to infer the evolutionary mechanisms that may be acting on the genes. Haplotype 
networks were also created to investigate the S. aureus population to determine the diversity of the 
population, determine any geographical relationship and further investigate the classification HA, CA & 
LA that has been given in literature. This study concluded that the presence of functional Panton-
Valentine Leukocidin (PVL) a bi-component virulence factor encoded by the lukS-PV and lukF-PV genes, 
typically found in highly virulent CA S. aureus strains, were detected in these virulent strains, but 
surprisingly also in the novel livestock-associated strains. This study also concluded that the population 
of S. aureus was very diverse and a geographical relationship was not observed. It was further concluded 
that the selective pressures on individual virulence factor genes causes S. aureus to evolve, with a 
number of genes recognised as undergoing positive selection; lukS-PV, lekF-PV, chp, sspA, vwb, lip, 
lip1, nucA, hysA, hysA1, aur, fnb, ebpS, bbp, entE, seb and tst. It was also suggested that the 3 
classifications denoted in the literature may possibly be artificial and at a molecular level the strains are 
in fact very similar and do not represent genuine divisions. This has also been recently published by Bal 
et al. (2016) and this thesis supports their hypothesis; they describe the blurring of each of the 3 
epidemiological groups (HA, CA & LA), demonstrating the limited relevance of this classification.  
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the S. aureus virulence factor genes. The error bars represent the standard 
deviation of the nodal support values. 
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4.3 A Maximum Likelihood phylogenetic analysis, based on the General Time 
Reversible (GTR-G) evolution model. The relationship of hospital-associated, 
community-associated and livestock-associated S. aureus strains for the PBP2 
gene which encodes Penicillin-binding protein 2. The numbers at the nodes are 
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bootstrap percent probabilities values based on 500 replications. Coloured 
boxes are consistent with strain classifications. 
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4.4 A Maximum Likelihood phylogenetic analysis, based on the Tamura Nei 
(TN93+G) model of evolution. The relationship of hospital-associated, 
community-associated and livestock-associated S. aureus strains for the lukF-
PV gene which encodes Panton-Valentine leucocidin subunit F. The numbers 
at the nodes are bootstrap percent probabilities values based on 500 
replications. Coloured boxes are consistent with strain classifications. 
 
 
 
 
 
 
183 
4.5 Figure 4.5: A Maximum Likelihood phylogenetic analysis, based on the Tamura 
3-parameter (T92). The relationship of hospital-associated, community-
associated and livestock-associated S. aureus strains for the vwb gene which 
encodes von Willebrand factor-binding protein. The numbers at the nodes are 
bootstrap percent probabilities values based on 500 replications Coloured 
boxes are consistent with strain classifications. 
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4.6 A Maximum Likelihood phylogenetic, based on the Hasegawa-Kisaino-Yano 
parameter (HKY). The relationship of hospital-associated, community-
associated and livestock-associated S. aureus strains for the seb gene which 
encodes enterotoxin B. The numbers at the nodes are bootstrap percent 
probabilities values based on 500 replications Coloured boxes are consistent 
with strain classifications. 
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4.7 A Maximum Likelihood phylogenetic analysis, based on the General Time 
Reversible (GTR-G) parameter. The relationship of hospital-associated, 
community-associated and livestock-associated S. aureus strains for the clf 
gene which encodes clumping factor. The numbers at the nodes are bootstrap 
percent probabilities values based on 500 replications. Coloured boxes are 
consistent with strain classifications. 
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5.1 A graph representing the nucleotide diversity (π) of the S. aureus virulence 
factor genes. The error bars represent the standard deviation of the nucleotide 
diversity. Data was generated using DnaSP. The complete data generates is 
shown in Appendix 1. 
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5.2a A graph showing the dN/dS ratio (ω) of all of the virulence factor genes in all 
of the strains. Complete data is availible in Appendix 1.	
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5.2b A graph showing the dN/dS ratio (ω) of the virulence factor that are present in 
the livestock-associated strains. Complete data is available in Appendix 1. 
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5.3a A regression analysis showing the observed nucleotide diversity (π) vs the 
length of the virulence factor gene. The trend line is shown. (Slope: 0.000024; 
Intercept 0.017501; r2 0.292441; DoF 42; P=0.000151 therefore P<0.001). 	
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5.3b A regression analysis showing the observed dN/dS ratio (ω) vs the length of 
the virulence factor gene. The trend line is shown. (Slope: -0.000127; 
Intercept 2.271417; r2 0.003483; DoF 42; P=0.704).	
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5.4a A regression analysis showing the observed nucleotide diversity (π) vs the 
length of the virulence factor gene in livestock-associated strains. The trend line 
is shown. (Slope: 0.00003; Intercept 0.018278; r2 0.248114; DoF 34; 
P=0.001991 therefore P<0.001).	
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5.4b A regression analysis showing the observed nucleotide diversity (π) vs the 
length of the virulence factor gene in livestock-associated strains. The rend line 
is shown. (Slope: 0.000414; Intercept 0.951858; r2 0.061562; DoF 34; 
P=0.145).	
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5.5 A graph representing the pairwise nucleotide differences observed between two 
populations (Dx & Dy). This is used to quantify divergence within the 
populations. 
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6.1a-c Figure 6.1a is a graph representing the relationship between the number of 
variable sites and nucleotide diversity per site of the S. aureus population. 
Figure 6.1b is a graph representing the relationship between the number of 
haplotypes and the nucleotide diversity. Figure 6.1c is a graph representing the 
relationship between the number of variable sites and haplotype diversity per 
site of the S. aureus populations. 
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6.2a-b Are haplotype network representing the SCIN & PBP2 virulence factor genes, 
created using the TCS methodology. The areas of the circle are proportionate 
to the number of individual strains harbouring the specific haplotype and the 
different colours represent the country of origin of the isolate. The numbers in 
brackets represent the mutational steps between the haplotypes and the small 
black circles indicate missing haplotypes. 
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6.3a A haplotype network that was created for the Staphylocoagulase (coa) 
virulence factor gene, created using the TCS methodology. The areas of the 
circle are proportionate to the number of individual strains harbouring the 
specific haplotype and the different colours represent the country of origin of 
the isolate. The numbers in brackets represent the mutational steps between 
the haplotypes and the small black circles indicate missing haplotypes. 
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6.3b A haplotype network that was created for the Thermonuclease (nucA) virulence 
factor gene, created using the TCS methodology. The areas of the circle are 
proportionate to the number of individual strains harbouring the specific 
haplotype and the different colours represent the country of origin of the isolate. 
The numbers in brackets represent the mutational steps between the 
haplotypes and the small black circles indicate missing haplotypes. 
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6.3c A haplotype network that was created for the Thermonuclease (nucA) virulence 
factor gene, created using the TCS methodology. The areas of the circle are 
proportionate to the number of individual strains harbouring the specific 
haplotype and the different colours represent the country of origin of the isolate. 
The numbers in brackets represent the mutational steps between the 
haplotypes and the small black circles indicate missing haplotypes. 
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6.3d A haplotype network that was created for the enterotoxin B (seb) virulence 
factor gene, created using the TCS methodology. The areas of the circle are 
proportionate to the number of individual strains harbouring the specific 
haplotype and the different colours represent the country of origin of the isolate. 
The numbers in brackets represent the mutational steps between the 
haplotypes and the small black circles indicate missing haplotypes. 
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6.3e Figures 6.3e: A haplotype network that was created for the Panton-Valentine 
toxin, subunit F (lukF-PV) virulence factor gene, created using the TCS 
methodology. The areas of the circle are proportionate to the number of 
individual strains harbouring the specific haplotype and the different colours 
represent the country of origin of the isolate. The numbers in brackets represent 
the mutational steps between the haplotypes and the small black circles 
indicate missing haplotypes. 
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6.4a-e Sliding window analysis showing the ratio of synonymous and nonsynonymous 
polymorphism observed in a number of S. aureus virulence factor genes: a) 
lukF-PV, b) nucA, c) vwb, d) coa and d) seb. The nonsynonymous mutations 
are highlighted in red and the synonymous or silent mutations are highlighted 
in blue. 
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6.5a-e Pairwise distributio analysis for a number of S. aureus virulence factor genes: 
a) lukF-PV, b) nucA, c) vwb, d) coa and d) seb. All analysis are shoing a 
multimodal distributon and as such are not significant.  
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1.1 Discovery of Staphylococcus aureus  
 In the late 1860’s, a British surgeon influenced by Louis Pasteur’s work on infectious diseases, promoted 
the idea of sterile surgery while working at the Glasgow Royal Infirmary. Joseph Lister successfully introduced 
carbolic acid, now known as phenol, to sterilise surgical instruments and clean wounds which directly led to the 
reduction of wound infections and thus making surgery safer (Smith, 2012; Lister, 1867). Joseph Lister observed, 
in 1867, that when he applied his antiseptic techniques towards the general cleanliness of the hospital wards 
where he was working at the time, not even a single case of pyraemia, hospital gangrene or erysipelas (skin 
infection) occurred during the 9 months of this trial. Previous to this, the hospital ward was rife with infections. 
This helped Lister show the importance of using carbolic acid as an antiseptic agent and for the general 
cleanliness of the hospital to his peers (Lister, 1867). In 1878, Staphylococci were seen in pus by Robert Koch 
and they were then cultured by Pasteur in 1880. However, it was Alexander Ogston who made the initial detailed 
studies. Ogston, A Scottish surgeon who was working at the the Aberdeen Royal Infirmary opened the wound 
of one of his patients and drew some pus and examined it under the microscope (Newsom, 2008). 
“My delight may be conceived when there were revealed to me beautiful tangles, tufts and chains of round 
organisms in great numbers, which stood out clear and distinct among the pus cells and debris, all stained with 
aniline-violet solution ...” (Wilson, 1987; Newsom, 2008). 
 
 Ogston then decided to see if abscess would occur in the testing animals if he injected pus from acute 
abscess into guinea pigs, wild mice and white mice. The animals developed similar pathological features, a new 
abscess was formed, followed by signs of septicaemia (Wilson, 1987; Newsom, 2008). 
 
“The animals refused food, sat cowering in a retired place in their case, were listless and apathetic, their coat 
was disordered and sometimes wet, their eyes were kept closed save when startled, and the mice showed 
purulent conjunctivitis and gluing together of the eyelids described by Koch in his experiments on septicaemia” 
(Wilson, 1987; Newsom, 2008). 
 If, however, he pre-treated the pus with carbolic acid or heat before injecting it into the animals, abscess 
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formation was avoided and signs of infection were not present. Ogston named the clustered micrococci 
“staphylococci” from the Greek word “staphyle”, which had the meaning; bunch of grapes (Newsom, 2008; 
Ogston, 1881). A short time later, in 1884, Rosenbach, a German scientist, isolated two strains of staphylococci, 
which he named for the pigmented colour of their colonies; Staphylococcus aureus, from the Latin ‘aurum’ for 
gold and Staphylococcus albus (now called Staphylococcus epidermis) from the Latin ‘albus’, meaning white 
(Cowan et al., 1954; Wilson, 1987). 
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1.2 Staphylococci  
 Staphylococcus aureus is a Gram-positive bacterium, member of the Firmicutes phylum (Frank et al., 
2010). To date, 36 species and 9 subspecies of the genus of Staphylococcus have been identified (Kazmierczak 
et al., 2014). These bacteria are non-motile, non-spore forming facultative anaerobes (Plata et al., 2009) with 
diameters of approximately 1 µm. When observed under the microscope they resemble grape-like-clusters, 
since cell division takes place in more than one plane (Goss & Muhlebach, 2011; Plata et al., 2009; Pinchuck et 
al., 2012;).  S. aureus is also catalase-positive, oxidase negative and require scomplex nutritional requirements, 
such as many acids and vitamins for growth. S. aureus is very tolerant of high concentrations of salt, up to 1.7 
molar (Plata et al., 2009). Coagulase is an enzyme produced by several bacteria that enables the conversion of 
fibrinogen to fibrin and is used to distinguish between different types of Staphylococcus isolates. The majority of 
these staphylococci are coagulase-negative, with the exception of: S. aureus, Staphylococcus intermedius, 
Staphylococci delphini, Staphylococcus schleiferi subs. coagulans and some strains of Staphylococcus hyicus 
(Kwok et al., 1999). 
 
S. aureus is frequently part of the human micro-flora (Sousa & Lenastre, 2004). In a healthy population, 
approximately 20% of individuals are colonised with S. aureus and are thus called persistent carriers. Another 
30% of the individuals are intermittently colonised for example the organism may or may not be isolated at 
different intervals, and the remaining 50% of the population appear not to be susceptible to this bacterium and 
therefore called non-carriers (Kluytmans et al., 1997, Heidi et al., 2009). In humans, S. aureus colonisation 
occurs most commonly in the nose with a reported 40 - 44% of individuals displaying this trait (Kluytmans et al., 
1997, Williams, 1963), more specifically arising in the anterior nares (the nostrils). This has shown to be the 
case because there are no human defences present to resist against the bacterium before they colonise (Heidi 
et al., 2009). It has been observed that when the nares are treated for the carriage of S. aureus, the organism 
will also disappear from other parts of the body (Kluytmans et al., 1997). Other body sites such as the perineum 
and throat may also be colonised (Heidi et al., 2009).  If this bacterium is present anywhere else in the body 
such as the gastrointestinal tract or gains entry via an open wound or catheterisation, it is known as an 
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opportunistic pathogen and can cause disease especially if the immune system is compromised (Sousa & 
Lencastre, 2004). 
	
	
1.3 Treatment of Staphylococcus aureus Infections 
1.3.1 Pre-antibiotic era 
 In the pre-antibiotic era, patients with S. aureus infection were associated with a mortality rate that 
exceeded 80% with over 70% developing metastatic infections (Lowy, 2003).  This situation changed markedly 
after the introduction of Penicillin in the early 1940s and consequently improved the prognosis of patients with 
S. aureus infections. However, it was as early as 1942 that S. aureus strains resistant to Penicillin had been 
detected in St Mary’s Hospital in London and subsequently in the community (Lowy, 2003). 
 
1.3.2 The era of antibiotics   
 If S. aureus is to be treated effectively, appropriate antibiotics must be administered. In 1928, Alexander 
Fleming observed that when a culture plate of bacteria became contaminated with Penicillium notatum mould, 
it was noted that this fungus appeared to inhibit the growth of bacteria; the mould was also non-toxic when it 
was injected into mice and rabbits (Fleming, 1929; Rolinson, 1998). It was not until 1940 that this antibacterial 
substance was isolated in pure culture by Florey and Chain and their colleagues in Oxford, UK and subsequently 
named Penicillin (Rolinson, 1998). A short time later, it was tested on mice that were infected with a lethal 
streptococcal infection; Penicillin was injected subcutaneously and was considered a highly effective treatment 
(Rolison, 1998). Penicillin was consequently considered a bactericidal agent that now belongs to a large group 
of antibiotics knows as beta-lactams (ß-lactams); these antibiotics have been used to treat most Gram-positive 
bacterial infections, including S. aureus and some Gram-negative infections (Martin et al., 2010). Other members 
of the ß-lactam antibiotic family include Cephalosporins, Carbapenems and Monobactams that are characterised 
by a common ß-lactam ring (James & Gurk-Turner, 2001). Penicillins contain a bicyclic nucleus, which includes 
the ß-lactam ring and a thiazolidine ring; in Cephalosporins the thiazolidine ring is replaced by a dihydrothiazine 
ring; Carbapenems also contain a bicyclic nucleus with a ß-lactam ring; the only exception is the Monobactam 
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antibiotic, as it contains a ß-lactam ring but no bicyclic ring structure (James & Gurk-Turner, 2001). 
 
1.3.3 Structure of the bacterial cell wall 
 ß-lactams target the proteins involved in the synthesis of the cell wall (Martin et al., 2010). Peptidoglycan 
is a macromolecule present in the cell wall of Gram-positive bacteria, such as S. aureus and is essential for 
maintaining the size, shape, mechanical and structural integrity of the bacteria (Wilke et al., 2005). This 
macromolecule is composed of glycan chains cross-linked with peptides (Wilke et al., 2005; Meroueh et al., 
2006). The glycan portion contains alternating units of N- acetylmuramic acid (NAM) and N-acetylglucosamine 
(NAG), with the latter sugar in this disaccharide being modified by a characteristic pentapeptide which varies 
amongst the Gram-positive and Gram-negative bacterium but always terminates in two D-alanine residues 
(Wilke et al., 2005; Meroueh et al., 2006). The peptides from adjacent glycan strands are cross linked and form 
the characteristic structure of peptidoglycan; this reaction is called transglycolation and is catalysed by 
transpeptidase enzymes, also called penicillin binding proteins (PBPs) (Wilke et al., 2005). Although the 
individual peptidoglycan units are produced inside the cell, transglycosylation occurs outside the cytoplasmic 
membrane (Wilke et al., 2005). 
 
1.3.4 Penicillin resistance  
 Resistance of Staphylococcal infections to Pencillin is mediated by the blaZ genes that encode ß-
lactamase, an enzyme that is synthesised when the bacteria are exposed to ß-lactam antibiotics (Figure 1.1a). 
This enzyme hydrolyses the ß-lactam ring of the antibiotic, rendering the drug inactive (Zhang et al., 2001; 
Lowey, 2003).  Two adjacent regulatory genes; blaR1, (the anti-repressor) and blal (the repressor) control the 
blaZ gene. Signalling pathways responsible for ß-lactamase synthesis requires sequential cleavage of the 
regulatory proteins; BlaR1 and B1al (Zhang et al., 2001; Lowey, 2003). After exposure to ß-lactam antibiotics, 
B1aR1, a transmembrane sensory transducer cleaves itself, this cleaved protein then functions as a protease 
that cleaves the repressor Blal and allows expression of the blaZ genes and synthesis of the ß-lactamase 
(Gregory et al., 1997; Zhang et al., 2001). 
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1.3.5 Methicillin resistance  
 Methicillin, a semi-synthetic derivative of Penicillin, was introduced in 1959 and overcame the problem of 
Penicillin-resistance (Taubes, 2008). Normally, ß-lactam antibiotics such as methicillin successfully inhibit the 
bacterial transpeptidase enzymes, also called PBPs by mimicking the D-alanine-D-alanine substrate to bind to 
the active site of the transpeptidase and then react covalently with the enzyme (Wilke et al., 2005). During this 
time this enzyme will not be able to carry out its normal function of peptidoglycan assembly (Wilke et al., 2005; 
Fisher & Mobashery, 2010). This results in weakly cross-linked peptidoglycan, which hinders the mechanical 
strength of the bacterial cell wall, eventually weakening it and causing the cell to become deformed and 
Figure 1.1a: Taken from Lowey., 2003. (I) B1aI, a DNA binding protein binds to the operator region 
which supresses RNA transcription from both blaZ and blaR1; in the absence of penicillin, β-
lactamase I suppressed at lower levels. (II) The binding of penicillin to the transmembrane sensor-
transducer B1aR1 stimulates B1aR1 autocatalytic activation. (III – IV) Active B1aR1 cleaves (via 
second proetein, BlaR2) B1a1 into inactive fragments allowing the transcription of the blaZ genes 
to commence. These genes allow the synthesis of β-lactamase to occur. (V) β-lactamase 
hydrolyses the β-lactam ring of penicillin. (VI) it therefore renders the penicillin inactive and penicillin 
resistance occurs  (Lowey., 2003). 
	
 8	
consequently lyse (Wilke et al., 2005; Fisher & Mobashery, 2010). However, MRSA was subsequently oberved 
in 1961 with some reports of resistance reported within a few months of the introduction of Methicillin in hospitals 
located in England (Jevons, 1961; Taubes, 2008). Since then, it has become an important pathogen in both 
health-care setting and communities around the world (Taubes, 2008). A study performed by Cosgrove et al., 
(2003) between 1980 and 2000 concluded that the therapeutic outcomes of infection due to MRSA are far worse 
than the outcome of those that result from methicillin-sensitive strains (MSSA) and that MRSA bacteraemia is 
associated with a higher mortality rate. Normally, S. aureus has the ability to produce four penicillin-binding 
proteins (PBPs) involved in cell wall synthesis, in addition to these PBPs, a novel PBP was discovered in MRSA 
termed PBP2a which is encoded by the presence of the methicillin resistance gene (mecA) (Weilders et al., 
2001). As discussed earlier, PBPs are enzymes that catalyse the transpeptidase reaction, required for the 
formation of the cell wall (Wilke et al., 2005). PBP2a substitutes for other PBPs because of its reduced binding 
affinity for ß-lactam antibiotics; this enables the bacteria to survive exposure to high concentrations of these 
agents and therefore resistance to methicillin occurs (Rice, 2012). The mecA gene, present in all strains of 
MRSA, is carried on a 21 – to – 60-kb DNA cassette; the Staphylococcal Cassette Chromosome (SCCmec) and 
is required for methicillin resistance to occur (Ito & Hiramatsu, 1998; Katayma, Ito & Hiramatsu, 2000). The 
SCCmec, is a large genetic mobile element that differs in genetic composition and also contains genetic 
structures such as Tn554, pUB110 and pT181 which all encode resistance to non- ß-lactam antibiotics 
(Deurenberg et al., 2006; Ito & Hiramatsu, 1998). For instance, pT181 codes for tetracycline resistance, and 
Tn554 is responsible for lincosamide and streptogramin resistance (Deurenberg et al., 2006). Kreiswirth et al 
(1993) proposed that all MRSA strains were descended from a single S. aureus strain, however; more recent 
studies by Fitzgerald et al (2001), show that the mecA gene has been horizontally transferred into S. aureus 
numerous times, concluding that methicillin resistant strains have evolved from multiple independent strains and 
not just one single ancestral strain (Fitzgerald et al., 2001). 
 
1.3.6 Treatment options for S. aureus infections 
 The choice of treatment against MRSA has been limited, with the antibacterial therapy of choice being 
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the antibiotic vancomycin, a glycopeptide (Smith et al., 1999). MRSA strains with reduced susceptibility to 
vancomycin have been reported in clinical specimens since the late 1990s; this is possibly due to the misuse 
and/ or the over-prescription of this antibiotic which has resulted in Vancomycin-resistant S. aureus (VRSA) 
(Appelbaum, 2006). This is a real concern, if VRSA becomes prevalent globally, and new, effective antibiotics 
are not discovered to treat this threat, it could result in a high mortality rate and it threatens to return the world 
to the pre-antibiotic area. Administration of vancomycin should therefore be restricted and methods for detecting 
resistant bacteria must be improved (Smith et al., 1999; Chang et al., 2003).  
 A recent report to determine the global priority list of antibiotic resistant bacteria to guide research, 
discovery and development of new antibiotics by was published by The World Health Organisation (WHO) 
(WHO-2., 2017). This report categorises pathogens as either Priority 1, stating that there is a critical need; 
priority 2, stating that there is a high need; or priority 3, stating that there is a medium need. This report 
determined that S. aureus that are either Methicillin-resistant or Vancomcyin-intermediate resistant are a priority 
2 (WHO-2., 2017).  
 
In 2015, a new class of antibiotic was discovered called Teixobactin (Ventola., 2015). This antibiotic is produced 
by Eleftheria terrae, a previously impossible-to-culture microbe; but with new techniques this was made possible 
(Ventola., 2015). Figure 1.1 is an overview flow diagram of some of the antibiotics used to treat S. aureus 
infections taken from the WHO website 
(http://www.who.int/patientsafety/events/05/apsd/EURO_Initiatives_on_blood_safety_Hafner.pdf.) (WHO-1, 
2012). It shows when S. aureus became resistant to penicillin, methicillin, the emergence of vancomycin 
intermediate strains (VISA) and finally the vancomycin resistant strains (VRSA).  
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Figure 1.1b: A flow cycle for the evolution of drug resistance in S. aureus (Adapted from WHO-1, 2012). 
This diagram shows that every time that a new antibiotic is discovered to combat the S. aureus; drug 
resistance will follow. Notably, Teixobactin is the first of a new class of antibiotic that has been 
discovered, in January 2015. The question mark for ‘2015 >?’ represents that it takes years for new 
drugs to be developed, but only a short amount of time for antibiotic resistance to be detected (Ventola., 
2015). 
	
(2015	>	?	
Teixobactin	
 11	
 
1.4 Staphylococcus aureus genome 
The first genomes of S. aureus to be published were strains N315 and Mu50 in 2001 (Baba et al., 2002). 
Figure 1.2 shows the genome of S. aureus MW2, a highly virulent MRSA that was linked to four paediatric deaths 
in Minnesota and North Dakota, in 1998; the genome of MW2 is 2820462 base pairs (bp) long (Baba et al., 
2002). GView was used by the author to produce Figure 1.2; it is a software package that has the capabilities to 
pan-and-zoom bacterial genomes (Petaku et al., 2010). This figure also only shows a snapshot of the genes 
that are present; the more you zoom, the greater the content that you can see. 
 
In order for bacteria such as S. aureus to become pathogens, they must have the ability to accomplish 
infection and consequently cause disease in the host. This is known as pathogenicity and virulence is a degree 
of the pathogenicity observed. Virulence factors are encoded by genes of the pathogen which contribute to the 
pathogenicity. The locations of numerous genes including the virulence factor genes of interest are shown on 
the genetic map (Figure 1.2) of S. aureus MW2, highlighted in blue. 
 
 
Figure 1.2. A map of the 
genome of S. aureus MW2. 
This genome is 282,0462 base 
pairs long. 
 
This map was created by the 
me using GView, an interactive 
Genomic Viewer (Petkau, 
Stuart-Edwards & Van 
Domselaar, 2010). 
 
The location of numerous 
genes including virulence factor 
genes are shown on both the 
positive strand and negative 
strand of the DNA. All of the 
genes shown were not 
investigated in this study 
instead the genes highlighted in 
blue were investigated, along 
with others that are not 
represented on this map. 
 
It is important to mention that 
only chromosomal genes were 
investigated in this study. 
Staphylococcus aureus subsp. 
aureus strain MW2 (2820462 
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1.5 Virulence Factors 
In this study, bioinformatics methods will be employed to investigate the arsenal of virulence 
factors produced by S. aureus and the role they play, including some of those highlighted in Figure 
1.2 will be investigated. The genes needed for methicillin resistance, adhesion factors; needed for 
host attachment, persistence factors; needed for biofilm accumulation and intracellular persistence, 
immune evasions factors; needed for evading/ or destroying host defences that include the innate 
and complement immune systems, enzymes and other secreted proteins; that include a range of 
functions such as tissue invasion and destruction, cytotoxins; that include the lysis of erythrocytes 
and neutrophils and enterotoxins; that involve toxin mediated disease or sepsis such as food 
poisoning, toxic shock syndrome and scalded skin syndrome. 
 
This study only investigated chromosomal virulence factor genes and not plasmid virulence genes. 
A plasmid is a small, circular, double-stranded DNA molecule that is distinct from a cell’s 
chromosomal DNA (Solar et al., 1998). Plasmids have the potential to carry resistance genes and 
virulence genes and are spread through S. aureus populations by horizontal gene transfer (HGT) 
mechanisms (McCarthy & Lindsay., 2012). 
 
1.5.1 Virulence associated genes 
1.5.1.1 mecA gene and Penicillin binding protein 2 (PBP2a) 
 The mecA gene is part of a 21- to 60-kB Staphylococcal Cassette Chromosome (SCC), a 
mobile genetic mobile element which may differ in genetic composition (Ito & Hiramatsu, 1998). mecA 
is 2010 bp long and PBP2a consists of 670 amino acids (Ito & Hiramatsu, 1998). PBP2a substitutes 
for other PBPs because of its reduced binding affinity for β-lactam antibiotics and PBP2a differs from 
other PBPs in that its active site blocks binding of all β-lactam antibiotics but allows the 
transpeptidation reactions to proceed (Lim & Strynadka, 2002). PBP2a permits transpeptidase 
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activity to allow cell wall synthesis at concentrations of β-lactams which would otherwise inhibit 
transpeptidation (Lim & Strynadka, 2002; Rice, 2012). 
 
1.5.2 Adhesion genes 
 Adhesion is the first step in colonisation and the subsequent infection of the host. In order to 
initiate infection, adhesins which are bacterial proteins, adhere to components of the host 
extracellular matrix (ECM). Adherence is mediated by surface protein adhesions called MSCRAMM 
(microbial surface components recognising adhesive matrix molecules) family, which in most cases 
are covalently anchored to the cell wall peptidoglycan (Foster & Hook, 1998).  
 
1.5.2.1 Fibronectin-binding protein 
 Fibronectin binding protein belongs to the MSCRAMMs family of proteins. The majority of S. 
aureus strains express two binding proteins, FnbpA and FnbpB which are encoded by closely linked 
genes termed fnbpA and fnbpB (Wann et al., 2000). These closely linked genes and the proteins 
they encode, facilitate the attachment of S. aureus to human mucosal epithelium (Foster & Hook, 
1998). Studies by Mongodin et al (2002) have shown that FnBPs are involved in the adherence and 
colonisation to the human airway epithelium with further research by Shinji et al (2011) suggesting 
that fibrontectin-binding protein are also important for not only in vitro and in vivo adhesion to cells 
but may also have a secondary role of internalisation by cells. 
 
1.5.2.2 Collagen-binding protein  
 Collagen is targeted by the collagen-binding adhesin which is encoded by the cna gene, this 
adhesin also belongs to the MSCRAMMs family of proteins (Foster & Hook, 1998). cna is not present 
in all strains but where it is present the collagen binding adhesin binds to collagen substrates and 
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collagenous tissue with a high degree of specificity and affinity to humans which is an important step 
in pathogenesis of osteomyelitis and septic arthritis (Patti et al., 1992; Rhem et al., 2000).   
 
1..5.2.3 Elastin-binding protein 
 Elastin is a major component of the ECM and plays a crucial role in maintaining structural 
integrity of tissues which gives it the property of reversible elasticity, it is present in abundance in the 
lung, skin and major blood vessels (Nakakido, Yoshikazu & Tsumoto, 2007). Elastin-binding protein 
which is encoded by the ebpS gene has been shown to bind both soluble elastin and tropoelastin 
and S. aureus can therefore adhere to and colonise the host tissue (Downer et al., 2002).  
 
1.5.2.4 Bone-sialoprotein binding protein 
 Bone-sialoprotein (Bsp) is a glycoprotein of the bone and dentine extracellular matrix (Tung 
et al., 2000). The identification of S. aureus strains that cause osteomyelitis has consequently led to 
the discovery that they interact with bone-sialoprotein (Tung et al., 1989). S. aureus bind to bone-
sialoprotein via a bone-sialiprotein-binding protein (Bbp) which belongs to the Sdr family of proteins 
(Tung et al., 2000; Perrson, Johansson & Ryden, 2009). The Sdr family of proteins, SdrC, SdrD and 
SdrE are a collection of surface proteins with no ligand specificity that recognise adhesive matrix 
molecules and are consequently members of the MSCRAMM family that are encoded respectively 
by the sdrC, sdrD and sdrE genes (Sabat et al., 2006; Vasquez et al., 2011). Bbp, also a member of 
the MSCRAMM family is a 97-kDa protein initially isolated from S. aureus strain 024 and has an A 
and B domain that is 76% and 96% homologous to SdrE domains (Perrson et al., 2009).  
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1.5.2.5 Clumping factor 
 Fibrinogen (Fg) plays a major role in blood clotting, fibrinogenesis, the inflammatory 
response and wound healing, it is a large 340-kDa plasma glycoprotein composed of two sets of 
three polypeptides chains Aɑ, Bβ and γ that are linked by disulphide bonds that are essential for 
maintaining normal homeostasis (Palma et al., 2001; Mosesson, 2005). Clumping factors A and B 
(ClfA and ClfB) belong to the bifunctional MACRAMM family of proteins and bind to different sites on 
fibrinogen; clfA binds to the Ɣ-chain and clfB binds to the α-chain (Wertheim et al., 2008). Interactions 
between the ClfB and the α-chain is also important in platelet activation and aggregation (Xiang et 
al., 2012).  
 
1.5.2.6 Extracellular fibrinogen-binding protein 
 Extracellular fibrinogen-binding protein (Efb) is a 15.8-kDa extracellular protein that has two 
repeated regions and consequently has two binding sites for fibrinogen located at both the N-terminal 
and C-terminal regions that form a divalent interaction with fibrinogen (Fg) resulting in an Efb-Fg 
complex (Palma et al., 2001). Efb is usually produced in large quantities during the post exponential 
phase of bacterial growth and is associated with a more severe infection (Palma et al., 2001). 
However, studies by Shannon et al., (2006) concluded that immunisation with Efb produces a 
protective antibody response to Efb from S. aureus which is important as it resulted in the vaccinated 
animals developing less severe infection then the unvaccinated controls.  
 
1.5.2.7 Extracellular adherence protein 
 Extracellular adherence protein (Eap) is a 72-kDa protein consisting of 689 amino acids, 
which includes a 110-amino-acid sequence that is repeated six times. Within each domain there is a 
subdomain that consists of 31 residues that has high homology to the N-terminal β-chain of many 
major histocompatibility complex (MHC) class II molecule and lacks the LPXTG motif which is 
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essential for membrane anchoring (Harraghy et al., 2003). Eap has the ability to bind to numerous 
plasma proteins including fibronectin, fibrinogen and prothrombin (Haggar et al., 2003). Eap has also 
been shown to play a crucial role in the complex internalisation process of S. aureus into non-
professional phagocytes and can also cause agglutination (Haggar et al., 2003).  
 
1.5.3 Virulence Factors Involved in Persistence  
Once attachment has been established by S. aureus to the host, other factors that cause relapsing 
infections are readily available to adapt different environmental niches of the host. 
 
1.5.3.1 Delta-aminolevulinic acid dehydratase 
 Staphylococcus aureus can be isolated from the chronically infected airways of patients who 
suffer from cystic fibrosis, and such S. aureus isolates are termed small-colony variants (SCV), that 
are characterised by the slow growing morphological variants associated with persistence and 
antibiotic resistant infections (Besier et al., 2007). SCV’s that are isolated from patients with chronic 
or relapsing infections often indicate that they are auxotrophic for compounds, such as hemin that 
are involved in the synthesis of the electron transport chain, suggesting that the SCV phenotype is 
associated with genetic changes that consequently impair electron transport (Sifri et al., 2006). The 
hemB gene is part of the family of genes encoding enzymes of the porphyrin biosynthetic pathway 
and specifically codes for the enzyme porphobilinogen synthase. This enzyme is responsible for the 
conversion of delta-aminoevulinic acid to porphobilinogen of the electron transport system (Kafala & 
Sasarman, 1994). Studies by von Eiff et al (1997) have concluded that a defect in the electron 
transport system allows for S. aureus SCVs to persist intracellularly as well as resist aminoglycoside 
antibiotics. Stable mutants of the electron transport chain were generated by interrupting the hemB 
gene, and in vitro studies showed that the mutant showed typical characteristics of SCVs, which 
included slow growth and persistence within the cultured endothelial cells (von Eiff et al., 1997). 
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Studies by Vaudaux et al. (2002) have also suggested that there is an increased expression of 
clumping factor and fibrontectin-binding protein by hemB mutants. 
 
1.5.3.2 Bacterial efflux pumps 
 Bacterial efflux pumps are responsible for expelling a broad range of substances such as 
toxins and antibiotics out of the cell. An over expression of multi drug efflux pumps have also been 
found to be associated with drug resistance because they lower the intracellular concentration of 
antibiotics, hindering the effect of the antibiotic (Naruni et al., 2002). A multi drug efflux gene, termed 
staphylococcal efflux pump gene (sepA) was investigated in this study, it is 474 bps and encodes the 
drug efflux pump that has four predicted transmembrane segments (Narui et al., 2002). 
 
1.5.4 Immune Evasion genes 
Once persistence has been achieved by S.aureus, the organism has developed methods to 
achieve host immune evasion. 
 
1.5.4.1 Staphylokinase  
 Staphylokinase, is secreted by many S. aureus strains that infect humans (Kwiecinski et al., 
2013). The highly conserved Staphylokinase gene (sak) is carried on a bacteriophage that also 
contains other important genes, such as complementary inhibitory factors and enterotoxins 
(Peetermans et al., 2014). The sak gene is investigated further in the results chapters. Studies have 
suggested that three natural variants of the sak gene have been identified with only 4 nucleotide 
differences found in the coding regions of these variants (Kim et al., 1997). Staphylokinase is 
synthesised as a polypeptide precursor of 163 amino acids which includes a 27 amino acid signal 
peptide in a single polypeptide chain without sulphide bridges and is itself not an enzyme, instead it 
forms a 1:1 stoichiometric complex with plasminogen that in turn activates other plasminogen 
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molecules, promoting fibrinolysis (Kim et al., 1997). Staphylokinase has a dual role; studies have 
suggested that increased production promotes the establishment of S. aureus skin infections and 
increased bacterial penetration through skin barriers whilst surprisingly decreasing the severity of the 
disease (Kwienski et al., 2013). Once penetration has occurred through the skin barriers, 
staphylokinase activates plasminogen molecules to plasmin, which is an enzyme that degrades fibrin, 
a protein component of the extracellular matrix (ECM). This consequently results in the evasion of 
the host tissue with S. aureus (Kwienski et al., 2013). This contributes to the infection by spreading 
the bacterium. 
 
1.5.4.2 Staphylococcal complement inhibitor (SCIN) 
 The complement system is part of the human immune system that has the ability to enhance 
antibodies to phagocytose cells which defend and clear against any invading pathogens, which 
include S. aureus (Rooijakers et al., 2007). S. aureus has developed factors that can evade and 
counteract the hosts complement immune response by secreting a unique Staphylococcal 
Complement Inhibitor (SCIN) which enables it to survive and persist in the host (Jongerius et al., 
2009). The SCIN gene (scn) is an 85 amino acids (aa) residue that is part of the immune evasion 
cluster (IEC-1) along with Chemotaxis Inhibitory Protein (CHIPS) on a bacteriophage that also 
encodes staphylokinase and enterotoxin A (van Wamel et al., 2006; Jongerius et al., 2007).  SCIN, 
an innate immune modulator of S. aureus is a C3 convertase inhibitor of the complement system, on 
the surface of the bacterium that blocks the formation of C3b deposition and C5a generation and 
therefore blocks all downstream effector functions; this in turn reduces or stops phagocytosis by 
human neutrophils following opsonisation and ensures the survival of the pathogen in the host (van 
Wamel et al., 2006; Rooijakers et al., 2007). 
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1.5.4.3 Chemotaxis inhibitory protein (CHIPS) 
 The CHIPS gene (chp) is also located in the immune evasion cluster and is found in in >60% 
of all clinical isolates of S. aureus (de Haas et al., 2004; van Wamel et al., 2006). CHIPS is a 14.1-
kDa protein that is secreted by S. aureus to specifically impair the response of neutrophils and 
monocytes (de Haas et al., 2004). It attenuates the responses of both the C5a receptor as well as 
the formylated peptide receptor of human neutrophils (van Wamel et al., 2006). 
 
1.5.4.4 IgG binding protein 
 Staphylococcus aureus also secretes a 436-residue protein called Staphylococcal 
Immunoglobulin-binding protein (Burman et al., 2008). Sbi (Second binding protein of 
immunoglobulin), has two IgG-binding domains (D1 and D2) at its N-terminus that have a similar 
sequence to Protein A (spa) which was thought to be the only IgG-binding protein in S. aureus (Smith 
et al., 2011). Sbi also has two independently folded domains, D3 and D4 that bind to complement 
factor C3, with the C-terminal domain which is rich in the amino acids tyrosine and threonine, likely 
to be involved in attaching the protein to the cell envelope (Smith et al., 2011). The sbi gene which 
was selected for further studies shows levels of high conservation in both nucleotide and protein 
sequences and the size of the gene can range from 1311 to 1314 nucleotides, it is dependent on the 
human strain isolated (Atkins et al., 2008). Sbi helps the S. aureus to avoid the hosts innate immune 
defence, this ensures the survival of the bacteria in the host (Atkins et al., 2011). 
 
1.5.5 Enzymes and other secreted proteins 
1.5.5.1 Serine Protease (sspA), cysteine protease precursor (sspB), cysteine protease (sspC) 
 Serine protease (ssp) was one of the first secreted enzymes of S. aureus to be purified and 
characterised in detail; it is a member of the glutamyl endopeptidase family of enzymes (Drapeau et 
al., 1972). The serine protease structural gene sspA is followed closely by an open reading frame 
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(ORF) encoding a cysteine protease, designated sspB. The sspA and sspB proteases are transcribed 
as an operon, which also includes a third open reading frame sspC, of unknown function (Rice et al., 
2001). sspA is required for the maturation of sspB, which encodes a 40.6-kDa cysteine protease and 
plays a crucial role in controlling autolytic activity (Rice et al., 2001). A secreted sspA may also 
promote invasion by degrading the bacterial cell surface fibrontectin-binding protein (FnBP), a 
member of the MSCRAMM family (McGavin et al., 1997). sspA, sspB and sspC were selected for 
further investigation in this thesis.  
 
1.5.5.2 Aureolysin  
 The complement system is part of the innate immune system and is the first defence against 
bacteria, once activated it attracts neutrophils to the site of infections and opsonises bacteria to 
facilitate phagocytosis (Laarman et al., 2011). S. aureus has successfully developed ways to evade 
the human complement system; Metalloprotease aureolysin is a potent complement inhibitor, it 
functions by inhibiting the central complement protein C3 by cleaving it, preventing phagocytosis of 
the bacteria, contributing to the S. aureus survival in the host (Laarman et al., 2011). 
 
1.5.5.3 Hyaluronate lyase 
 Hyaluronate lyase is an extracellular enzyme produced by approximately 91.2% of S. aureus 
strains (Makris et al., 2004). The genes that encode this enzyme are hysA. HysA1 and hysA2 and 
were subsequently further investigated in this thesis. Studies suggest that it is capable of degrading 
acidic mucopolysaccharide hyaluronic acid, a major component of the human and animal connective 
tissue and has a crucial role in the early stages of subcutaneous infections (Makris et al., 2004). 
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1.5.5.4 Staphylococcal Coagulase (Coa) 
 The gene that encodes coagulase is coa (Shopsin et al., 2000). Coagulase (Coa) is a protein 
of approximately 670 amino acids secreted by S. aureus that promotes coagulation by activating 
prothrombin, which in turn, converts fibrinogen into fibrin and promotes the clotting of plasma or blood 
(McAdow et al., 2012). The N-terminal end of Coa associates with the pro site of prothrombin that 
completes an active site that is otherwise only formed in thrombin (McAdow et al., 2012). This gene 
was further investigated in this thesis.  
 
1.5.5.5 von Willebrand factor binding protein (vWbp) 
 Staphylococcus aureus also secretes a secondary coagulase exoenzyme called von 
Willebrand factor-binding protein (vWbp) of approximately 482 amino acids that has an N-terminal 
homologous to coagulase (Bjerketorp et al., 2004). The gene that encodes von Willebrand binding-
protein is vwb (Bjerktorp et al., 2002). The N-terminal end of vWbp associates with the pro site of 
prothrombin that completes an active site that is otherwise only formed in thrombin (McAdow et al., 
2012). 
 
1.5.5.6 Lipase 
 Nine different lipase genes have been identified from six Staphylococcus species which 
secrete lipase exoenzymes that degrade or digest lipids (Rosenstein & Gotz, 2000). One of the 
lipases is encoded by the geh gene (Rosenstein & Gotz, 2000). The lipase is secreted as a 82-kDa 
pro lipase protein that comprises of 295 amino acids with full enzymatic activity that is subsequently 
processed into a mature 45- to 46-kDa protein (Rollof & Normak, 1992). When the body is fighting a 
bacterial infection, the number of granulocytes and specifically neutrophils in the body will increase 
(Molne et al., 2000). Staphylococcal lipase will in turn interact with human granulocytes and cause 
aggregation (Rollof et al., 1992). Studies involving anti-lipase serum have hypothesised that lipase 
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may also have a secondary role in the process of biofilm formation in S. aureus (Xiong et al., 2009). 
More recent studies have strengthened this hypothesis; Hu et al (2012) concluded that the deletion 
of the lipase coding gene reduced biofilm formation.  
 
1.5.5.7 Staphylococcal nuclease 
 Staphylococcus aureus produces an exoenzyme called Staphylococcal nuclease that can 
hydrolyse both DNA and RNA in the host resulting in tissue destruction and promotes the further 
spreading of the disease (Hu et al., 2013). Staphylococcal nuclease is encoded by the nuc gene 
(Tang et al., 2008), this gene was further investigated in this thesis. Nucleases can be characterised 
as either sugar specific nucleases which include ribonuclease and deoxyribonuclease, or the sugar 
non-specific nucleases which includes the Staphylococcal nuclease, which is characterised by its 
ability to hydrolyse both DNA and RNA, without exhibiting base preference (Ragarajan & Shankar, 
2001). Staphylococcal nuclease functions by hydrolysing the phosphodiester bonds on the DNA or 
RNA to yield 3’mono-nucleotides (Tang et al., 2008). 
 
1.5.5.8 Thermonuclease  
 The second nuclease of S. aureus is called thermo-nuclease, and it was annotated on the 
whole genome sequencing data of methicillin-resistant S. aureus, as N315 and Mu50 (Kuroda et al., 
2001). More recently, it has been made clear that thermo-nuclease (TNase) is encoded by the nucA 
gene (Tang et al., 2008). It is a heat-stable nuclease with both endo- and exo-nucleoytic properties 
that can hydrolyse both DNA and RNA and has been used as a specific PCR diagnostic test to 
identify S. aureus contamination in blood cultures (Kaplan, 2003). 
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1.5.5.9 1-phosphatidylinositol phosphodiesterase (plc) 
S. aureus produces an exoenzyme called 1-phosphatidylinositol phosphodiesterase (plc) 
which was further investigated in this thesis, that was part of the group of molecules identified in CA-
MRSA culture media that may be involved in bacteria-host interaction and also act as a membrane 
damaging phospholipase, however it is not well characterised (Burlak et al., 2007; Suzuki et al., 
2012). However, the phosphatidylinositol-specific phospholipase C (PI-PLC-) of Listeria 
monocytogenes promotes adhesion to epithelial cells and mediates the escape of pathogens from 
phagosomes which in turn allows it to proliferate and grow in the host cells cytosol and consequently 
spread to neighbouring cells (Wei et al., 2005). Studies have also shown that plc in Bacillus substilis 
strains plays an accessory role that enhances bacterial binding to epithelial cells prior to its 
internalisation (Krawczyk-Balska & Bielecki, 2005). 
 
1.5.6 Cytotoxins  
1.5.6.1 Alpha Hemolysin 
 Staphylococcus aureus secretes a pore-forming cytotoxin called alpha-hemolysin (Bhakdi & 
Tranum-Jenson, 2009). It is pore forming because it has the ability to form a 2-nm heptameric pore 
in the plasma membrane of susceptible cells (Ragle & Waldenburg, 2009). The alpha, beta and delta 
toxins are also the primary cause of erythrocyte lysis that induce the release of cytokines and 
chemokines such as IL-6, IL1β, IL-1α, IL-8, TNF-α, KC and MIP-2 (Burnside et al., 2010). The first 
26 residues of the secreted alpha-hemolysin protein is cleaved under secretion and the mature 
protein comprises of 239 residues, that have a molecular weight of 33-kDa (Dinges, Orwin & 
Schlievert, 2000). The alpha-hemolysin also has no cysteine amino acids and is instead 
compromised of primarily β-sheets (65%), with α-helical structures making up a much smaller 
percentage (10%) of the secondary structure (Dinges, Orwin & Schlievert, 2000). The alpha-
hemolysin is encoded by the hla gene and is important for S. aureus pneumonia (Burnside et al., 
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2010). Studies have also concluded that immunisation with anti-alpha-hemolysin monoclonal 
antibodies mediate protection against S. aureus pneumonia (Ragle & Waldenburg, 2009). 
 
1.5.6.2 Beta Hemolysin 
Beta-hemolysin (HLB) is well known for its haemolytic activity of erythrocytes (Katayama et 
al., 2012). This gene was selected for further study in this thesis. HLB is an exotoxin with a molecular 
weight of 35-kDa that is encoded by the beta-hemolysin gene, termed hlb, that is chromosomaly 
located on a 4-kb DNA fragment (Dinges, Orwin & Schlievert, 2000). Recent studies have also 
suggested that HLB may have a dual role and that it also plays an important role in skin colonisation; 
the study constructed two S. aureus MW2 strains in vitro, both with and without the hlb gene. 
Colonisation tests concluded that colonisation efficiency was 50-fold greater with the hlb gene than 
without the hlb gene (Katayama et al., 2012). 
 
1.5.6.3 Gamma Hemolysin and Panton-Valentine Leuckocidin  
 Staphylococcus aureus also produces two other cytotoxins called gamma-hemolysin and 
Panton-Valentine leuckocidin (PVL) toxin; both function as bi-component toxins and play a crucial 
role in the disruption and subsequent lysis of erythrocytes and leukocytes (Gouaux, Hobaugh & 
Song, 1997; Dinges, Orwin & Schlivert, 2000). Each of these toxins are made up of two non-
associated secreted proteins, referred to as S and F components (for slow- and fast-eluting proteins 
in an ion exchange column) (Dinges, Orwin & Schlievert, 2000). Gamma-hemolysin is present in 
virtually all human strains (99.3%) whilst the PV leuckocidin is not as widely distributed (Spaan et al., 
2014). The genes for gamma-hemolysin are transcribed from a single locus, located on a 5.4-kb 
ScaI-digested chromosomal fragment; the open reading frames are named hlgA, hlgC and hlgB 
(Table 3.5) (Dinges, Orwin & Schlievert, 2000). hlgC and hlgB have molecular weights of 34-kDa and 
32.5-kDa, respectively, and are transcribed on a single mRNA, whilst hlgA has a molecular weight of 
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32-kDa, and is expressed separately (Dinges, Orwin & Schlievert, 2000). The genes encoding PV-
Leukocidin are named lukS-PV and lukF-PV, are expressed as an operon and the lukS-PV gene 
encodes a 312-amino acid polypeptide, including a 28 residue signal sequence that is cleaved to 
produce the mature protein with a molecular weight of 32-kDa (Dinges, Orwin & Schlievert, 2000). 
The lukS gene encodes the S-component of Staphylococcal leukocidin and contains 857 bp 
(Rahman et al., 1991).  
 
1.5.7 Enterotoxins  
1.5.7.1 Staphylococcal Enterotoxins 
 Staphylococcal Enterotoxins are a family of nine major serological types of heat stable 
enterotoxins, SEA through SEE and SEG through to SEJ, that cause sporadic food-poisoning 
outbreaks in both the hospital and community environment (Balaban & Rasooly, 2000; Ortego et al., 
2010). Staphylococcal food poisoning is characterised by a short incubation period, approximately 
2- 6 hours and is followed by symptom's such as nausea, vomiting, abdominal pain and diarrhoea, 
although not lethal, the elderly are more susceptible to morbidity and mortality (Balaban & Rasooly, 
2000).  
 
 The enterotoxins are bi-functional; they act as potent gastrointestinal toxins and also as 
super antigens that stimulate non-specific T cell proliferation; both functions are located in two 
separate domains that target different host tissues (Balaban & Rasooly, 2000; Ortego et al., 2010). 
However, the mechanisms are not very well understood (Rasooly & Hernlem, 2014). The 
enterotoxins all share common phylogenetic, structure, function and sequence homology (Rasooly 
& Hemlem, 2014). Enterotoxin A (SEA) is, however, the most common toxin implicated in 
staphylococcal food poisoning (Rasooly & Hemlem, 2014). SEA is carried by the entA gene on a 
bacteriophage and is composed of 771 base pairs, it also encodes a enterotoxin A precursor of 257 
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amino acids (Balaban & Rasooly, 2000). Studies have suggested that the amount of enterotoxin 
needed to cause food poisoning is very small, the emetic dose in primate assays was approximately 
5-20 µg per animal (Balaban & Rasooly, 2000). 
 
1.5.7.2 Toxic shock syndrome toxin-1 (TSST-1) 
 Approximately 20% of all S. aureus isolates also possess the gene encoding TSST-1 (tst) 
(Table 3.5), which is harboured by a family of mobile staphylococcus pathogenicity islands 
designated SaPI, that is not carried by all S. aureus strains (Al Laham et al., 2014). It is carried by S. 
aureus strains RN4282, N315, Mu50, RN3984 and RF122 in mobile pathogenicity islands termed 
SaPI1, SaPIn1, SaPIm1, SaPI2 and SaPIbov1, respectively (Andrey et al., 2015). TSST-1 is a potent 
super antigen and is the most common cause of toxic shock syndrome (tss), it is a life threatening 
multi system disorder characterised by a high fever, hypotension, rash and skin desquamation 
(peeling) upon recovery (Prasad et al., 1997). 
 
1.6 Clinical Significance & Epidemiology 
 It is evident that methicillin resistant S. aureus infections pose a significant health burden 
around the globe. Figures 1.3 and 1.4 are heat maps taken from the annual report of the European 
Antimicrobial Resistance Surveillance Network (EARS-Net). Figures 1.3 and 1.4 show that the 
incidence of MRSA is changing around Europe. An improvement has been observed in the UK; in 
2009, 28% of the S. aureus isolates were resistant to methicillin, in 2014, only 11% of the 3551 
isolates were resistant to methicillin (ECDC-1, 2010; ECDC-2, 2015). A slight decrease in the number 
of MRSA reported has also been observed in Spain where the number of S. aureus isolates resistant 
to methicillin decreased from 26% to 22% from 2009 to 2014. Other countries have remained 
consistently high. Portugal reported that in 2009, 53% of the isolates were methicillin resistant; in 
2014, 47% of the S. aureus isolates were methicillin resistant (ECDC-1, 2010; ECDC-2, 2015). 
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It is also interesting to note that the surveillance of S. aureus has also improved. Slovakia 
did not report at all in 2009; however, in 2014, 28% of the 640 S. aureus isolates reported were 
MRSA. Romania reported only 48 S. aureus isolates in 2009 of which 38% were MRSA. This 
increased to 399, in 2014 of which 54% were methicillin resistant. The number of laboratories 
contributing to the EARS-Net surveillance has also been increasing. Portugal had 20 laboratories in 
2009, this increased to 53 in 2014. The same trend is shown in Italy, where the number of laboratories 
doubled from 23 in 2009 to 46 in 2014 (ECDC-1, 2010; ECDC-2, 2015). In contrast, countries like 
Sweden and The Netherlands have remained consistently low. In 2009, The Netherlands reported 
1035 isolates of S. aureus, of which <1% were resistant to methicillin. The same trend continued in 
2014 even though the number of S. aureus isolates reported was 2580. The same trend was 
observed in Sweden; in 2009 and 2014, 2460 and 3501 isolates of S. aureus were reported. 
Nevertheless, the number of samples resistant to methicillin was <1% (ECDC, 2010 & 2015).		
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Figure 1.3: taken from the Annual report of the European Antimicrobial Resistance Surveillance 
Network (EARS-Net); showing the percentage (%) of S. aureus isolates with resistance to 
methicillin (MRSA), by countries in 2009 (ECDC-1, 2010). 
	
Figure 1.4: taken from the Annual report of the European Antimicrobial Resistance Surveillance 
Network (EARS-Net); showing the percentage (%) of S. aureus isolates with resistance to 
methicillin (MRSA), by countries in 2014 (ECDC-2, 2015). 
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 The Office of National Statistics in England and Wales has also published the number of 
reported deaths caused by S. aureus. Figure 1.5 is a graph showing the number of death certificates 
mentioning MRSA between 1993 and 2012. The number of deaths from MRSA between 1993 and 
2006 has risen from 430 in 1993, peaking in 2005 (2,099) and 2006 (2,150) and gradually decreasing 
to 557 in 2012 (ONS-1, 2013); this is nevertheless a cause for concern. The graph is also showing 
the number of death certificates mentioning S. aureus that are either not specified as resistant or 
strains that are resistant to antibiotics (MRSA). Interestingly, between 1993 – 2000 the majority of 
death certificates mentioning S. aureus were not specified as resistant, this could be due to the lack 
of testing for antibiotic resistance. It is not a surprise that the majority of strains that cause deaths 
between 2000 – 2009 are resistant (MRSA), with 2010 being the anomaly to this trend. 
 
 
 
 
Figure 1.5: A graph representing the number of death certificates mentioning S. aureus: by Methicillin 
Resistant Staphylococcus aureus (MRSA) in England & Wales. The data was adapted from the Office 
for National Statistics (ONS, 2013). 
 Figure 1.6 is a graph representing the number of death certificates mentioning MRSA by sex 
and age group from 2008 to 2012 (ONS-1, 2013). It is interesting to note that males are more 
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susceptible to MRSA then females in all age groups. The Office for National Statistics has also 
concluded that the morbidity rate due to MRSA is greater in the elderly (ONS-1, 2011). This is the 
trend that can be seen here with males 75 and over far more likely to have death certificates 
mentioning MRSA. 
 
 
 
Figure 1.6:  Age specific mortality rates for deaths mentioning MRSA by sex and age group between 
2008 and 2012, in England and Wales; rates per million population. The data was adapted from the 
Office for National Statistics (ONS, 2013). 
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gradually reduced from 4,451 (between April 2008 – March 2009) to 1,898 (April 2009 – March 2010) 
to a decreased rate of 823 (between April 2015 – March 2016) (HPA-1, 2011). 
 
 
 
Figure 1.7: A graph representing the annual MRSA counts from April 2007 to March 2016. The data 
was adapted from the Health Protection Agency which is now a part of the Public Health England 
(HPA-1, 2016). 
	
 
1.7 Symptoms and Clinical Presentation 
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Skin and Soft Tissue Infections (SSTI). Among the SSTI cases the three most common diagnoses 
were cellulitis (62%), carbuncle (17%) and impetigo (12%) (Casey et al., 2013). Infections with this 
organism are not just restricted to humans; the bacteria have the ability to invade and cause harm to 
a diverse range of animal species which include commercially important species such as cattle, 
sheep, swine and poultry, as well as companion animals and horses. S. aureus can cause an 
assortment of clinical symptoms and diseases ranging from superficial to potential life threatening 
illnesses, as can be seen in Table 1.1. 
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Table 1.1: Clinical symptoms and diseases associated with S. aureus in different hosts. 
 
 
 
Host Clinical symptoms/ diseases associated with S. 
aureus infections 
References 
Human • Blood stream infections 
 
• Toxic shock syndrome 
 
• Scalded skin syndrome 
 
• Impetigo  
 
• Folliculitis  
 
• Cellulitis  
Amaral et al., 2005 
 
DeVries et al., 2011 
 
Shi et al., 2011 
 
Pereira, 2012 
 
Nichols & Florman, 2001 
 
Khawcharoenporn et al., 2010 
Horses • Wound infection, infected joints and suspected 
infections of various organ systems 
 
• Septic arthritis/ Pneumonia 
Cuny et al., 2006 
 
 
Weese et al., 2006 
Cattle • Mastitis  
• Purulent dermatitis  
Haran et al., 2012 
Grinberg et al., 2004 
Sheep • Mastitis  
• Pyemia 
Chu et al., 2012 
Companion 
animals  
• Skin and soft tissue infections 
• Pleuropneumonia 
Pantosti, 2012 
Baptiste et al., 2005 
Swine • Exudative epidermitis  
• Infections of the urogenital tract, uterus & 
mammary glands. 
• Septicaemia  
van Duijkeren et al., 2007 
 
Crombe et al., 2013 
Rabbit • Mastitis 
• Gangrene mastitis  
• Dermal lesions 
• Subcutaneous abscess 
Hamed & Ahmed, 2013 
 
Vautor et al., 2009 
 
Poultry • Bacterial chondronecrosis with osteomyelitis 
(BCO) 
• Septicaemia 
McNamee et al., 2010 
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1.7.1 Cellulitis 
 Cellulitis is one of the most common out-patient infections presented to physicians 
(Khawcharoenporn et al., 2010).  It is an acute infection of the skin and underlying soft tissue and is 
usually present amongst the elderly or immunocompromised (Nichols & Florman, 2001). It presents 
as tender red but firm areas of the skin and has the potential to lead to necrotizing fasciitis and 
gangrene (Nichols & Florman, 2001). 
 
1.7.2 Impetigo 
 Impetigo is the most common bacterial infection of the skin caused by S. aureus. There are 
two types of impetigo; bullous impetigo and non-bullous impetigo (Pereira, 2012). Non-bullous 
impetigo represents 70% of all cases of impetigo and is recognised by the development of a serous, 
yellow-brown exudate which dries into a golden crust (Nichols & Florman, 2001). Non-bullous 
impetigo generally occurs in adults and children, although rarely in children under 2 years of age 
(Pireira, 2012). Bullous impetigo is caused by exfolitave toxin A and is most common among children 
aged two to five years (Pereira, 2012). 
 
1.7.3 Folliculitis  
 Folliculitis is a pyoderma that arises within a hair follicle and usually occur in the moist areas 
of the body that undergo friction and perspiration (Nichols & Florman, 2001). The incidence of 
folliculitis is higher among patients who receive treatment with corticosteroids or cytotoxic agents 
(Nichols & Florman, 2001). 
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1.7.4 Toxic Shock Syndrome  
In addition to this, S. aureus also has the ability to cause toxinoses such as scalded skin 
syndrome and toxic shock syndrome by releasing super antigens into the blood stream (Sousa & 
Lencastre, 2004). 
 Methicillin resistant S. aureus can excrete toxins that can potentially cause toxic shock 
syndrome (TSS), a rare life threatening illness that is defined by clinical and laboratory evidence of 
fever, rash, skin desquamation, hypotension and multiple organ failure (Prasad et al., 1997). A 
population based surveillance study conducted from 2000 – 2006 in the Minneapolis – St. Paul area 
(population 2,642,056), has concluded that the average annual incidence of toxic shock syndrome is 
0.52 per 100,000 of the population, the rate was slightly higher in menstrual TSS (0.69) with women 
aged 13 – 24 years having the highest incidence at 1.41 (DeVries et al., 2011). 
 
1.7.5 Scalded Skin Syndrome  
 Staphylococcal Scalded skin syndrome (SSSS) is caused by MRSA that produce exfoliative 
toxins. It is a life threatening infection for neonates in neonatal units and can develop in extremely 
low-birth-weight neonates (Shi et al., 2011). It usually affects infants and children, but has also been 
reported in adults associated with immunosuppression and/or renal failure resulting in a high mortality 
rate (Ito et al., 2002). A retrospective study conducted on 399 children under the age of 1-year old 
(177 girls/ 222 boys) hospitalised in the Czech Republic from 1994 – 2009 concluded that the average 
incidence of SSSS was 25.11 cases per 100,000 with 1994 resulting in the highest incidence of 53.47 
per 100,000 children. (Lipovy et al., 2011). 
 
S. aureus can also cause urinary tract infections (UTIs), difficult to treat infections of the 
blood, cardiovascular infections and in severe life threatening cases, it can cause; osteomyelitis, 
meningitis, brain abscess and endocarditis (Amaral et al., 2005; Klein et al., 2007; Sheng-Yun et al., 
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2011). This bacterium is also a major cause of food poisoning; it achieves this by releasing 
enterotoxins, specifically Enterotoxin C, into the food (Aydin et al., 2011). Recently developed 
economic simulation models to help quantify the costs associated with MRSA infection and the 
outcomes are alarming (Lee et al., 2013). In the USA, depending on the MRSA incidence, this 
bacterium alone can cause an annual economic burden of $478 million – $2.2 billion on third-party 
payers and $1.4 billion – $13.8 billion on society (Lee et al., 2013). This clearly demonstrates the 
importance of S. aureus as a pathogen 
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1.8 MRSA Evolution 
1.8.1 Hospital-associated MRSA 
 It was once recognised that MRSA only occurred in health-care settings such as inpatient 
hospital admission, haemodialysis units or same-day surgery, and was therefore defined as a health 
care-associated infection (HAI), with patients who were generally older and immunocompromised 
being most at risk (Sydnor & Perl, 2011). MRSA found in the health-care setting were therefore 
termed health-care associated MRSA/ hospital-associated MRSA (HA-MRSA) (Fey et al., 2003). 
HAIs can have a devastating impact in the hospital environment by increasing morbidity, mortality, 
length of stay and dramatically increasing the cost (Sydnor & Perl, 2011). The US Centre for Disease 
Control and prevention (CDC) have provided definitions of HA-MRSA and Community-associated 
(CA) -MRSA. “HA-MRSA is identified >48h after admission of a healthcare facility, or if an individual 
has previously had a history of MRSA infection or colonisation, admission to a healthcare facility, 
dialysis, surgery or insertion or indwelling devices in the past year” (Bal et al., 2016). 
 
 
1.8.2 Community-associated MRSA 
It is now recognised that MRSA is not just restricted to the health-care setting. A shift in 
MRSA epidemiology occurred when cases of MRSA started appearing in the community in the 1990’s 
and affected persons with no healthcare-related predisposing factors and were termed community-
associated MRSA (CA-MRSA) (Frazee et al., 2005). Initial reports of a new type of MRSA causing 
infections amongst healthy individuals was reported in the remote Aboriginal communities of Western 
Australia (Deurenberg & Stobberingh, 2008). Now, CA-MRSA have become increasingly endemic in 
many communities and are responsible for a large proportion of the disease burden and certain 
strains have the potential to cause fatal infections in otherwise healthy individuals (Baba et al., 2002). 
CA-MRSA is now the most common cause of skin and soft tissue infections (SSTIs) presenting in 
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the American hospital emergency rooms (Chen et al., 2011). In the 1990s, cases started occurring 
among children who had none of the common identifiable predisposing risk factors (Herold et al., 
1998). In one particular instance, between 1997 – 1999 four healthy children from a relatively small 
region in the USA died of clonally related MRSA strains (CDC, 1999). In these cases, the patients 
were initially treated with cephalosporin antibiotics. The delayed use of the correct antibiotic to which 
MRSA is susceptible may have contributed to the fatal outcomes, as a result of this and so that the 
correct therapies could be administrated, patients are now routinely screened for MRSA cultures 
upon admission in America (CDC, 1999; Manian et al., 2012). The CDC defines CA-MRSA as “being 
identified in the outpatient setting or within 48h following hospital admission in an individual with no 
medical history or MRSA infection or colonisation, admission to a healthcare facility, dialysis, surgery 
or insertion of indwelling devices in the past year” (Bal et al., 2016). 
 An example of a CA-MRSA isolate is USA300. A cohort study by Kreisel et al. (2011), carried 
out between 1997 to 2008 in four hospitals in the USA compared sepsis in response to infection in 
271 patients. Kreisel et al. (2011) concluded that 25% (67 strains of USA300 MRS) of the patients 
with MRSA bacteraemia were USA300 MRSA and 75% (204 strains non-USA300 MRSA) were non-
USA300 MRSA. USA300 MRSA were categorised because they possessed two unique virulence 
factors in the genome; the genes for PVL and the arginin catabolic mobibile element (ACME) (Kreisel 
et al. (2011)).  USA300 MRSA increased over time and patients with USA300 MRSA were more likely 
to have severe sepsis or septic shock in response to their infection than patients with non-USA300 
MRSA (Kreisel et al., 2011). The patients with USA300 MRSA bacteraemia were younger then 
patients with non-USA300 MRSA bacteraemia and were considered less likely to be hospitalised, 
had surgery or to acquired their infection nosocomially (Kreisel et al., 2011). This study shows 
evidence that the community-associated USA300 MRSA strains may be more virulent than other 
strains of MRSA. A study by Diep et al (2006), showed that the major differences between HA-MRSA 
and CA-MRSA are that HA-MRSA strains harbour the SCCmec type II element, whereas CA-MRSA 
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strains harbour the SCCmec type IV element. Certain strains of CA-MRSA also harbour genes for 
the Panton-Valentine Leukocidin (PVL), a bi-component cytolytic toxin (1.5.6.3). It is also noted that 
PVL is not essential for CA-MRSA infection but may be partly responsible for the increased virulence 
(Diep et al., 2006; Boyle-Vavra & Daum, 2007). This observation has led to a change in that the 
presence of PVL is no longer an indicator of a strain that is Community-acquired.  
 
 
1.8.3 Livestock-associated MRSA 
Initial reports of MRSA in farm food-producing animals were published in 1972; the bacteria 
were isolated at a low prevalence, from dairy cows with mastitis in Belgium, and sporadic cases were 
occasionally reported (Weese, 2010). It was not until 2004 that significant concerns about MRSA and 
food animals emerged (Weese, 2010). Reports of MRSA in livestock, and particularly in pigs and 
individuals who work with pigs emerged in The Netherlands (Arman-Lefevre et al., 2005). This 
particular MRSA clone was not related to the historic HA-MRSA or even the CA-MRSA clones due 
to the presence of a novel DNA methylation enzyme that was not typeable by PFGE (pulse gel field 
electrophoresis), the gold standard for typing S. aureus strains; further typing concluded that this 
clone was ST398 (Sequence Type 398) (Deurenberg & Stobberingh, 2008). 
A novel MRSA reservoir had therefore been identified, with reports of MRSA isolation from 
pigs and pig-farmers (Arman-Lefevre et al., 2005). This has provided evidence of a live-stock 
associated reservoir and live-stock associated MRSA (LA-MRSA) are mainly associated with clonal 
complex (CC) 398; although CC398 does not have host specificity and can colonise or infect a variety 
or animals (Cuny et al., 2013).  However, because ST398 strains have been predominantly reported 
in pigs around the globe, it has been suggested that this strain emerged among pigs and was 
subsequently disseminated to other species (Weese, 2010).  These animals were food-producing 
animals and were given heavy loads of antimicrobial agents and were therefore likely to be highly 
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colonised with resistant bacteria due to antimicrobial selective pressure; consequently, the farmers 
are at a particular risk of infection due to their close contact with these animals (Arman-Lefevre et 
al., 2005). These clones have now been categorised as live-stock associated MRSA (LA-MRSA) and 
are predominately found in the Netherlands, Denmark, Belgium and surrounding countries but are 
rapidly disseminating around the world (Lindsay, 2010). 
 
The US Centre for Disease Control and prevention (CDC) have provided definitions of HA-MRSA 
and  CA-MRSA. The CDC defines CA-MRSA is identified in the outpatient setting or within 48h 
following hospital admission in an individual with no medical history or MRSA infection or 
colonisation, admission to a healthcare facility, dialysis, surgery or insertion of indwelling devices in 
the past year. 
 
1.9 Next Generation Sequencing  
 In 1977, Frederick Sanger and his colleagues announced a new method for DNA sequencing 
which was later commonly called ‘Sanger Sequencing” (Sanger, Nicklen & Couslen, 1977). This 
method was very labour intensive and expensive but nevertheless revolutionised the field of 
molecular biology. Over the years, DNA sequencing has been optimised to make it considerably 
cheaper and more efficient. The first whole genome to be sequenced was of the bacterium 
Haemophilus influenzae; the complete nucleotide sequence consisted of 1,830,137 base pairs 
(Fleischmann et al., 1995). Since then, hundreds of microorganisms have been sequenced and can 
be publicly accessed using GenBank which was set up by the National Centre for Biotechnology and 
Information (NCBI) (Bansal, 2005).  The revolution in DNA sequencing began 10 years later in 2005 
with 454 Life Science, which was the first of the 2nd- generation techniques of DNA sequencing 
(Rothberg & Laemon, 2008). The dawn of this technology allowed DNA sequencing to be carried out 
in a fraction of the time and at a reduced cost (Rothberg & Laemon, 2008). Over the same time 
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period, competing companies; Illumina and Applied Biosystems have developed their own sequence 
platform and technologies; the Genome Analyser and SOLiD system, respectively Rothberg & 
Laemon, 2008). 
In this study, the DNA sequencing will be undertaken using the Life Technologies Ion Torrent 
platform. This 3rd-generation technology is cost effective, not labour intensive and is comparatively 
rapid (Daum et al., 2012). Ion Torrent technology uses a semiconductor platform that utilises a small 
chip to measure the release of hydrogen ions emitted during DNA polymerisation (Daum et al., 2012). 
 
1.10 Bioinformatics and its use in the study of S. aureus 
Bioinformatics was developed in the 1980s. In the past, scientists would study one gene at 
a time. This was due to the limitation of computer technology; however, since the rapid evolution in 
computer technology and the ever increasing improvement of memory storage capabilities; it has 
been possible to store the extremely large information data sets of the organism’s whole genome 
(Bansal, 2005). The advancement of internet has also allowed researchers to upload the complete 
sequence to open access databases (Bansal, 2005). The advantages of bioinformatics are that it has 
and will continue to provide invaluable information; for instance, improve laboratory diagnosis for 
infectious (and non-infectious) disease markers, help improve/ develop new drugs, help the 
production of cheaper yet effective vaccines, and help understand the mechanisms of virulent genes 
and how they preform at a cellular, molecular and systemic level (Bansal, 2005). One such area of 
bioinformatics, which is used in this thesis is the use of Basic Local Alignment Search Tool Nucleotide 
(BLASTn) which permits a queried sequence to be compared with known sequences whether it is 
from the same species or from a completely different genus (Altschul et al., 1990; Altschul et al., 
1997; Wren & Parkhill, 2011). As previously described in Section 1.3.6, effective treatment options 
for drug resistant S. aureus are becoming less available. A computational analysis by Yadav et al 
(2012), has led to the identification of novel potential therapeutic drug. All the gene products involved 
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in metabolic pathways of community-associated MRSA in the KEGG database were searched 
against the human genome; and using the BLAST program seven targets were identified as potential 
therapeutic drug targets (Yadav et al., 2012). The KEGG database consists of of metabolic pathway 
maps for cellular and organism functions, complete genomes and the drug interactions associated 
with it (Kanehisa, 2002). These gene products have the potential to be future targets of any drugs 
that may be developed to combat S. aureus infections. 
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1.11 Aims and objectives 
  
• This thesis will evaluate the the three classifications that have been defined in the literature 
(hospital-associated, community-associated and livestock-associated) for S. aureus by 
performing a comparative genomic analysis of the genomes of published and novel strains. 
 
• Investigate the presence/ absence of virulence factor genes that are expressed on the 
genomes of these S. aureus strains and infer how this may contribute to the virulence of the 
strains. 
 
• Investigate and attempt to establish a phylogenetic relationship between the S. aureus 
strains isolated from hospital-associated, community-associated and livestock-associated 
settings. 
 
• Investigate the importance of positive selection in the evolution of the S. aureus species, by 
identifying the virulence factor genes that are showing this characteristic and determine how 
positive selection of virulence factor genes may affect the adaptation to the hosts. 
 
• Investigate the geographical relationship of the S. aureus strains and determine the 
subsequent genetic diversity of the population. 
 
  
 
 
 
 
 
 
 
2.0 Materials and Methods 
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2.1 Bacterial Strains 
 Isolates of Staphylococcus aureus from human and animal hosts were investigated in this study. 
Strains from various host species were kindly provided by Dr Patrick Butaye (Veterinary & Agrochemical 
Research Centre, Brussels, Belgium). These included: human (pig farmers, n=4), pig (surveillance study, 
n=5), cattle (mastitis, n=3), horse (various infections, n=3), chicken (surveillance study, n=4) and rat 
(surveillance study, n=3), and were collected   in Belgium between 2008 and 2010. Isolates from human 
patients were kindly provided by Professor Valerie Edward-Jones (Manchester Metropolitan University, UK). 
The isolates included: outpatients (n=10), inpatients (n=10) and burns patients (n=10). The School of 
Healthcare Science, Manchester Metropolitan University specialises in infectious disease, antimicrobial 
resistance and alternative antimicrobial therapies. The Veterinary & Agrochemical Research Centre 
specialises in research that contributes to international public healthcare policy focusing on food production 
and animal health.  
 
 From this diverse range of isolates available for use (n=52), a mixed sample set of human and animal 
S. aureus strains (n=6) were used for further studies (Table 2.1), and the remaining samples (n=46) were 
frozen (-80° C) in vials. The strains that were used, included animal S. aureus strains B53, S62 and AS3, 
from cattle, chicken and swine, respectively and were all designated livestock-associated strains by The 
Veterinary & Agrochemical Research Centre. As well as human S. aureus strains, OP100, B51 and IP70 
from an outpatient, inpatient and burns patient, respectively, that have all been designated as hospital-
associated strains by the Manchester Metropolitan collaborators. 
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2.2 Storage of Isolates  
 The human Isolates from Manchester Metropolitan University were transported to Kingston 
University February 2015 on swabs in transport medium and in a temperature controlled box with ice. Upon 
arrival, all of the S. aureus isolates (n=30) were transferred to Brain-Heart Infusion agar (BHI agar) to 
generate overnight mass cultures. These cultures were then streaked on BHI agar to produce single colonies. 
All isolates were then transferred to 1 mL aliquots of Brain-heart infusion broth, containing 15% glycerol and 
frozen at -80° C, for long term storage. The Belgium cultures (S. aureus B53, S62 & AS3) were also sent to 
Kingston University on swab cultures and streaked on BHI agar. 
 
2.3 Resuscitation of Isolates prior to use 
 To generate an overnight culture, isolates were removed from the -80°C storage and using aseptic 
technique; a swab was taken on the inside of the tube and swabbed onto the BHI agar. Plates were then 
incubated for 14 - 16 hours at 37° C producing a mass culture. The isolate was then aseptically inoculated 
onto to Brain-Heart Infusion agar or inoculated in Brain-Heart Infusion Broth and was incubated for a further 
14 - 16 hours at 37° C. 
Isolate Isolated 
from: 
Institution  Kingston University date 
of arrival 
OP100 Out patient  
Manchester Metropolitan University, UK 
 
12th February 2015 B51 Burns patient 
IP70 In patient 
B53 Cattle Veterinary & Agrochemical Research 
Centre, Belgium 
 
2012 S62 Chicken 
AS3 Swine 
Table 2.1: The animal and human Staphylococcus aureus strains that will be used for further 
studies along with its date of arrival at Kingston University. 
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2.4 Isolation of Bacterial Genomic DNA 
Pure genomic DNA was isolated from six Staphylococcus aureus strains (OP100, B51, IP70, B53, 
S62 & AS3) using the Bacterial Genomic DNA Kit (Sigma-Aldrich GenElute™, Dorset England) following the 
manufactures instructions with minor modifications. Briefly, the isolation of genomic DNA was performed as 
follows. 
The GenElute™ Bacterial Genomic DNA kit reagents were stored at room temperature; any reagents 
that formed a precipitate before use were warmed at 55 in a preheated water bath (Grant Instruments, 
Cambridge, UK.) until the precipitate was dissolved. For each S. aureus strain, 200 µL of Lysozyme Solution 
was prepared by dissolving 2.115 x 106 unit/mL Lysozyme in 1.5 mL of Gram-positive lysis buffer. This was 
further supplemented with a 250 units/mL of Lysostaphin; the solution was thoroughly mixed before use. 
Overnight cultures of the bacteria were grown in 5 mL of Brain Heart Infusion (BHI) broth and 1.5 mL was 
transferred to a sterile micro-centrifuge tube and pellet by centrifuging for 2 minutes at 12,000 x g, the culture 
medium subsequently completely removed and discarded. The pellet was then re-suspended in 200 µL of 
freshly prepared Lysozyme Solution, and incubated in a preheated water bath (37 for 30 minutes) to 
achieve cell wall digestion. RNase A solution (20 µL) from the kit was added and incubated for a further 2 
minutes at room temperature to ensure that RNA-free genomic DNA is achieved. Proteinase K powder (10 
mg) was dissolved in 0.5 mL of water to obtain a 20 mg/mL stock solution and stored at room temperature. 
To lyse the cell, 20 µL of Proteinase K was added to each sample, followed by 200 µL of Lysis Solution C. 
The mixture was mixed thoroughly using a vortex (15 seconds) and incubated in a preheated water bath 
(55 for 15 minutes).  Column preparation solution (500 µL) was added to each pre-assembled GenElute 
MiniPrep Binding Column, seated in a 2mL collection tube and centrifuged (12,000 x g for 1 minute), the 
eluate was subsequently discarded. This process achieved maximum binding of DNA to the membrane of 
the GenElute binding column.  Ethanol (95 – 100%/ 200 µL) was added to the lysate mixture and thoroughly 
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mixed with the use of a vortex (10 seconds), ensuring a homogenous solution. The entire contents were 
transferred to the prepared GenElute binding column using a wide bore pipette, to reduce shearing of the 
DNA and centrifuged (6500 x g for 1 minute). The collection tube containing the eluate was discarded and 
placed in a new 2 mL collection tube. Wash Solution 1 (500 µL) was added to the GenElute binding column 
and centrifuged (6500 x g for 1 minute), the collection tube and eluate was discarded and the column placed 
in a new 2 mL collection tube. For the second wash, the Wash Solution Concentrate bottle (20 mL) was 
diluted with 95 – 100% ethanol (80 mL) and mixed by inverting. Wash solution Concentrate (500 µL) was 
added to the column and centrifuged (16,000 x g for 3 minutes) to dry the column and further centrifuged 
(16,000 x g for 1 minute) to remove any residual ethanol, ensuring an ethanol-free column. The collection 
tube was discarded and placed in a new 2 mL collection tube. Molecular biology grade water (200 µL) was 
transferred directly to the center of the GenElute column and incubated at room temperature for 5 minutes 
and subsequently centrifuged (16,000 x g for 1 minute) to elute the DNA. Using the same collection tube, a 
further 200 µL of molecular grade water was transferred to the center of the column and incubate for a further 
5 minutes at room temperature, centrifuged (12,000 x g for 1 minute) to elute the DNA. The eluate in the 
collection tube contains the RNA-free genomic DNA, approximately 400 µL and was stored at 2 – 8  until 
the next stage. 
 
 
 
 
 
 
 
	
	
50	
2.5 Spectrophotometric analysis  
 A GE Healthcare NanoVue™ Plus Spectrophotometer was used to determine the concentration and 
purity check for the DNA samples. The spectrophotometer was programmed to read DNA samples. Using a 
Gilson® P100 pipette, 0.5 µL of molecular grade water was loaded directly on the sample plate. This was 
used as the reference sample, to ensure that the machine was blanked and readings were accurate. The 
loading plate was cleaned using a sterile disposable wipe and 0.5 µL of the RNA-free genomic DNA was 
loaded directly on to the loading plate. The average concentration (A260/ A280) and protein concentration 
(A260/ A230) readings of the samples were tabulated (Table 3.3). 
 
2.6 Gel Electrophoresis  
 Isolated RNA-free genomic DNA was analysed by Gel Electrophoresis. A batch of TBE 10X running 
buffer was prepared by adding 800mL of distilled water to 108g of tris base, 55g boric acid and 7.5g of EDTA 
di-sodium salt, the volume was then adjusted to 1 litre by topping it up with more distilled water and the 
mixture was thoroughly mixed. The agarose gel was prepared using 0.75 g agarose gel, 75 mL 1XTBE, 
prepared earlier and 7.5 µl SYBR safe dye, this was stirred using a magnetic stirrer and heated at 55 for 
15 mins to reach it’s boiling point. The agarose gel was immediately transferred to the gel tanks, the comb 
was put in place and the gel was allowed to solidify at room temperature for 10 minutes. Once solidified, the 
comb was removed and the wells were exposed. Nothing was loaded in the side wells (1 and 10). Well 2 was 
loaded with a 100 – 1000 bp gene ladder and wells 3, 4, 5, 6, 7 & 8 was loaded with the DNA sample. 
 Gels were run in a FlowGen Gel Electrophoresis system in 1X TBE buffer at Voltage 200V for 3 
hours The gel was placed in a Molecular Imager® Gel Doc™ XR System. The image was captured with a 
Windows computer and the Imager® software. 
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2.7 Ion Torrent: Next Generation Sequencing  
 High-quality RNA-free genomic DNA (gDNA) that was isolated from the six Staphylococcus aureus 
isolates (OP100, B51, IP70, B53, S62 & AS3) using the Sigma-Aldrich GenElutetm Bacterial Genomic DNA 
Kit (see section 2.4), was used with the next generation sequencing system (NGS) (Life Technologies, USA). 
The manufacturers instructions were followed during stage one of the Ion Xpress™ Plus gDNA Fragment 
Library Preparation, stage two of the Ion PGM™ Template OT2 400 Kit and the third stage of the Ion PGM™ 
Sequencing 400 Kit protocols, with minor modifications developed during the trial and error phase.  
 
2.7.1 Ion Xpress™ Plus gDNA Fragment Library Preparation 
2.7.1.1 Fragmentation of the DNA 
 The initial stage of the library preparation included the use of Ion Shear™ Plus Reagents to fragment 
the gDNA to the desired median fragment size of 350 - 450 base pairs (bp) for use with the 400-library kit. 
The Ion Shear™ Plus 10X Reaction Buffer and the Ion Shear™ Plus Enzyme Mix II were both vortexed for 
5 seconds and centrifuged (using the Eppendorf centrifuge), using the pulse-spin function and placed on ice. 
The concentration of each S. aureus genomic DNA sample was adjusted to 100 ng/µL using Nuclease-free 
water and 10 µL was subsequently added to a 1.5 mL Eppendorf LoBind® tube. Ion Shear™ Plus 10X 
Reaction Buffer (5 µL) and Nuclease-free water (25 µL) were also added to the Eppendorf LoBind® tube 
and were mixed vigorously by vortexing and centrifuging, using the pulse spin feature. A Gilson™ P10 - P20 
pipette was then used to add 10 µL of Ion Shear™ Plus Enzyme Mix II to the samples, bringing the total 
reaction volume to 50 µL. It was then immediately mixed using a Gilson™ P100 - P200 pipette, by pipetting 
up and down 10 times and the mixture was instantly incubated in a water bath set at 37 for a total of 10 
minutes, as per the protocol, to reach the desired gDNA median fragment size of 350 - 450 bp. After 
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incubation, the Ion Shear™ Stop Buffer (5 µL) was immediately added to each sample and thoroughly 
vortexed for 5 seconds to stop the reaction, and placed on ice. 
 
2.7.1.2 Clean up using Agencourt® AMPure® XP Reagents 
 Agencourt® AMPure® XP Reagents (99 µL) was added to the sheared DNA samples. A pipette was 
used to mix the bead suspension, by pipetting the mixture up and down 5 times. It was centrifuged with the 
pulse spin feature and incubated for 5 minutes at room temperature. The tubes were placed in a magnetic 
DynaMag™-2 rack for 3 minutes and the supernatant was carefully removed without disturbing the bead 
pellet. With the tube still in the magnetic rack, 500 µL of freshly prepared 70% ethanol (4.9ml of 100% ethanol 
added to 2.1 mL MilliQ, to prepare 7ml of 70% ethanol) was added to the samples and incubated for 30 
seconds, turning the tube around twice in the magnet rack to ensure that the beads move around. Once the 
solution had cleared, the supernatant was removed and discarded without disturbing the pellet and left to air-
dry on the rack at room temperature for 5 minutes. The tubes were then removed from the magnetic rack 
and 25 µL of Low TE buffer was added directly to the pellet to disperse the beads. It was then mixed by 
pipetting the suspension up and down 5 times and vortexing the sample for 10 seconds and placed on the 
magnetic rack for 1 minute, in which time the solution cleared. The supernatant contains the eluted DNA and 
was transferred to a new 0.2-mL PCR tube without disturbing the pellet, removing 2 µL from each sample 
for the Bioanalyser® instrument analysis and storing the remaining DNA samples at -10 to -30. 
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2.7.1.3 Bioanalyser  
 The fragment size of the eluted DNA (from step 2.7.1b) was checked using the Agilent® 2100 
Bioanalyser® instrumentation and Agilent High Sensitivity DNA Kit which will confirm the desired DNA 
fragment size range. Before beginning the chip preparation protocol, the Chip Priming Station’s base plate 
was adjusted to suit the High Sensitivity DNA Chip and the syringe clip was adjusted to the lowest position 
(figure 2.1a). The Agilent® 2100 Bioanalyser® was also adjusted to accommodate the DNA Chip by removing 
the pressure cartridge and inserting the electrode cartridge. The 2100 Expert software that corresponds with 
the Agilent® 2100 Bioanalyser® instrument was calibrated so that it communicated with the High Sensitivity 
DNA Chip that that was inserted. The Agilent® High sensitivity DNA kit includes a High Sensitivity DNA dye 
concentrate and also a High Sensitivity DNA gel matrix, both were equilibrated at room temperature (30 mins) 
ensuring that they are protected from any light sources. Care must also be taken with the High Sensitivity 
DNA dye-concentrate as it contains dimethyl sulfoxide (DMSO), a potential mutagen that requires the aid of 
gloves. The vial containing the High Sensitivity DNA dye concentrate is then mixed using a vortex for 10 
seconds and using a pipette, 15 µL is added to the High Sensitivity DNA gel matrix vial. The complete gel-
dye mix was transferred to the top receptacle of a spin filter and placed in a micro-centrifuge (6000 rpm) for 
10 minutes at room temperature. The filter was discarded and the gel-dye mix was stored away from light 
and equilibrated for 30 minutes at room temperature. A High Sensitivity DNA chip (shown in figure 2.10) was 
then placed on the chip priming station at position C. Using a pipette, 9.0 µL of the gel-dye mix was dispensed 
to the bottom of the well marked , ensuring that the no air bubbles were formed. The plunger of the syringe 
on the chip priming station was set to 1 mL. The plunger was subsequently pressed until it was held by the 
latch, to pressurise the DNA chip and released after exactly 60 seconds. The plunger was visually inspected 
to ensure that it moved back to the 0.3 mL. Waiting a further 5 seconds, the plunger was slowly pulled back 
to the 1 mL position on the chop priming station. The gel-dye mix (9.0 µL) was transferred into each of the 
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wells marked G. The High Sensitivity DNA marker (5 µL) was transferred into the wells marked with the 
ladder symbol and the remaining 11 sample wells, leaving no wells empty. The DNA samples (1 µL) were 
then loaded in to each of the individual sample wells, noting the location. The High Sensitivity DNA ladder (1 
µL) was subsequently loaded into the wells marked with the ladder symbol and the sample wells that have 
the DNA.  
 The DNA chip was then placed horizontally in the adapter of the vortex (2000rpm for 60 seconds) 
and placed carefully in the receptacle of the Agilent® 2100 Bioanalyser® instrument, closing the lid. The 
computer displayed the DNA chip, and the names of the samples were added to the corresponding well that 
were noted previously. The Bioanalyser® was run overnight to preform size fractionation and quantification 
of the DNA samples. Once the assay was complete the chip was removed and the cleaning cycle was run. 
Using a new electrode cleaner after each run, the wells were filled with deionised analysis-grade water (350 
µL) and placed in the instrument for 10 seconds, closing the lid. Once complete, it was immediately removed 
to allow the water on the electrodes to evaporate by air drying for a further 10 seconds, before closing the 
lid. 
 
2.7.1.4 Ligate Adapters 
 The following reagents, provided in the Ion Xpress™ Barcode Adapters Kit were added to a 0.2-mL 
PCR tube for a total reaction volume of 100 µL:  fragmented DNA sample (25 µL), 10x Ligase Buffer (10 
µL), Ion P1 Adapter (10 µL), dNTP Mix (2 µL), Nuclease-free water (31 µL), DNA Ligase (4 µL), Nick Repair 
Polymerase (8 µL) and the Ion Xpress™ Barcodes X (10 µL) (33 to 38). When handling the IonXpress™ 
Barcoded adapters, gloves were changed frequently to avoid cross contamination as the adapters were 
specific to each sample. The specific barcode adaptor used were as follows; OP100: 33, B51: 34, IP70: 35, 
B53: 36, S62: 37 and AS3: 38. The PCR tubes were subsequently placed in the C1000 Thermal Cycler and 
programed to run the sequence shown in table 2.2.  
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Once complete, the entire mixture from the PCR tube was added to a 1.5-mL Eppendorf LoBind® 
tube and was cleaned using the Agencourt® AMPure® XP Reagents described in section 2.7.1.2, using 100 
µL as the reaction volume. 
 
2.7.1.5 E-Gel® SizeSelect™ Agarose Electrophoresis  
 The E-Gel® iBase™ unit and E-Gel® Safe Imager™ were assembled and the “SizeSelect™ 2%” 
program loaded onto the system. The E-Gel® cassette was taken out from the package, the comb removed 
from the gel and firmly inserted into the apparatus so that a steady light illuminated. The DNA ladder (cat. 
No. 10416-014), suitable for 400-base read libraries was diluted in Low TE buffer to achieve a 1:40 dilution. 
Using a pipette, 10 µL of the diluted DNA ladder was carefully added to the middle well (Figure 2.1), ensuring 
that the tip does not pierce the agarose at the bottom of the well. In the same fashion, ligated DNA samples 
(20 µL) was added to the top loading wells numbered #2, #3, #4, #5, #6 & #7 and deionised water was added 
to the wells marked #1 and #8. Deionised water (25 µL) was also added to the bottom collection well and 10 
µL to the well marked M on the bottom row. 
  
 
 
 
 
Stage Temperature Time 
Hold 25C 15 minutes 
Hold 72C 5 minutes 
Hold 4C Hold 
	
Table 2.2: The thermal cycler was programed to run the sequence shown in the table for this stage. 
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Once loaded, the amber filter was placed over the E-Gel® iBase™ unit and the electrophoresis was 
initiated, leaving it to run for 16 - 20 minutes, allowing for more time if needed at the end of the run if the band 
had not reached the reference line. Once the band reached the reference line, the collection well was refilled 
with 10- µL of nuclease-free water and the E-Gel® was run for a further 2 - 2.5 minutes, stopping once the 
band of interest had migrated into the collection well. Once complete, the solution was collected using a 
pipette, without piercing the bottom of the well. The wells were filled with a further 10 µL of nuclease-free 
water to wash and rinse the collection wells and collected, the total recovered volume from each well was 
60 µL. 
 
2.7.1.6 Amplify and Purify Libraries 
 The following reagents: Platinum® PCR SuperMix High Fidelity (200 µL), Library Amplification 
Primer Mix (10 µL) and the DNA Library (50 µL) were combined in a vial and thoroughly mixed by pipetting 
up and down. The 260 µL reaction mixture was equally split placed into 0.2-mL PCR tubes and subsequently 
placed in a thermal cycler following the cycling program indicated in the table 2.3 below. 
 
 
Figure 2.1: An example of the E-Gel® SizeSelect™ gel that was used. 
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Once complete the entire reaction mixture (260 µL) was added to a new 1.5-mL Eppendorf LoBind® 
tube and underwent the clean up step using the Agencourt® AMPure® XP Reagents described in step 2.7.1b. 
The supernatant which contains the final amplified library was transferred to 3 aliquots and stored at -30 
to -10, to reduce the number of freeze-thaw cycles which could potentially damage the DNA.  
 
2.7.1.7 Quantify and Pool barcoded libraries  
  The barcoded libraries were individually quantified and pooled in equal-molar amounts to 
ensure equal representation of each library, initially there were several pools at different concentrations. The 
Bioanalyser® software was used to assess the barcoded library samples (1 µL) at the highest possible equal-
molar concentrations. 
 
 
 
 
 
Stage Step Temperature Time 
Holding Denature 95 5 mins 
Cycling x 5 Denature 95 15 sec 
Anneal 58 15 sec 
Extend 70 1 min 
Holding - 4 Hold 
	Table 2.3: The thermal cycler was programed to run the sequence shown in the table, cycling for a 
maximum of 5 times. 
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2.7.2 Ion PGM™ Template OT2 400 Kit 
2.7.2.1 Configuring the machine  
The IonOneTouch™ 2 Instrument layout is shown in Figure 2.2 below. Using the materials provided in the 
Ion PGM™ Template OT2 Supplies 400 Kit and the Ion PGM™ Template OT2 Solutions 400 Kit, the machine 
was configured.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The touch screen display on the instrument was used to open the lid on the centrifuge. The Ion OneTouch™ 
Recovery Tubes and Ion OneTouch™ Recovery Router were installed into each of the slots in the centrifuge 
(Figure 2.3), ensuring that it was seated flat and securely in place, the lid of the centrifuge was subsequently 
closed.  
 
 
Figure 2.2: Layout of the IonOneTouch™ 2 Instrument. Image taken from the 
manufacturer manual.  
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The used Ion oneTouch™ 2 Cleaning Adapter was removed from the system and the handles were pushed 
back to open the heat block. An IonOneTouch™ Amplification Plate, which has a connected disposable 
tubing and disposable injector, was installed by inserting the amplification plate into the heat block, threading 
the tubing though the Ion OneTouch™ DL Tubing Catch, closing the handle on the heat block, inserting the 
disposable tubing into the pinch valve (Figure 2.4) and finally inserting the disposal injector into the port of 
the Ion OneTouch™ DL injector hub so that it stops at the base of the router (Figure 2.5). 
 
 
 
 
 
 
 
 
 
Figure 2.4: The disposable tubing in the pinch 
valve with the handle on the heat block closed. 
Image taken from the manufacturer 
manual.  
 
Figure 2.3: An enhanced view of the IonOneTouch™ 2 built in centrifuge with the replaceable recovery 
tubes (x2) and recovery router (x1) shown in situ. Image taken from the manufacturer manual.  
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 Using a new reagent tube from the kit and wearing fresh gloves, the Luer-Lok® was attached to the 
end of a new IonTouch™ Sipper tube to the left port of the instrument, ensuring that the Sipper Tube did not 
touch any surface or become contaminated. The Ion OneTouch™ Oil bottle was inverted 3 times to mix and 
the Reagent Tube was filled half-way with the oil, minimising any bubbles. The Ion OneTouch™ Reagent 
Tube with the Ion OneTouch™ Oil was firmly screwed into the front left port, one quarter turn on the 
instrument. The Recovery Solution was heated in a water bath (30) water bath until the solution was clear. 
Using a new Reagent Tube from the kit the Luer-Lok® was attached to the end of a Ion Touch™ Sipper tube 
to the right port of the instrument. The Recovery Solution bottle was inverted 3 times to mix and the Reagent 
Tube was filled with the solution, quarter-full. The filled Reagent Tube was attached to the right port and 
screwed firmly into place in. The Waste Container was also emptied. The Ion PGM™ Template OT2 400 
Reagents Mix and Ion PGM™ Template OT2 400 PCR Reagent B were incubated at room temperature and 
mixed by vortexing for 30 seconds and 60 seconds, respectively. Both reagents were centrifuged for 2 
seconds and visually inspected to ensure so that no residual precipitate was present at the bottom of the 
tube, they were subsequently stored at room temperate. The Ion PGM™ Template OT2 400 Enzyme Mix 
Figure 2.5: The disposable injector being inserted 
into the injector hub at the base of the router. 
Image taken from the manufacturer manual.  
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and Ion PGM™ Template OT2 Reagent X were centrifuged for 2 seconds and placed on ice and the PGM™ 
Template OT2 400 Ion Sphere™ Particles (ISPs) at room temperate. 
An aliquot of the barcoded DNA library was incubated at room temperature and 2 µL was added to 
23 µL nuclease-free water. The diluted library was mixed by vortexing for 5 seconds, centrifuged for a further 
2 seconds. Using a new 1.5 mL Eppendorf LoBind® Tube the following reagents were added: Ion PGM™ 
Template OT2 400 Reagent Mix (500 µL), Ion PGM™ Template OT2 400 PCR Reagent B (285 µL), Ion 
PGM™ Template OT2 400 Enzyme Mix (50 µL), Ion PGM™ Template OT2 400 Reagent X (40 µL) and the 
diluted library (25 µL) to create a total amplification solution mix. The amplification solution was mixed by 
pipetting up and down, vortexing for 5 seconds and centrifuging for a further 2 seconds. The ISPs were mixed 
at maximum speed by vortexing for 1 minute and centrifuging for a further 2 seconds to re-suspend the 
particles, 100 µL was immediately added to the amplification solution and the total amplification solution 
(1000 µL) was mixed using the vortex for 5 seconds. 
 
2.7.2.2 Loading Ion PGM OneTouch Plus Reaction Filter  
 A new Ion PGM OneTouch Plus Reaction Filter Assembly was placed into a tube rack so that the 3 
ports of filter face up (Figure 2.6). 
 
 
 
 
 
 
 
Figure 2.6: An example of 
the Ion PGM OneTouch 
Plus Reaction Filter 
Assembly that was used. 
Image taken from the 
manufacturer manual.  
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Using a Gilson P1000, the amplification solution (1000 µL) was slowly transferred into the Reaction Filter. 
This was achieved by ensuring that the tip of the pipette was inserted into the sample port forming a tight 
seal, once transferred the plunger of the pipette was kept depressed to avoid aspirating the solution from the 
reaction filter. Using a new tip each time and in the same process described, 1000 µL and then 500 µL of 
the Ion OneTouch™ Reaction Oil was also transferred into the sample port of the Reaction Filter. The 
Reaction Filter was subsequently oriented in a specific way; first the Reaction Filter was lifted out of the tube 
rack so that the sample port was on the left, it was then rotated to the right until the Reaction Tube was 
inverted and the 3 ports of the Filter face down (Figure 2.7), and placed firmly into the three holes on the top 
stage of the Instrument. 
 
 
 
 
 
 
 
 The centrifuge lid was closed on the OneTouch™ 2 Instrument and the touch display screen was 
used to load the specific ‘PGM: Ion PGM™ Template OT2 400 Kit’ program from the drop down menu and 
the on screen instructions were followed to initiate a run, lasting for 16 hours as per the manufactures 
instructions.  
 
 
 
Figure 2.7: A representation of how the Ion PGM OneTouch Plus Reaction Filter was inverted, 
concluding with the 3 ports of the filter facing down. Image taken from the manufacturer manual.  
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2.7.2.3 Recover the template-positive Ion PGM™ Template OT2 400 Ion Sphere™ Particles 
 Before removing the sample, the instrument was used to perform a 10-minute centrifuge run. Once 
complete, the Recovery Router was removed and discarded, and the Recovery Tubes from the instrument 
were placed in a tube rack. Using a pipette, all but 100 µL of the Ion OneTouch™ Recovery solution was 
removed from each Recovery Tube, withdrawing the supernatant from the surface and on the opposite side 
from the pellet, removing any white flocculent material and ensuring that the ISP pellet was not disturbed. 
With a new tip and using the same tip for both tubes, the ISPs were resuspended in the remaining Ion 
OneTouch™ Recovery solution by pipetting the pellet up and down until each pellet dispersed in the solution. 
Ion OneTouch™ Wash Solution (500 µL) was then added to each Recovery Tube and mixed by pipetting to 
disperse the ISPs. The suspension was subsequently transferred to a new 1.5-mL Eppendorf LoBind® Tube 
and heated, using a heat block (50) for 2 minutes followed by centrifuging (15,000 x g) for 2.5 minutes. A 
pipette was then used to remove all but 100 µL of the Wash Solution from the tube, withdrawing the 
supernatant from the surface and on the opposite side of the pellet.  
 
A 8-well strip (Figure 2.8) was obtained from the Ion OneTouch™ ES Supplies Kit and orientated so that the 
square-shaped tab on the 8-Well strip was on the left. The suspension from the tube (100 µL) was transferred 
into Well-1 and a small aliquot of the sample was retained for quality assessment using a Qubit® 2.0 
Fluorometer. 
 
 
 
 
 
Figure 2.8: A representation of the 8-well strip that was used. 
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2.7.2.4 Enrich the template-positive Ion PGM™ Template OT2 400 Ion Sphere™ Particles 
 The tube containing the Dynabeads® MyOne™ Streptavidin C1 Beads was resuspended by 
vortexing (30 seconds) and centrifuging (2 seconds). The tube was the then opened and using a pipette, the 
beads were further mixed by pipetting the mixture up and down and 13 µL was immediately transferred to a 
new 1.5-mL Eppendorf LoBind® Tube. The tube was placed on a DynaMag™-2 magnet rack for 2 minutes 
and the supernatant was carefully removed without disturbing the pellet, and discarded. MyOne™Beads 
Wash Solution (130 µL) was added to the tube and removed from the magnet rack, vortexed (30 seconds), 
centrifuged (2 seconds) and subsequently dispensed into the 8-well strip mentioned in Section 2.7.2.3 Well-
2. Ion OneTouch™ Wash Solution (300 µL) was transferred to Well-3, Well-4 and Well-5. Fresh melt-off 
solution was prepared by combining Tween® Solution (280 µL) and 1 M NaOH (40 µL) and 300 µL was 
transferred to well-7. Well-6 remained empty. The Ion OneTouch™ ES instrument was set up according to 
the manufactures instruction, the 8-Well strip was then inserted in to the slot of the Ion OneTouch™ ES, 
ensuring that the square-shaped tab sits on the left. A new tip was placed in the instruments Tip Loader arm 
and a new, opened 0.2 mL PCR tube was loaded into it’s hole. Before the run was performed, the contents 
of Well-2 was mixed with the aid of a pipette, being careful not to introduce bubbles into the solution. The run 
took 35 minutes, and at the end when the alarm sounded, the PCR tube was immediately closed and the 
enriched IPSs were stored at 2 to 8. 
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2.7.3 Ion PGM™ Sequencing 400 Kit 
 Figure 2.9 below shows the Ion PGM™ System with Reagent and Wash Bottles attached. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The Torrent Server connected to the Ion PGM™ System is accessible through the Torrent Browser 
which was accessed to create a planned run, using the planned run wizard. Briefly, in the Application tab: 
whole genome sequencing with a forward run type was selected. Kits tab: Ion PGM™ Template OT2 400 Kit 
was selected and the strain names with the corresponding Ion Xpress™ Barcode Adapter was entered. 
Monitor tab: Monitor the progress of the run and enter a name for the new planned run. Once the plan was 
created, it was loaded onto the Ion PGM™ Sequencer instrument.  
Before starting the run, the cleaning log was checked to ensure that the Ion PGM™ System was 
cleaned as per the manufactures instructions. The dNTP stock solutions (Ion PGM™ Sequencing 400 dGTP, 
Ion PGM™ Sequencing 400 dCTP, Ion PGM™ Sequencing 400 dATP and Ion PGM™ Sequencing 400 
Label Component 
A Touchscreen 
B Chip clamp 
C Grounding plate 
D Power button 
E Reagent bottles 
F Wash 1 Bottle  
G Wash 2 Bottle 
H Wash 3 Bottle 
I Waste Bottle 
	
Figure 2.9: The layout of the Ion PGM™ instrument with the reagent and wash bottle. 
Image taken from the manufacturer manual. 
 
	
	
66	
dTTP) were removed from the freezer and placed on ice to thaw slowly. Wash Bottle 1, Wash bottle 2 and 
Wash bottle 3 were obtained from the Ion PGM™ Sequencing 400 Kit and rinsed three times with 18 MΩ 
water. 100 mM NaOH (350 µL) was added to Wash Bottle 1; 2 litres of 18 MΩ water, entire contents of the 
Ion PGM™ Sequencing 400 W2 solution, and freshly prepared 100 mM NaOH (140 µL) was added to wash 
bottle 2, the bottle was capped and inverted 5 times to mix; and Ion PGM 1X W3 solution was added to the 
50 mL line marked on Wash 3 Bottle. The old sipper tubes from the dNTP ports and the cleaning chip that 
was used to clean the Ion PGM™ system remained in place during the initialisation steps, and were only 
changed when instructed to do so. The barcode on the Ion PGM™Sequencing 400 W2 Bottle was scanned 
and the corresponding Ion PGM™ Sequencing Kit was loaded on the Ion PGM™ Sequencer. The touch 
screen display then started the initialisation wizard. The on-screen instructions were followed to verify the 
gas pressure, once verified and wearing new gloves each time, new sipper tubes were firmly attached to the 
caps in the three wash bottles, making sure that the sipper tube did not touch any other surface to avoid 
contamination. The Ion PGM™ System tested the bottles for leaks, fill the Wash 1 Bottle, then adjust the pH 
of the W2 Solution, this process is automated. After each dNTP stock solution had thawed, it was vortexed 
and centrifuged to collect the contents, and put back on ice. Four new Reagent Bottles were labelled as 
dGTP, dCTP, dATP and dTTP, using filtered pipettes and changing gloves after handling every dNTP stock 
solution, 20 µL of each dNTP stock solution was transferred to its respective labelled bottle.  After the wash 
solutions had initialised, the onscreen prompts instructed to remove the used sipper tubes and collection tray 
from the dNTP ports, and wearing gloves, new sipper tubes were inserted into each dNTP port. The Reagent 
Bottle was firmly attached to its corresponding correct dNTP port, ensuring that it was not over tightened. 
The Ion PGM™ System will check the pressure of the Reagent Bottles and fill each Reagent Bottle with 40 
mL of W2 solution, an automated process.  At the end of the initialisation, the Ion PGM™ System measured 
the pH of the Reagents and if every Reagent is in the target pH range, a green Passed screen was displayed. 
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 The contents of the the tube contains the enriched ISPs were mixed by thoroughly pipetting it up 
and down and centrifuging for 2 minutes (15,000 X g). The supernatant was carefully removed without 
disturbing the pellet and 15 µL of the enriched ISPs were left in the tube, this was achieved by visually 
comparing it to an identical tube loaded with 15 µL of liquid. Sequencing Primer (12 µL) was added to the 
tube and the contents were thoroughly mixed by pipetting up and down gently to disrupt the pellet. The total 
volume of the tube was 27 µL, this was added to a thermal cycler programmed at 95 for 2 minutes and 
then 37 for a further 2 minutes, using the heated lid option. After cycling, the reaction mixture remained in 
the cycler at room temperature until the chip check was preformed.   
 
2.7.3.1 Chip Check 
 Chip Check test ensures that it is functioning properly prior to loading the samples. A new chip was 
removed from its packaging and labelled to identify the experiment.  The chip was placed on the Ion PGM™ 
Sequencer grounding plate to ensure that the chip will not be damaged from any static electricity. The person 
operating the chip also grounded their self. The cleaning chip was removed and the new chip was placed in 
the chip socket, and the chip clamp was closed. Chip check was initiated on the touch screen display, and 
once complete, the chip was removed from the chip socket, placed on the grounding plate and replaced with 
the cleaning chip. 
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2.7.3.2 Loading the Chip 
 The ISPs were removed from the thermal cycler and 3 µL of Ion PGM™ Sequencing Polymerase 
was added to it, bringing the total final volume up to 30 µL. This solution was thoroughly mixed by pipetting 
the mixture up and down and incubated at room temperature for 5 minutes.  The chip (Figure 2.10) was tilted 
45 degrees so that the loading port became the lower port and a pipette tip was inserted to remove as much 
liquid as possible. The chip was then placed upside down in the centrifuge adapter bucket in a MiniFuge with 
the chip tab pointing in, it was balanced with another used chip of the same type and was subsequently 
centrifuged for 5 seconds, ensuring that the chip was completely empty of any liquid.  
 
 
 
 
 
 
The centrifuge adapter bucket was then removed from the MiniFuge and placed on the bench top, a flat 
stable surface. The entire ~30 µL was then collected in a pipette tip, which was inserted into the loading port 
of the chip. The pipette was then dialled down, extremely slowly, at the rate of ~1 µL/ per second which 
avoids the introduction of bubbles into the chip, leaving a small amount of sample (~0.5 µL) in the tip of the 
pipette. The chip was then transferred to the MiniFuge, and was centrifuged for 30 seconds. The chip was 
removed from the bucket and tilted 45 degrees, and using a pipette, with the volume set to 25 µL, the tip is 
inserted into the loading port and without removing the tip, the sample was slowly pipette in and out of the 
chip 3 times, to avoid bubbles. This chip mixing method was repeated, this time pipetting the sample in and 
out of the chip five times. The chip was then tilted to a 45-degree angle and the liquid was slowly removed 
from the loading port. A quick 5 second spin with the tab pointing out was performed to remove any additional 
Figure 2.10: A picture 
representing the - Ion 
316™ Chip v2 that was 
used. Image taken 
from the manufacturer 
manual.  
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liquid. The chip was also lightly and rapidly tapped against the bench a few times to discard any final liquid 
that may have been present.  
The planned run on the Ion Torrent PGM™ instrument was initiated and when prompted by the 
instrument, the chip was loaded and clamped into place. Monitoring the run and the output of the sequencing 
run was made available on the Ion Torrent Server via the Ion Torrent Browser.  
 
2.7.3.3 Ion Torrent 
 Once the Ion Torrent had completed the sequencing, the output of the sequencing runs was made 
available on the Ion Torrent server via the Ion Torrent browser. It was possible to download the sequence 
files as either .BAI, .BAM, .UBAM or FASTQ format. 
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2.8 CLC Bio 
 CLC Bio Genomics Workbench (version 8.5.1), a software package that analyses and visualises 
data from all major Next Generation Sequencing platforms, including Ion Torrent was used to map sequence 
reads onto reference S. aureus genome sequences. 
 
2.8.1 Uploading files to CLC Bio 
 The downloaded .FATSQ files for the six MRSA genomes were uploaded to the CLC Genomics 
workbench platform, as shown in Figure 2.11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: The CLC Genomics Workbench platform with the novel 
MRSA genomes uploaded. 
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2.8.2 Read Mapping 
 The read mapping functionality of the CLC Genomic Workbench was initially used. Each un-
assembled genome was mapped to both MRSA NCTC 8325 and MRSA MW2 reference strains which were 
also annotated. Mapping to NCTC 8325 reference strain with a known gene and its corresponding consensus 
sequence is shown in Figure 2.12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12: An output of the the NCTC 8325 reference strain that has been mapped 
to a gene (SAOUHSC_02861) and the consensus sequence of the MRSA OP100 
isolates displayed. 
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2.8.3 Virulence factor database 
 A virulence factor database was created in the CLC Genomics workbench package. The virulence 
factors were uploaded to the software in .FASTA format, as shown in Figure 2.13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13: CLC Genomics workbench software showing the uploaded virulence factor 
genes. 
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2.8.4 Extracting virulence factors. 
 Because the reference strains are annotated; the virulence factors can be located on the consensus 
sequence by simply searching for it using its name or symbol (or both) (Figure 2.14). There is also another 
option to search for the query virulence gene. It is also possible to use BLAST as a method for finding the 
gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: The search box of the software package with the ‘alpha-hemolysin’ gene 
as the query gene, and an output of the annotated consensus sequence that 
corresponds to this gene. This consensus sequence can be extracted for further 
analysis. 
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2.9 GenBank® 
 GenBank® (http://www.ncbi.nlm.nih.gov/genbank) an online genetic sequence database that 
contains annotated collections of publicly available DNA sequences and its corresponding bibliographic 
information was used. GenBank® is built and distributed by the National Centre for Biotechnology Information 
(NCBI) (http://www.ncbi.nlm.nih.gov), a division of the National Library of Medicine (NLM) 
(https://www.nlm.nih.gov), located at the National Institutes of Health (NIH) in the USA. GenBank® is part of 
the International Nucleotide Sequence Database Collaboration (INSDC) (http://www.insdc.org) that partners 
with the DNA DataBank of Japan (DDBJ) (http://www.ddbj.nig.ac.jp) and the European Molecular Biology 
Laboratory (EMBL) (http://www.ebi.ac.uk/ena)  (Benson et al., 2012). 
 
NCBI builds its GenBank® database primarily from the submission of sequence data from numerous research 
institutions. NCBI, 2015 reports that with the publication of ‘Release 3’ it brought 606 sequences into the 
public domain. The records for whole-genome shotgun (WGS) sequences projects processed at GenBank, 
began with ‘Release 129.0’ included the publication of 172768 WGS sequences and 16769983 total 
sequences (NCBI., 2015). To date (October 2015), with the publication of ‘Release 210.0’, the database 
stores an overwhelming 188,372,017 non-WGS sequences and 309,198,943 WGS sequences. For 
downloading purposes, the uncompressed GenBank flat files for this release requires approximately 742 GB 
of storage space (NCBI., 2015). 
 
 
2.9.1 Acquiring the Bacterial Genome 
 A thorough and detailed search of GenBank® was conducted.  In the Genome section of GenBank, 
Staphylococcus aureus was used as the keyword in the search box. Staphylococcus aureus strains that have 
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had their genomes mapped and published were found, and the sequences were presented as a dendrogram 
(Figure 2.15). 
 
 
 
S. aureus subsp. aureus ED133 was chosen because it was a representative live-stock associated strain 
that was of interest in the literature. By selecting the corresponding strain name from the dendogram, the 
genome assembly and annotation report are available to download in various formats (Figure 2.16). 
 
Figure 2.15: A dendogram showing the Staphylococcus aureus genomes that have 
been mapped. 
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The S. aureus subsp. aureus ED133 sequence was downloaded and saved in FASTA (.fas) format, 
a text-based format that represents the nucleotide using single letter codes (e.g. TCAG). A sequence in 
FASTA format begins with a single line description followed by lines of the sequence data, differentiated by 
a greater-than (‘>’) symbol at the start of the descriptor/ header line.  
 
2.9.2 S. aureus literature review 
A literature review was carried out on the strains of S. aureus that were identified. Two search 
engines were used to carry out the literature review, which included; PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed) and Science Direct (http://www.sciencedirect.com/).  
The specific S. aureus strain that was identified in GenBank was also used as the key word, for 
instance “Staphylococcus aureus subsp. aureus ED133” was entered into the search field and the relevant 
articles were viewed and information was collated. This information included; host (animal or human), year it 
was isolated, country of isolation and any other features. This information was subsequently collated into a 
table. 
Figure 2.16: An organism overview showing the Genome assembly and annotation report of 
Staphylococcus aureus subsp. aureus ED133. 
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2.9.3 Virulence Factor literature review 
 A literature review was then carried out on S. aureus virulence and the virulence factors that are 
associated with it. Keywords that were used in PubMed and Science Direct included; S. aureus, 
Staphylococcus aureus, virulence, virulence determinants, enhanced virulence, pathogenicity. A list of 
virulence factor determinants and the subsequent genes was collated. Along with information corresponding 
to the function of the virulence. 
 
2.9.4 Acquiring the Virulence Factor Genes 
A list of virulence factors was compiled. The virulence factor genes were searched in the GenBank® 
database in the same way as the S. aureus genomes. Using the GenBank® database search box, the query 
gene name was used as the key word, for example, alpha hemolysin or its corresponding gene abbreviation, 
HLA (Figure 2.17). GenBank® was used to search all of the nucleotide sequences that have been uploaded 
to its database corresponding to the search name, the results page shows the alpha-hemolysin gene from 
different organisms. Figure 2.17 shows the alpha-hemolysin present in the S. aureus subsp. aureus 
NCTC8325 strain as well as Cyanidioschyzon merolae, a unicellular haploid red alga. It is important to select 
the gene that is located in a S. aureus genome, as shown in the description column. 
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The alpha-hemolysin gene (SAOUHSC_01121) that is found in the S. aureus subsp. aureus NCTC 8325 was 
selected and an extensive amount of information was presented (Figure 2.18). It was important to check if 
the gene had been reviewed, this was found under the summary tab and it ensured that the gene was 
authentic. The gene was then downloaded in FASTA format and GenBank format. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17: A results page 
output of the GenBank® 
database showing the 
presence of the alpha-
hemolysin gene in both 
Staphylococcus aureus and 
Cyanidioschyzon merolae 
species. 
	
Figure 2.18: An output of 
the alpha-hemolysion 
(SAOUHSC-01121) gene 
that is present in 
Staphylococcus aureus 
subsp. aureus NCTC 8325. 
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2.10 MAUVE 
 A Bioinformatic software called MAUVE, developed at The Darling Lab at the University of 
Technology Sydney, was used to compare the S. aureus genomes uploaded from GenBank® (Darling et al., 
2004); however, it was not used to compare the 6 novel S. aureus strains that were sequenced. The software 
is publicly available to download (http://darlinglab.org/mauve/download.html). MAUVE is a multiple genome 
alignment software for comparative genomic and evolutionary dynamic studies, that works well on closely 
related species  
 
Genome sequences can undergo small local changes caused by nucleotide substitutions resulting in SNPs, 
including insertion or deletion of regions of DNA (Indels) or inversions They can also undergo large-scale 
changes as they evolve. Recombination can cause major changes which includes gene loss, duplication and 
rearrangement, the process that creates genetic diversity. MAUVE used this information during the alignment 
process and identified conserved segments that appeared to be free from genome rearrangements, such 
regions are referred to as Locally Collinear Blocks (LCBs) and are represented by the coloured blocks in the 
MAUVE display. LCBs are selected as Mauve requires that each LCB regions appear as genome 
arrangements and that each region of the alignment meets a ‘minimum weight’ criteria. The weight of an LCB 
is a measure of confidence that it is a true genome arrangement, rather than a false match. Mauve also uses 
the anchored alignment method to align the sequences using inexact, un-gapped matches as alignment 
anchors (Darling et al., 2004). 
Figure 2.19 shows an alignment of six S. aureus strains (04-02981, OBA02176, 11819-17, 502A, 
55-2053 and 6850) generated with Mauve 2.1 using the progressive Mauve algorithm. The strains were 
uploaded into the programme in FASTA format. Each genome is laid out horizontally with the position of the 
nucleotides numbered across the top. The LCBs in the genomes are the coloured blocks and shows 
differences and similarities between the genome sequence. Blocks with no colour represent regions specific 
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to that strain, whereas homologous segments are shown as coloured blocks that are connected across the 
genomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The aligned sequences can also be loaded into the programme with its corresponding GenBank® file, which 
contains the known annotated features of the genome. The annotations only appear once the tool is focused 
on a sufficiently small region of the genomes e.g. less than 1Mbp of the sequence; so the more that the user 
zooms in the more likelihood that annotation (if any) will appear. The toolbar at the top of the home screen 
has a number of tools (Figure 2.20) the helps navigate the alignment. 
 
 
 
Figure 2.19: An alignment of six S. aureus strains (04-02981, OBA02176, 11819-17, 
502A, 55-2053 and 6850) generated with Mauve 2.1 using the progressive Mauve 
algorithm. 
	
Figure 2.20: An output showing the Mauve toolbar with the various toolS available. 
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To zoom in on the alignment, the magnifying glass button from the toolbar was used. Once zoomed in, the 
annotated CDS features showed up as white boxes and the NCBI website can be accessed directly from the 
Mauve software to find out additional features on that particular gene. The software also has a powerful 
interface to search genome annotations and its corresponding position in the genome (Figure 2.21).  
 
 
 
 
 
 
 
Annotations can be searched by the identification of the query coding sequence name, amino acid sequence, 
gene ontology and other fields. It is also possible to search for S. aureus proteins associated with 
pathogenicity, for example, alpha-hemolysin. The software also has the ability to zoom in all the way down 
to the base level of the DNA so that any changes that occur at the base level of the genomes can be noted 
(Figure 2.22). 
 
 
 
 
 
 
 
 
 
Figure 2.21: An output showing Mauve search tools interface that will also display the 
corresponding position of the genome.   
	
Figure 2.22: An output showing the software’s functionality to zoom in all the way down to 
the base level of the DNA. 
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2.11 BLAST 
 An open access tool available at the National Centre for Biotechnology Information (NCBI) website 
called Basic Local Alignment Search Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi.) was used to find 
query regions, for example virulence genes, of local similarity between a query sequence and the sequences 
held within the GenBank database or a specified sub-section of the database (Altschul et al., 1990). The tool 
has the ability to compare query nucleotide or protein sequences to the GenBank® database. BLAST can 
also read sequences to its complimentary strand or reverse-complement counter part and calculates the 
statistical significance of the matches. 
 
There are many different BLAST programs to choose from depending on the type of query seqeunce. The 
different options include: Nucleotide BLAST (which searches nucleotide databases using a nucleotide 
query), Protein BLAST (which searches protein databases using a protein query), BLASTx (which searches 
protein databases using a translated nucleotide query), tBLASTn (which searches translated nucleotide 
databases using a protein query) and tBLASTx (which searches translated nucleotide databases using a 
translated nucleotide query). 
 
 For this study, Nucleotide BLAST was used to help identify if virulence factor genes were present in 
some or all of the S. aureus strains, shown in Figures 2.23 a – d). The strain containing the virulence factor 
genes was identified. The specific region of the bacterial genome was subsequently extracted in a FASTA 
format and recorded electronically by setting up an account with NCBI, as well as downloaded to a local 
database. The cut of value to determine if the virulence factor sequence was present in a particular strain 
was was set at 90% query coverage, 85% identity and an E value of <0.01; this data is shown in Appendix 2. 
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Figure 2.23a. The Complete genome of S. aureus subsp. aureus ED133 and the virulence 
factor gene of alpha-hemolysin, also from S. aureus was acquired through GenBank.  
	
Figure 2.23b. After hitting ‘BLAST’, the description box is presented which highlights the region 
of the S. aureus subsp. aureus ED133 that corresponds to the alpha-hemolysin gene.  
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Figure 2.23c. This box is 
then presented which 
shows the query sequence 
(alpha-hemolysin) aligned 
with the corresponding 
section of the subject strain 
(S. aureus ED133) genome 
sequence.  
 
Similarity between the 
ED133 and hla virulence 
factor seqeunces is 99% 
suggesting that the 
sequences are highly 
related.  The comparison 
shows a total of 7 SNPs of 
which 6 are synonymous 
mutations and only one 
G>T transversion at 702 is 
nonsynonymous giving a E 
to D amino acid change 
(Glutamic acid to aspartic 
acid). 
	
Figure 2.23d. The region of the query genome was then entered (‘1184334 - 1183375’) into 
the ‘selected region’ view. The FASTA output shown is the region of the ED133 genome 
that coincides with the coding region of the alpha-hemolysin gene. 
	
	
	
85	
2.12 MEGA 
 A publicly available bioinformatics software called MEGA (Molecular Evolutionary Genetics Analysis) 
is used for comparative analysis of DNA and protein sequences, as well as estimating evolutionary distances 
and constructing phylogenetic trees (Kumar et al., 2004; Tamura et al., 2013). The software was downloaded 
from http://www.megasoftware.net/. 
 
2.12.1 Load Sequence 
Load MEGA (version 6.0.6) and the home screen is presented with numerous options (Figure 2.24). 
  
 
 
 
 
 
 
 
 
 
The Align Tab was selected and the Edit/ Build Alignment option was chosen; a new screen was then 
presented. Select create a new alignment and then click OK as show below. Another screen will then be 
generated asking “Are you building a DNA or Protein sequence alignment?”. On this occasion, click DNA 
(Figure 2.25). 
 
 
Figure 2.24: An output showing the home screen of MEGA (version 6.0.6). 
	
	
	
86	
 
 
 
 
 
 
 
 
 
Subsequently, select ‘Data’ from the home screen and choose ‘Retrieve sequences from file?’ Open up the 
FASTA file for the virulence factor and import the aligned sequences. The Alignment Explorer screen will be 
presented (Figure 2.26 in the MEGA program. Click on the data tab, select the ‘Select Genetic Code’ tab and 
ensure that the standard genetic code has been selected. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.25: An output of MEGA showing the options needed to be selected 
for a DNA alignment.  
	
 Figure 2.26: An output showing the Alignment Explorer screen with the aligned S. aureus 
sequences. 
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Reduce the size of the alignment window so that it looks like figure 2.27. The sequences are now ready to 
be analysed phylogenetically. 
 
 
 
 
 
 
 
 
 
 
 
2.12.2 Constructing a Neighbour-joining Tree 
 The neighbour joining trees are constructed based on genetic distance measured by comparing the 
number of nucleotide differences between each sequence. To construct a tree, select the ‘Phylogeny’ icon 
and click the ‘Construct/ Test Neighbour-joining tree’ for the aligned sequence data. A new window will be 
presented; change the parameters so that they match Figure 2.28.  
Briefly, for Test of Phylogeny, select ‘Bootstrap-method’; ‘500’ for the number of bootstrap 
replications; substitution type should be ‘Nucleotide’; select the ‘kimura 2-parameter model’; substitution to 
include ‘Transitions and Transversions’ and finally ‘Complete Deletion’ should be selected for gaps/ missing 
data treatment (Figure 2.28). 
 
 
Figure 2.27: An output of the MEGA home screen with the aligned sequences now ready 
to be analysed phylogenetically.  
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Once the parameters have been selected, press compute and a progress screen will be presented (Figure 
2.29). 
 
 
 
 
 
 
 
 
 
Figure 2.28: An output showing the Analysis Preferences in order to construct a 
Neighbour Joining Tree. 
	
Figure 2.29: An output of the progress screen. 
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Once the analysis has been completed, the neighbour-joining tree will be presented in a new window. The 
neighbour-joining tree should be saved in both standard format and Newick format, so that the tree can be 
edited at a later stage.  
 
2.12.3 Constructing a Maximum-parsimony Tree 
 This tree takes into account the evolutionary process affecting sequences. Maximum-parsimony 
chooses the tree(s) that require the fewest evolutionary changes and involves no substitution model to guide 
the evolutionary process. To construct the tree, select the Phylogeny icon and click the ‘Construct/ Test 
Maximum-parsimony tree and confirm that you want to use the currently active data and a window will open 
(Figure 2.30). In the window, change the parameters so that they match the figure below. Briefly, for Test of 
Phylogeny, select ‘Bootstrap-method’; setting the number of Bootstrap Replications to ‘500’; substitution type 
should be ‘Nucleotide’; and finally ‘Complete Deletion’ should be selected for gaps/ missing data treatment. 
 
 
 
 
 
 
 
 
 
 
Figure 2.30: An output showing the Analysis Preferences in order to construct a 
Maximum Parsimony Tree. 
	
	
	
90	
Click compute and the progress screen will be shown. Once the analysis completes, a new screen will open 
presenting the phylogenetic tree; this is one of many trees that the maximum-parsimony analysis will produce 
(Figure 2.31). This alpha-hemolysin gene has produced 97 trees.  
 
 
 
 
 
 
The next step is to produce a consensus tree based upon all the trees generated by the. To do this, press 
the compute consensus command in the toolbar (Figure 2.32). A new window will be presented ‘Tree Options’ 
and will state ‘Cut-off Value for Consensus Tree 50%’. At this stage press OK, this will produce the maximum-
parsimony consensus tree. Once complete, save the tree in both standard format and Newick format. To 
ensure that it can be edited for further studies. 
 
 
 
 
 
 
 
 
 
 
Figure 2.31: An output of the Tree Explorer window which shows that the alpha-
hemolysin gene has produced 97 trees. 
	
Figure 2.32: An output 
showing the Tree Options 
windows to compute a 
consensus tree. 
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2.12.4 Constructing a Maximum-Likelihood Tree 
 The maximum likelihood tree will also be constructed. This analysis takes into account the patterns 
of evolution in the sequence alignment and uses a specified molecular model to construct and infer the 
evolutionary histories and relationships.  
Begin by identifying the correct model for the virulence factor that is being queried. In this example 
begin with the alpha-hemolysin alignment. Start by selecting the ‘Models’ tab and choosing the ’Find Best 
DNA/ Protein Models (ML)’, see figure 2.27 (MEGA homescreen). A new window will be presented (Figure 
2.33), keep the default settings and click compute. 
 
 
 
 
 
 
 
 
 
 
 
A new table will be presented showing the models that fits best with the data (Figure 2.34). At the bottom of 
the table (not shown), there is a description of all the codes for the different parameters and components of 
the models. Ensure that the results of the top 3 models are tabulated in a local database that best fits the 
data. The abbreviations for the models are as follows: GTR; General Time Reversible, HKY; Hasegawa-
Kisaino-Yano, T93; Tamaura-Nei, T92; Tamura 3-parameter, K2; Kimura 2-parameter and JC; Jukes-Cantor. 
Figure 2.33: An output of the Analysis preference for finding the best DNA Model for a 
particular virulence factor. 
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For this dataset, T92+G is the best model to be used. It is now possible to construct the maximum-likelihood 
phylogeny. Select the phylogeny tab and select Construct/ Test Maximum-likelihood Tree. You will be 
presented with a windows relating to the parameters of the analysis (Figure 2.35). 
 
  
 
 
 
 
 
 
 
 
 
Briefly, ensure that the Bootstrap method and 500 replicates is selected. Specify that the model that has been 
predicted for the data model, in this case T92+G, so select ‘Tamura-Nei’ model from the drop down menu. 
Figure 2.34: An output of a table showing the Maximum likelihood fits of 24 
different nucleotide substitutions models.  
Figure 2.35: An output showing 
the Analysis Preferences in order 
to construct a Maximum 
Likelihood Tree. 
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Select ‘Gamma Distributed (G)’ from the Rates among Sites tab, this corresponds with the G from the T92+G 
model. Once parameters have been set, click compute. Once analysis have been completed, the maximum-
likelihood tree will be produced. 
Once complete, save the tree in both standard format and Newick format. To ensure that it can be 
edited for further studies. 
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2.13 Muscle 
 A publicly available software called MUSCLE (MUltiple Sequence Comparison by Log-Expectation) 
(http://www.ebi.ac.uk/Tools/msa/muscle) was used to align the S. aureus genome sequences to arrange the 
sequences so that regions of similarity can be readily identified. MUSCLE is a fast method for aligning large 
numbers of sequences and when compared it achieved greater accuracy than both ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2) and T-Coffee (http://www.ebi.ac.uk/Tools/msa/tcoffee), two other 
widely used multiple sequence alignment programmes (Edgar, 2004). Multiple alignment is an essential 
perquisite to any further phylogenetic analysis, it allows DNA sequences to be compared to each other and 
also allows nucleotide difference to be highlighted. 
On the MUSCLE tool homepage, shown in figure 2.36, a set of virulence factor gene sequences 
(alpha-hemolysin in the example shown) was pasted, in FASTA format into the input window ensuring that 
the output format is set to Pearson/ FASTA, and the job was submitted. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.36. An output showing 
the MUSCLE tool homepage 
with the alpha-hemolysin 
virulence factor pasted in 
FASTA format. 
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The job will only take a few minutes to appear in a new browser and the results will also be saved for 7 days 
on the server. Once completed, the aligned sequence results will be shown as FASTA format in the browser 
window (Figure 2.37). Simply ‘copy and paste’ the aligned FASTA format sequence into a text-file, this 
conserves the FASTA format. This process was preformed for all the sets of virulence factor gene sequences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.37: An output of the aligned sequence results shown on the 
MUSCLE homepage.  
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2.14 Phylogeny.fr 
 Phylogeny fr. (http://www.phylogeny.fr/index.cgi) is a publicly available online tool used for the 
identification of homologous sequences, their multiple alignment, phylogenetic tree reconstruction and the 
graphical representation of the inferred tree (Dereeper et al., 2008; Dereeper et al., 2010). Phylogeny fr. has 
three modes of use. The ‘One Click’ Mode is designed for users who have little experience in the field of 
phylogenetic’s. Insert a set of FASTA sequences into the submission box and this mode will use a specific 
workflow that includes MUSCLE for multiple alignment, PhyML tool for tree building and TreeDyn for tree 
rendering (Dereeper et al., 2008; Guindon & Gascuel., 2003). The ‘Advance Mode’ allows the parameters of 
each of the programs, in the above workflow to be customised. The ‘A La Carte’ mode allows a lot more 
flexibility. The user can create a customised phylogeny workflow using different programs from its server.  
(Dereeper et al., 2008; 2010). 
 Select the ‘One Click’ mode and paste the set of alpha-hemolysin sequences into the field in FASTA 
format (Figure 2.38). Name the analysis, choosing a name that reflects the data set. Enter an email address 
to receive the results and simply click submit. Once complete, the window will show a phylogenetic tree. Save 
as PDF and Newick file. 
 
 
 
 
 
 
 
 
 
Figure 2.38. An output 
showing a set of alpha-
hemolysin FASTA 
sequences pasted in to 
the phylogeny.fr query 
box. 
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2.15 DNA Sequence Polymorphism (DnaSP) 
 DnaSP, is a publicly available software package, developed for molecular population geneticists for 
the analysis of nucleotide polymorphism from aligned DNA sequence data and can handle a large number 
of sequences (Rozas & Rozas., 1995).  DnaSP is limited to run on Microsoft Windows® but can run on Apple 
and Linux based platforms with the use of an emulator software (Rozas et al., 2003).  
 
 In this analysis DnaSP version 5.10.01 was used. It is available to academic users from: 
http://www.ub.edu/dnasp.  DnaSP can read and export multiple-aligned nucleotide sequence file formats in 
FASTA, MEGA, NBFR/ PIR, NEXUS and PHYLIP (Rozas et al., 2003). DnaSP can estimate several 
measures of DNA sequence variation between populations, in noncoding, synonymous or non synonymous 
sites and analyse the evolutionary pattern of preferred and unpreferred codons (Rozas et al., 2003). DnaSP 
v5 can also allow for analysis on multiple files, haplotype phasing and analysis on insertion/ deletion 
polymorphism data and implements new algorithms and methods to identify conserved DNA regions, a useful 
feature for phylogenetic foot printing based analysis (Librado et al., 2009). DnaSP can also carry out several 
tests of neutrality, Tajimas test (Tajima., 1989) and Fu & Li’s test (Fu & li., 1993) are statistical tests for testing 
neutral mutation hypothesis. 
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2.15.1 Load Sequence Alignment 
 To begin, load the DnaSP program and you will be presented with the home screen (Figure 2.39a) 
 
 
 
 
 
 
 
 
 
 
Select ‘File’ in the top left hand of the window and choose the option to open a data file. Open a sequence 
alignment of your choice, in this example alpha-hemolysin is used and a new window will be presented 
(Figure 2.39b). 
 
 
 
 
 
 
 
 
 
 Figure 2.39a. An output of the 
DnaSP program showing the 
home screen. 
 Figure 2.39b. An output of the 
Data Information for this 
virulence factor. 
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The information presented in this screen needs to be changed, for example it is not a diploid number cell but 
instead haploid. Continue by closing this screen and you will return back to the home-screen and start 
formatting the data so that it matches your dataset. Select the ‘Data’ tab and choose ‘Format’, a new screen 
will be presented to you (Figure 2.39c). Ensure that ‘DNA’ Nucleotide Sequence, ‘Haploid’ Genomic State 
and ‘Prokaryotic’ Chromosomal Location is selected. Click OK and return back to the home screen. 
 
 
 
 
 
 
 
 
 
 
Select the ‘Data’ tab again and choose the ‘Protein Coding Regions’ tab, and a new window will be presented 
(Figure 2.39d). Ensure that the ‘Assigned the selected region as a protein coding region’ position has been 
set to ‘1’. Select ‘OK’ and another window stating that assignation has been done successful will open. It will 
then prompt for ‘Do you want to assign more regions?’ Select ‘No’ and return back to the home screen.  
 
 
 
 
 
 Figure 2.39c. An output 
showing the Nucleotide 
Sequence Format for alpha-
haemolysin. 
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Select the ‘Data’ tab for the third time and choose ‘Assign Genetic Code’. A new screen will be presented, 
ensure that ’Nuclear Universal’ is selected from the drop down menu and select ‘OK’ (Figure 2.39e). 
 
 
 
 
 
 
 
 
 
 
Figure 2.39d: An output showing the ‘Protein Coding Regions’ that need to 
be selected for this data set. 
Figure 2.39e: An output showing that the ‘Current Genetic Code’ option need 
to be set to ‘Nuclear Universal’. 
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Select the ‘Display’ tab and choose ‘Data Info’, a new screen will be presented showing the updated 
information, confirm that everything is OK. The sequence alignment data is now ready for DnaSP analysis, 
Figure 2.39f. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.39f: An output 
showing the updated 
information of the current 
dataset (alpha-hemolysin).  
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2.15.2 Generate Polymorphism Data 
 On the home screen select the ‘Overview’ tab and choose ‘Polymorphism Data. A new screen will 
be presented (Figure 2.40). Tabulate the data in an excel sheet ensure that it includes the ‘Number of 
sequences’, ‘Number of variable sites’, ‘Number of haplotypes’, ‘Haplotype diversity’, ‘Standard deviation of 
haplotype diversity’, ‘Nucleotide diversity’, ‘Stander deviation of Pi’, ‘Average number of nucleotide 
differences’, ‘Tajimas’s test of neutrality’ and ‘Fu & Li’s test of neutrality’. 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.40: An overview screen showing the Polymorphism Data 
for the dataset (alpha-hemolysin). 
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2.15.3 Generate Polymorphic Sites  
 On the home screen select the ‘Analysis’ tab and choose ‘Polymorphic Sites’. A new screen will be 
presented (Figure 2.41). Tabulate the ‘Total number of synonymous mutations’ and ‘Total number of 
replacement changes’ (non-synonymous mutations) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.41: An overview screen showing the Polymorphic Sites for the dataset 
(alpha-hemolysin). 
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2.15.4 Generate Synonymous and non-Synonymous Substitutions 
 On the home screen, select the ‘Analysis’ tab and choose the ‘Synonymous and non-Synonymous’ 
tab. A new screen will be presented (Figure 2.42), confirm that the ‘In Coding and Non-coding regions’ is 
selected in the ‘Silent Substitutions considered’ tab, and select ‘OK’. 
 
 
 
 
 
 
A new file will be generated (Figure 2.43), export the file and open in Microsoft excel. Subsequently, calculate 
the average of the Ks and Ka column and the standard deviation of the averages. Tabulate the results in a 
spreadsheet. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.42: An overview screen showing the options that need to be selected 
to generate synonymous and non-synonymous substitutions. 
Figure 2.43: The output file generated in DnaSP showing the synonymous and non-
synonymous mutations for this dataset (alpha-hemolysin). 
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2.15.5 Define Datasets 
 On the home screen, select the ‘Data’ tab and choose ‘Define Sequence Sets’ and a new screen will 
be presented (Figure 2.44). Create four new sequence sets. Move over all of the sequences that are being 
used in the study to the ‘Included List’, removing any strains that are no longer being used, for example the 
alpha-hemolysin reference sequence. Subsequently create a Hospital-associated, Community-associated 
and Livestock-associated sequence set, using information from the literature research. Save the file in an 
output file 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.44. An overview showing the ‘define data set’ screen with four data sets; all 
sequences, hospital associated, community associated and livestock associated. 
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2.15.6 DNA Divergence  
 Select the ‘Analysis’ tab and choose ‘DNA Divergence Between Populations’ and a new screen will 
be presented (Figure 2.45). Generate DNA divergence between different populations, i.e. ‘Livestock-
associated vs Community-associated’, ’Community-associated vs Hospital-associated’ and ‘Hospital-
associated vs Livestock-associated’. To do this, change the datasets by changing the ‘Population #1’ and 
‘Population #2’ drop down menu, select OK and a new screen will be presented with the output (Figure 2.46). 
 
 
 
 
 
 
 
 
 
 
 
Tabulate the average number of nucleotide differences between populations, the average number of 
nucleotide substitutions per site between populations (Dxy) and the number of net nucleotide substitutions 
per site between populations (Da) 
 
 
 
 
Figure 2.45: An overview screen showing the options that need to be 
selected to generate the DNA divergence data. 
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2.15.7 Generate Haplotype Data  
 On the home screen, select the ‘Generate’ tab and select ‘Haplotype Data File’ and a new window 
will be presented to you (Figure 2.47). 
 
 
 
 
 
 
 
Figure 2.46: An overview screen showing the results for the DNA divergence 
between populations data.  
Figure 2.47: An overview screen showing the options that need to be 
selected to generate the Haplotype data. 
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Select ‘All included (n=54) sequences’ from the data set drop down menu. ensure that Generate NEXUS 
Haplotype Data File is selected and press OK. A new window will be opened (Figure 2.48), Save the file in 
NEXUS format (*.nex) and in the Current Output format (*.out). Tabulate the Haplotype’s with its 
corresponding sequence name. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.48: An overview screen showing the results for the Haplotype 
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2.15.8 BioEdit 
 Open the sequence alignment file (alpha-hemolysin) in BioEDIT, a biological sequence alignment 
editor that is publicly available to download at: http://www.mbio.ncsu.edu/bioedit/bioedit.html. Once open, the 
screen will show the alignment (Figure 2.49) (Hall., 1999). 
 
 
  
 
 
 
 
 
 
The names of the Staphylococcus aureus sequences are on the left hand side and its corresponding 
nucleotide sequence is on the right, altogether there are 54 sequences. Select the drop down menu under 
the ‘Mode’ tab and change to Edit. Using the haplotype data from section H, delete all S. aureus sequences 
that are duplicate haplotypes, for example, Haplotype_2 consists of 3 haplotype sequences, namely MRSA 
OP100, MSSA476 & MW2. Select the 2 latter sequences on the left hand column and simply delete. The end 
process should include only 15 haplotype sequences. Using BioEdit, export the file as a FASTA file. 
 
 
 
 
 
Figure 2.49: An overview 
screen of BioEDIT showing 
the sequence alignment file 
for alpha-hemolysin.  
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2.15.9 Generating a NEXUS file 
 Open a new window on DnaSP and load the haplotype FASTA file that was formatted in BioEdit. On 
the home screen, select the ‘Generate’ tab and choose ‘Haplotype Data File’. Save the output as a NEXUS 
file. The file generated will be used for further studies. 
 
2.16 Population Analysis with Reticulate Trees (PopART) 
 PopART  is a software package publicly available at: http://popart.otago.ac.nz. PopART version 1.7 
was downloaded and used in this project (Popart., 2016). PopART provides a powerful and user friendly 
interface capable of producing minimum spanning, median-joining and TCS haplotype network (Leigh & 
Bryant., 2015). If the haplotype data also has corresponding geographical data, PopART can also use the 
map feature to place the the nucleotide sequences on a map viewer (Leigh & Bryant, 2015). PopART reads 
NEXUS-format alignments. Start by opening the file created in DnaSP section 2.15.9, in a text editor program, 
such as notepad and edit the data file. Arrange the data so that it is presented as shown in the Figure 2.50 
below. In this example the format labels correspond with the sequence data sets for alpha-hemolysin, created 
in section section 2.15.5. The define sequence data sets include 3 traits: Livestock_acquired, 
Hospital_acquired and Community_acquired. The haplotype that corresponds with that specific trait is 
grouped together to indicate how many are present in each trait.  
 
 
 
 
 
 
Figure 2.50: An example of a NEXUS file showing the haplotype data for alpha-hemolysin. 
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Edit the remaining alignment, label the taxa labels so that it corresponds with the traits edited previously and 
ensure that there are no gaps in the alignment, the final NEXUS file should look like the Figure 2.51. Save 
the file in NEXUS format. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.51: An overview screen showing the edited NEXUS file for alpha-hemolysin. 
	
	
112	
Open PopART (Figure 2.52). Using the toolbar at the top of the viewer, the nex tab, load the edited aligned 
NEXUS file. The file will appear in the data viewer and will display the 3 traits and the number of sequences 
and samples that correspond to it. 
 Using the Network tab, select the type of network you wish to use, for example TCS network. It will 
be displayed in the viewer where the TCS network can be viewed and evaluated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.52: An overview screen showing the PopART home screen with the 
toolbar and loaded NEXUS files. 
  
 
 
 
 
 
 
 
 
Chapter 3: 
 
Strain Selection, Strain Classification and Virulence Factor Extraction 
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3.1 Introduction 
 Methicillin-resistant S. aureus (MRSA) is a major pathogen that can cause a diverse array of clinical 
conditions and diseases in humans ranging from superficial infections of the skin to more severe soft tissue 
infections (Casey et al., 2013). MRSA infections are not restricted to humans; this bacterium has the ability 
to invade and cause harm to a diverse range of animal species including commercially important farm animals 
such as cattle, sheep, swine and poultry. Other animals such as horses, rabbits and companion animals, e.g. 
cats and dogs, are also susceptible. They can cause a variety of clinical symptoms and diseases which can 
cause illness and death. 
 
 
 Historically, MRSA only occurred in health-care settings and was therefore defined in the literature 
as a hospital-associated MRSA. (Sydnor & Perl, 2011). Eventually, MRSA was noted in the community, 
affecting patients who had no healthcare-related predisposing factors; these MRSA were subsequently 
termed community-associated MRSA (Deurenberg & Stobberingh, 2008). The community-associated MRSA 
became increasingly endemic and have now become the leading cause of skin and soft tissue infections 
(Chen et al., 2011). MRSA have also been identified in food-producing animals since the early 1970s, 
however humans were not implicated with the infection, instead the infection was limited to the animal 
(Weese, 2010). More recently, a third group of MRSA strains have been characterised with the identification 
of a novel MRSA reservoir associated with farm animals, and in particularly swine. These strains have been 
termed livestock-associated MRSA; and these MRSA have been identified globally as an emerging zoonotic 
agent with livestock constituting a reservoir of infection (Arman-Lefevre et al., 2005; Lindsay, 2010; Kimman 
et al., 2013). The present study will investigate the presence of genes encoding virulence factors that are 
associated with the S. aureus strains and determine what differentiates the classifications (HA, CA, LA), as 
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well as determining if the presence of certain virulence factor genes were responsible for the difference in 
pathogenicity between the different classifications.  
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3.2 Aims 
The aims of this present study were to: 
• Identify previously published sequenced genomes of known human and animal associated 
Staphylococcus aureus strains and classify them into either hospital-associated, community-
associated or livestock-associated strains as per the literature. The classification that was designated 
by the author was used in each case to designate if it was a HA, CA or LA strain.  
 
 
• Sequence and assemble into contigs the genomes of novel characterised MRSA strains from various 
host species that were acquired from The Veterinary & Agrochemical Research Centre in Brussels, 
Belgium as well as clinical human isolates collected from The Manchester Metropolitan University, 
UK. 
 
• From the literature, identify known S. aureus virulence factor genes and acquire their respective 
nucleotide sequences to establish if the virulence factors are present in both the previously published 
and novel strains; and extract its corresponding sequence.  
 
• Use MAUVE to compare the published S. aureus genome sequences. 
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3.3 Materials and Methods 
 
• The bacterial strains were cultured and maintained as carried out in Section 2.1, 2.2 and 2.3 and the 
isolation of Bacterial Genomic DNA using The GenElute™, as carried out in Section 2.4  
 
• The method for bacterial genomic DNA concentration and purity checks using spectrophotometric 
analysis and gel electrophoresis, as carried out in Section 2.5 & Section 2.6 
 
• The sequencing of the novel strains of S. aureus using Ion Torrent next generation sequencing, as 
carried out in Section 2.7. 
 
• The method for analysing and visualizing data from the novel S. aureus Next Generation Sequencing 
(NGS) as described in section 2.8. 
 
• The method for acquiring S. aureus genomes and virulence factors that have already been published 
as carried out in Section 2.9. 
 
• The method for identifying if virulence factor genes are present in some or all of the S. aureus strains 
as carried out in Section 2.11. 
 
• Using MAUVE for visually viewing and comparing the published S. aureus genomes as carried out in 
Section 2.10. 
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3.4 Results 
3.4.1 Strain Selection 
A total of 50 Staphylococcus aureus strains from human and animal origin were identified from 
GenBank®, an online genetic sequence database that is maintained by the National Centre for Biotechnology 
Information (NCBI). They were downloaded from the online database as described in section 2.9. Only 
complete, fully assembled and annotated genomes were collected into a local database. Important features, 
such as recording the NCBI accession number and the GenInfo Identifier (GI) number, the latter which the 
NCBI intend to discontinue from September 2016 were also recorded into the database. This is important as 
the sequence in the online database can be updated or changed and may differ if this study is reproduced. 
The S. aureus strains that were selected are listed in Table 3.1 
  
3.4.2 Strain classification 
Once the S. aureus genomes were acquired and placed in the local database, they were 
subsequently classified as per the literature as either; hospital-associated, community-associated or live-
stock associated S. aureus strains.   
At the initiation of this study there was no general consensus on a definitive definition of hospital-
associated, community-associated or livestock associated S. aureus strain. So for the purpose of this study 
it was decided that a working definition that matched the descriptive definitions used in the range of literature 
associated with S. aureus was used. Subsequent to the investigation of this study an almost identical set of 
definitions (that were described in Sections 1.8.1, 1.8,2 & 1.8.3) have been published by Bal et al. (2016). It 
is noteworthy to point out that information on the strains downloaded from GenBank (Table 3.1) was very 
limited with many journals not mentioning where the strain was isolated or under what circumstances (i.e 
hospital setting or community setting), so it was would have been very difficult to determine the classification 
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of the strain.  However, during the extensive literature review, the authors of the papers of the where the 
respective strain was studied almost always concluded what the classification of the strain was. 
 A thorough search of PubMed and GenBank was conducted and the table below was subsequently 
produced (Table 3.1). This table identifies the S. aureus strain, the NCBI/ GI accession numbers, the length 
of the genome, the classification and its corresponding literature reference. Not all strains are classified, as 
there was limited information present in the literature to classify them. In total, 3 strains could not be classified 
in Table 3.1; this included strains TCH60, NRS100 & 55/2053.  These strains  were excluded from all further 
analysis. 
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Table 3.1: Table identifying the the S. aureus strain acquired from GenBank, its corresponding NCBI/ GI accession numbers, the length of the genome in 
base pairs, classification and its corresponding reference in the literature. 
 
S. aureus strain NCBI accession & GI 
number 
Length (bp) Information about the Strain Classification Reference:  
08BA0216 NC_018608.1  
 
GI: 404477334 
2782313 A livestock associated MRSA strain that was isolated in 2008 in 
Canada from a human postoperative surgical site.  
 
This strain contains a novel staphylococcal cassette chromosome 
mec element type V (SCCmecV). 
Livestock Associated Golding et al., 
2012 
04-02981 NC_017340      
GI: 387149188 
2821452 A highly prevalent strain found in hospitals in Central Europe that was 
initially isolated in 2004 from Köln, Germany.  
Hospital Associated  Xue, et al., 2011 
Nűbel et al., 
2010 
11819-97 NC_017351.1   
 
GI: 385780298 
2846546 This 11819-97 is a ST80-IV representative that was isolated from a 
skin abscess from Denmark, in 1997. 
 
ST80-IV was initially identified in the early 1990’s and has historically 
dominated community associated infections in major parts of Europe 
that caused mostly skin and soft tissue infection. 
Community Associated Stegger et al., 
2012 
55/2053 NC_022113.1    
 
GI: 532358222 
2756919 Strain was sequenced on the 15th August 2015. 
 
No information found in literature. 
 Genome 
acquired from 
GenBank 
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502A CP007454.1      
 
GI: 595636499 
2764699 This strain was initially isolated from a nurse who become colonised 
when caring for 40 neonates, in 1963. 
 
In the 1960’s and 1970’s the 502A strain was used in bacterial 
interference programs. Infants were intentionally colonised with the 
502A strain to prevent colonisation with more invasive strains. This 
was eventually stopped as it caused several infections and deaths. 
Hospital Associated  Parker et al., 
2014 
6850 NC_022222.1   
 
GI:537441500 
2736560 6850 is a highly cytotoxic and clinically virulent Methicillin Sensitive 
S. aureus strain (MSSA). 
 
It was isolated from a patient with complicated S. aureus bacteraemia 
associated with osteomyelitis and septic arthritis. 
Hospital Associated  Fraunholz et al., 
2013 
 
Vann & Proctor, 
1987 
71193 NC_017673.1  
 
GI:386727822 
2715000 The initial ST398 MSSA strain was designated 71193 or 
ST398NMO1. It was isolated in 2004, with swine being identified as 
the major reservoir for infection. 
Livestock Associated Bhat et al., 2009 
 
Uhlemann et al., 
2012 
Bmb9393 NC_021670.1 
 
GI:521210823 
2980548 This strain was isolated in 2003 from a case of nosocomial 
bloodstream infections in Rio de Janeiro. It is now widely 
disseminated in Brazilian hospitals.  
Hospital Associated  Amaral et al., 
2005 
 
Costa et al., 
2013 
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COL NC_002951.2   
 
GI:57650036 
2809422 A strain that was isolated from an operating theatre in Colindale, 
England in the early 1960’s. It was initially identified as a penicillinase-
negative strain. 
Hospital Associated  Gill et al., 2005 
CN1 NC_022226.1  
 
GI:537459744 
2751266 This isolate CN1 is also termed HM1. It was initially obtained from the 
pus of a necrotising fasciitis infection in an 80-year old patient in the 
Seoul area of South Korea. 
 
Subsequently, it was also isolated from elderly patients between 2005 
to 2007; the sputum of a 68-year old male, the blood of a 71-year old 
female, the pus of an 82-year old male and 66-year old female. 
 
These are the most common strains of MRSA circulating the 
community in South Korea. 
Community Associated Li et al., 2010 
 
Lee et al., 2010 
 
Chen et al., 2013 
CA-347 NC_021554.1 
GI:514064966 
2850503 A community USA600 strain that was isolated from a bacteremia 
patient in California, in 2005. 
Community Associated Stegger et al., 
2013 
ECT-R2 NC_017343.1   
 
GI:384863396 
2729540 This strain caused a clonal outbreak in Ostergotland County, Sweden. 
It was originally isolated from a wound and was identified as a multi 
resistant methicillin-susceptible S. aureus (MR-MSSA).  
Community Associated Lindqvist et al., 
2012 
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ED133 NC_017337.1   
 
GI:384546269 
2832478 Strain 1774, designated ED133 (CC133 lineage/ ST133) was isolated 
from a case of bovine mastitis in France, in 1997. 
Livestock Associated Ben Zakour et 
al., 2008 
 
Guinane et al., 
2010 
ED98 NC_013450.1   
 
GI:269201690 
2824404 This strain was isolated from a chicken with bacterial chondronecrosis 
with osteomyelitis (BCO) in Ireland. Isolation date 1996 - 1997. 
Livestock Associated Rodgers et al., 
1999 
 
Lowder et al., 
2009 
H-EMRSA-15 NZ_CP007659.1 
 
GI:749295050 
2846320 A predominant health-care associated MRSA that was characterised 
as a prolific biofilm produce, emerged in the UK, in 1991 and rapidly 
displaced most other epidemic methicillin-resistant Staphylococcus 
aureus (EMRSA) strains. 
Hospital Associated  O’Neil et al., 
2001  
 
Sabirova et al., 
2014 
H0 5096 0412 NC_017763.1 
 
GI:386829725 
2832299 HO 5096 0412 is representative of the EMRSA-15 and is 99.4% 
similar to it. It was isolated in Suffolk, from a fatal neonatal infection, 
in 2005. 
Hospital Associated  Sabirova et al., 
2014  
 
Holden et al., 
2013 
JKD6008 NC_017341.1 
 
GI:384860682 
2924344 A strain that shows intermediate-level vancomycin resistance isolated 
in 2003 from the blood stream of a patient in New Zealand. 
Hospital Associated  Howden et al., 
2010 
 
Howden et al , 
2006 
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JKD6159 NC_017338.1 
 
GI:384548923 
2811435 A dominant Australian community-associated MRSA clone. It was 
identified in a intravenous drug user causing septicaemia, musculo-
skeletal abscess and outbreak of skin infection.  
Community Associated Chua et al., 2010 
JH1 NC_009487.1 
GI:148266447 
2906700 JH1, JH2, JH3, JH4, JH5, JH6 & JH9 are a series of MRSA strains 
that were isolated from a patient with congenital heart disease and 
endocarditis. 
 
This patient underwent antibiotic therapy which included vancomycin, 
rifampin and the β-lactam antibiotic imipenem and these MRSA 
evolved as a result of the impact of the therapy, the patient eventually 
died. 
 
JH1 was isolated at the beginning of this chemotherapy on the 
20/7/2000 and is susceptible to vancomycin and JH9 was isolated at 
the end of the chemotherapy and showed decreased susceptibility to 
vancomycin on the 13/10/2000. 
 
 
Hospital Associated  Mwangi et al., 
2007 
 
Sieradzki et al., 
2003 
JH9 NC_009632.1 
 
GI:150392480 
2906507 
LGA251 NC_017349.1 
 
GI:387779217 
2750834 This strain was isolated from a bulk milk sample from a farm in 
England, in May 2007. 
 
 
Livestock Associated Garcia-Alvarex et 
al., 2011 
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M1 NC_021059.1 
 
GI:479328021 
2864125 This strain was initially isolated in Denmark, in 2003. It subsequntly 
spread through the local hospital and eventually the nursing homes 
in the surrounding areas, affecting 501 patients and staff. This strain 
was not fully under control until 2009. 
Community Associated Larner-Svensson 
et al., 2013 
Mu50 NC_002758.2   
 
GI:57634611 
2878529 A clinical strain which showed resistance to vancomycin therapy from 
a 4-month old male Japanese infant. 
 
4-month old infant Japanese male patient who underwent heart 
surgery, in 1996. The site of the incision developed a purulent 
discharge which showed MRSA. 
Hospital Associated  Gill et al., 2005 
 
Hiramatsu et al., 
1997 
Mu3 NC_009782.1 
 
GI:156978331 
2880168 Isolated from the purulent sputum of a 64-year old Japanese male 
after a surgical operation for lung cancer, in 1996.   
Hospital Associated  Hiramstsu et al., 
1997 
MW2 NC_003923.1   
 
GI:21281729 
2820462 A highly virulent strain that was linked to four paediatric deaths in 
Minnesota and North Dakota. It was initially isolated from a 16-month 
old female from North Dakota, in 1998.  
Community Associated CDC, 1999 
 
Baba et al., 2002 
MSSA476 NC_002953.3 
 
GI:49484912 
2799802 Isolated from a 9-year old male, in 1998 with primary tibial 
osteomyelitis and bacteraemia who had no predisposing risk factors.  
Community Associated Holden et al., 
2004 
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MSHR1132 NC_016941.1 
 
GI:379794527 
2762785 Isolated from a blood culture of an indigenous female with necrotising 
fasciitis in September 2006. It is a strain that is dominant among 
indigenous communities in the Northern Territory of Australia.  
Community Associated Holt et al., 2006 
 
McDonald et al., 
2006 
MRSA252 NC_002952.2 
 
GI:49482253 
2902619 Isolated in 1997 from a 64-year-old female who acquired MRSA 
postoperatively.  
 
The organism was part of a miniature outbreak at an intensive 
treatment unit where all three of the infected patients who became 
infected died as a direct result of MRSA septicaemia. 
Hospital Associated  Holden et al., 
2004 
M013 NC_016928.1 
 
GI:379019812 
2788636 A PVL positive community-associated Taiwanese strain that was 
isolated from a wound specimen of a paediatric outpatient in 2002. 
Community Associated Huang et al., 
2012 
Newman NC_009641.1 
 
GI:151220212 
2878897 Isolated from a male, in 1952 from a case of secondarily infected 
tubercular osteomyelitis. 
Hospital Associated  Baba et al., 2008 
 
Duthie & Lorenz, 
1952 
NRS100 CP007539.1  GI:610395799 2823087 NRS100 is an identifier from the Network on Antimicrobial Resistance 
in Staphylococcus aureus (NARSA), and may be the same as strain 
COL. 
 Genome 
acquired from 
GenBank 
 
Gill, 2016 
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NCTC 8325 NC_007795.1   
 
GI:88193823 
2821361 This is a registered strain of the National Collection of Type Cultures 
and has been widely used as laboratory S. aureus strains.  
Hospital Associated  Baba et al., 2002 
N315 NC_002745.2 
 
GI:29165615 
2814816 A Japanese strain identified in 1982 from a pharyngeal smear. It was 
named after Nagasaki University Hospital, Japan, Isolate number 
315. 
Hospital Associated  Gill et al., 2005 
Kuroda et al., 
2001 
Baba et al., 2002 
RF122 NC_007622.1 
 
GI:82749777 
2742531 A bovine mastitis strain isolated from Ireland, in 1993. 
 
Livestock Associated Fitzgerald et al., 
2001 
Herron-Olsen et 
al., 2007 
Sung et al., 2008 
SA40 NC_022443.1 
 
GI:545636471 
2728308 A commensal Asian Pacific clone, that frequently colonises healthy 
children, isolated from a nasopharyngeal swab in 2005. 
Community Associated Chen et al., 2013 
SA957 NC_022442.1 
 
GI:545633528 
2789538 A virulent Taiwanese clone that was isolated from a 16-year male, in 
2000. It shows enhanced virulence in both humans and animal 
models.  
Community Associated Chen et al., 2013 
ST228 isolate 
18385 
NC_020568.1 
 
GI:470223734 
2759328 Eight different isolates of S. aureus belonging to ST228 lineage (spa 
type t041) collected between 2001 - 2008. at the tertiary care hospital 
in of Lausanne. 
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ST228 isolate 
16125 
HE579067.1 
 
GI:408430526 
2759457 The study concludes that eight isolates belonging to a lineage that 
spread over ten years within a tertiary care hospital with genomes that 
were extremely closely related. 
Only three of the eight isolates were included in this study because 
the dataset would have been to large. 
 
 
Hospital Associated  
 
 
Vogel et al., 
2010 
ST228 isolate 
16035 
HE579065.1 
GI:408428537 
2759835 
ST398 (S0385) NC_017333.1 
 
GI:387601291 
2872582 The initial ST398 strain was designated 71193 or ST398NMO1. It 
was isolated in 2004 from swine. 
 
A strain that poses a risk factor for humans working with intensively 
farmed animals such as pigs, cattle and poultry. 
Livestock Associated Schijffelen et al., 
2010 
 
Hernandez et 
al., 2013 
T0131 NC_017347.1 
 
GI:384868588 
2913900 An epidemic hospital-associated strain that was recovered from an 
87-year old patient in China, in 2006. 
Hospital Associated  Li et al., 2011 
TW20 NC_017331.1 
 
GI:387141638 
3043210 Isolated in 2003 during a 2-year outbreak of a highly transmissible 
MRSA, Sequence Type 239 in an intensive care unit in London. 
Hospital Associated  Edgeworth et al., 
2007 
 
Holden et al., 
2010 
TCH60 NC_017342.1 
GI:384865886 
2802675 A PVL (Panton-Valentine Leukocidin) positive strain that was isolated 
from the skin of a patient in Texas, USA.  
 McGavin et al., 
2012. 
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USA300_TCH151
6 
NC_010079.1 
 
GI:161508266 
 
2872915 USA300 strains are implicated in epidemiologically un-associated 
sporadic outbreaks of skin and soft tissue infections in healthy 
individuals. 
 
Isolate was obtained from an adolescent patient with severe sepsis 
syndrome. 
 
Community Associated 
 
Highlander et al., 
2007 
 
USA300-ISMMS1 CP007176.1 
 
GI:584463070 
2921008 Transmission of MRSA via a deceased donor liver transplantation 
from a 40-year old woman who presented with drug overdose and 
multifocal embolic cerebrovascular accident and MRSA endocarditis  
to a 64-year old man with cirrhosis from hepatitis C virus and 
hepatocellular carcinoma. 
Community Associated Altman et al., 
2014. 
USA300_FPR373
7 
NC_007793.1 
 
GI:87159884 
2872769 This strain was isolated from the wrist of a 36-year old HIV-positive 
male who has a history of intravenous drug use in September 2000. 
It was isolated by the clinical laboratory of a San Francisco hospital.  
Community Associated Diep et al., 2006 
UA-S391_USA300 CP007690.1 
 
GI:640834542 
2872916 A USA300 clonal lineage what was found to have a genome map 
identical to that of USA300_TCH1516. This strain is a prolific biofilm 
producer. 
Community Associated Sabirova et al., 
2014 
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VC40 NC_016912.1 
 
GI:379013365 
2692570 The overuse of Vancomycin has led to the emergence of vancomycin-
intermediate (VISA) and vancomycin-resistant (VRSA) S. aureus 
strains. It is termed VC40 because it is resistant to a vancomycin 
concentration of 40µg/ml. 
 
VC40 has been generated by serial passage of RN4220 strain with a 
mutS gene mutation. 
Hospital Associated  Schaaff et al., 
2002 
 
Sass et al., 2012 
 
Kreiswirth et al., 
1983 
XN108 CP007447.1 
 
GI:657154530 
3052055 Isolated from a 34-year old patient who had a wound infection and 
was hospitalised in February 2004 and underwent two skin 
operations, in mainland China. 
Hospital Associated  Zhang et al., 
2013 
 
Zhang et al., 
2014 
Z172 NC_022604.1 
 
GI:554642795 
2987966 A strain that was isolated from a blood specimen of an elderly 
intensive care unit patient. It is among the most prevalent of HA-
MRSA strains isolated in Taiwan. 
Hospital Associated  Chen et al., 2013 
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3.4.3 Mauve analysis  
MAUVE was used to compare the known and published S. aureus genomes that were extracted from 
GenBank®, as described in Section 2.10.  
 They were initially compared as total S. aureus sequences (Figure 3.1) and then as groups: Hospital-
associated (Figure 3.2), Community-associated (Figure 3.3), Livestock-associated (Figure 3.4) & Comparing 
the 3 groups (Figure 3.5). 
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Figure 3.1: An output of MAUVE 
representing 8 of the 47-published 
Methicillin-Resistant S. aureus genomes 
from Table 3.1. 3 strains which could not be 
classified were removed from this analysis 
(NRS100, TCH60 &55/2053). 
 
The in-set image is a magnified view of the 
MAUVE output and shows 8-MRSA strains. 
This is shown for representative purposes.   
 
The 6th sequence spears to be shorter in the 
inset figure, however, this is caused by a 
difference in the ‘origin’ used in assembling 
the genome.                                          
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Figure 3.2: An output of MAUVE representing the 24-
published Hospital-associated S. aureus genomes 
taken from Table 3.1.  
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Figure 3.3: An output of MAUVE representing the 16-published Community-associated S. aureus 
genomes from Table 3.1. 
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Figure 3.4: An output of MAUVE representing the 7-published Livestock-associated S. aureus 
genomes from Table 3.1. 
	
Figure 3.5: An output of MAUVE comparing a Hospital-associated (MRSA252), Community-
associated (USA300_FPR3757) and Livestock-associated (ST3980) S. aureus strains. 
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An output of MAUVE representing the 47-published S. aureus genomes is shown in Figure 3.1. This was an 
important step to visually see which genes these genomes share and which regions were unique to a 
particular genome(s).  
 
It is evident from Figure 3.1 that the 47-strains of S. aureus share regions that are homologous, but it is 
equally evident that the strains have regions that are unique to that strain. It was very difficult to view all 47 
strains at one time and extract any information that may be useful. Figure 3.1 also shows an inset image, it 
is a magnified view of the MAUVE output and shows 8 -MRSA strains.  
 It was decided that a smaller number of strains as well as comparing the three classes to examine the 
similarities and differences within each class would be applied to any future MAUVE analysis. 
 
 Outputs of MAUVE representing the Hospital-associated, Community-associated and Livestock-
associated groups were then created. Figure 3.2 is the output of Hospital-associated S. aureus (n=24). It is 
noticeable on the first instance that strain 502A differs greatly from the others (3rd strain down). All strains 
contain similar homologues segment; however, strain 502A’s segments position differs greatly. The reason 
for this is that it not a genuine rearrangement of the sequence, it is most likely caused by a different ‘origin’ 
when assembling the genome. It is also possible that the sequence in the database is for the complementary 
strand, when comparing it to the other sequences in this output. Although it is possible to undertake this 
analysis with the complementary sequence for 502A it would not be an easy task to rearrange the sequence. 
Strain 502A is unique because it was used to intentionally colonise infants with S. aureus to prevent 
colonisation with more invasive  strains, this practise was stopped as it caused severe infection and deaths 
(Parker et al., 2014).  The next noticeable strain is Bmb9393 (the 18th strain down from the top). This strain 
has undergone inversion of 3 regions or local collinear blocks, which is clearly shown in the output. It is 
interesting to note that this specific hospital-associated strain isolated from a case of nosocomial bloodstream 
137	
	
infection in Rio de Janeiro in 2003 is still widely disseminated in Brazilian hospitals (Costa et al., 2013). The 
average lengths of the individual hospital-associated genomes vary; from 2.6 Mbp for VC40 to 3.0 Mbp for 
XN108. It is worth noting that the whole-genome sequencing of S. aureus strain T0131 generated was 2.9 
Mbp (Li et al., 2011). It is therefore reasonable to suggest that Insertion/Deletion (Indel) events have taken 
place amongst the various genomes. The source of the strain may also be an indicator for the length of the 
strains. Strain 6850 was isolated from a patient with complicated S. aureus bacteraemia associated with 
osteomyelitis and septic arthritis whereas VC40 was generated by serial passage of RN422 strain that is 
resistant to Vancomycin. 
 Figure 3.3 is an output of MAUVE representing the Community-associated S. aureus strains (n=14). 
The Community-associated strains look very similar, this is demonstrated by the homologues segments and 
their respective nucleotide positions correlating between the various strains. It is noticeable that there is not 
much difference between the four USA300 strains (UA-S391_USA300, USA300_TCH1516, 
USA300_FPR3757 & USA300-ISMMS1). The alignment of these strains look almost identical with the 
exception of strain USA300-ISMMS1 that differs slightly at nucleotide position 2000000. The USA300 strains 
are all 2.8 Mbp, again with the exception of USA300-ISMMS1 which is 2.9 Mbp. This study coincides with 
the findings of Highlander et al (2007) and suggests that because the strains are highly similar based on the 
whole genome alignments undertaken with MAUVE, the differences in pathogenesis are likely due to very 
subtle changes of the virulence factor genes that have ultimately enhanced the organism’s fitness and 
pathogenicity. These subtle changes can be down to Single Nucleotide Polymorphism (SNP), a DNA 
sequence variation occurring when a single nucleotide changes and has the potential to alter the DNA and 
subsequent protein sequence.  
 Figure 3.4 is an output of MAUVE representing the Livestock-associated S. aureus strains (n=7). Strain 
ST398 and 08BA0126 are strikingly similar sequences of which both were isolated from humans. 71193 a 
methicillin-sensitive S. aureus (MSSA) strain isolated from humans also differs considerably at the segment 
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(coloured green) at points 1794397 to 1976645. Although there were no annotations at these points to 
determine what genes could be present, a blast search of the sequence at these point also didn’t yield any 
results.  ED133 and RF122 were both isolated from cases of bovine mastitis and it was interesting to note 
the two strains are significantly different from each other. Strains LGA251 and ED98 were isolated from a 
bulk milk sample and a chicken with chondronecrosis, respectively. Both strains share characteristics that 
are extremely similar to each other but different from the other LA-MRSA strains. For example, the red 
segment (located at nucleotide points 125436 to 413995) and orange segment (located at nucleotide points 
429183 to 1861135) are similar but differ greatly from the green segment (located at nucleotide points 
1887170 to 2030365), strain ED98 has regions that are strain specific and need further investigation. 
 Finally, Figure 3.5 is an output of MAUVE comparing a strain of hospital-associated (MRSA252), 
community-associated (USA300_FPR3757) and livestock-associated (ST3980) S. aureus strains. This is an 
interesting figure as it shows that not much difference exists between the various strains. The homologous 
regions that are shown in coloured blocks are shared throughout the 3 sequences. There are of course 
regions within the homologous blocks regions that are unique to the strain.  
 
3.4.4 Novel bacterial strain selection and classification: 
Along with the 50 published S. aureus isolates that were identified in this study, a selection of novel 
MRSA isolates from human and animal hosts were also investigated as described in section 2.1.  
 The information for these strains was provided by the collaborators. They were isolated from either 
human or animal sources, and were designated as the following: AS3, swine; B53, cattle; S62, chicken; B51, 
burns patient; IP70, inpatient and OP100, outpatient. It was confirmed by Dr Patrick Butaye (Veterinary & 
Agrochemical Research Centre, Belgium) and Prof. Valerie Edward-Jones (Manchester Metropolitan 
University) that the novel strains were all methicillin-resistant S. aureus isolates. The six strains were 
classified as either hospital-associated or live-stock associated MRSA strains, as shown in Table 3.2. They 
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were classified according to the information that was provided about them and their classification provided to 
us by our collaborators.
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 Staphylococcus aureus  
Strain 
Isolation Source Classification Reference:  
AS3 Swine Strain Livestock Associated  
 
 
 
Strain acquired from Dr Patrick Butaye. The Veterinary & Agrochemical 
Research Centre, Belgium 
B53 Cattle Strain Livestock Associated 
S62 Chicken Strain Livestock Associated 
B51 Burns Patient Hospital Associated   
 
 
 
Strain acquired from Prof Valerie Edward-Jones. Manchester Metropolitan 
University, UK 
IP70 In-patient strain Hospital Associated  
OP100 Out-patient Hospital Associated  
	
Table 3.2: Table identifying the the S. aureus strain acquired from the collaborators indicating its host, and the classification it has 
been designated. 
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3.4.5 Bacterial genomic DNA isolation 
The six bacterial strains were cultured and maintained as described in section 2.1, 2.2 and 2.3. The 
isolates were confirmed as being methicillin-resistant S. aureus (MRSA) samples so isolate identity was not 
carried out. Pure RNA-free genomic DNA was isolated from the six strains, as described in section 2.3. 
 
3.4.6 Spectrophotometric analysis 
 The purity and concentration of the DNA was determined by spectrophotometric analysis using the 
Nanodrop equipment as described in Section 2.5 and the results are given in Table 3.3. The results from all 
samples indicate that the DNA isolation had been successful. The A260/ A280 reading for DNA should be in 
the region 1.8 and RNA should be in the 2.0 range. It is evident from the results that pure DNA has been 
successfully isolated because all six of the reading were in the 1.8 range. The concentration is also in the 
expected region of 84.5 ng/µl – 190.0 ng/µl as indicated in the equipment’s user manual.  
 
 
 OP100 B51 IP70 B53 S62 AS3 
 Out patient Burns Patient In Patient 
Cattle 
Strain 
Chicken 
Strain 
Swine 
Strain 
Concentration 
(ng/ul)  84.5 192.0 152.7 95 85.5 108.0 
A260/ A280 1.837 1.82 1.848 1.845 1.839 1.846 
A260/ A230 3.25 2.233 3.211 1.9 2.375 2.077 
 
 
   
 
Table 3.3a: The results of the spectrophotometric analysis for the six S. aureus 
samples; which include the average concentration and the A260/ A280 readings.  
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3.4.7 Gel Electrophoresis 
 The isolated genomic bacterial DNA samples were analysed by gel electrophoresis as described in 
Section 2.6 and the results are given in Figure 3.6. 
 The results of the Gel Electrophoresis indicate that the DNA is intact and RNA-free as expected. 
Although there is little streaking and migration the majority of the DNA appears as large bands at the top of 
the gel; with the primary band for the isolated DNA being far larger then the largest fragment in the ladder 
(1000 bp). This is relevant becausep it shows that DNA fragments are much greater than the 100 – 1000 bp 
ladder that was used.  This clearly indicates the successful isolation of RNA-free DNA isolation of these 
bacteria.  
 
 
 
 
 
 
 
 
 
 
 Figure 3.6: An image of the gel electrophoresis results, the bands from left to right show; the 
ladder, MRSA OP100, B51, IP70, B53, S62 and AS3. The gel was run in a FlowGen Gel 
Electrophoresis system at a voltage of 200V for 3 hours and viewed using a Molecular Imager® 
Gel Doc™ XR System. 
1			2				3			4			5			6 
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3.4.8 Next Generation Sequencing 
The high quality RNA-free genomic DNA (gDNA) that was isolated from the six MRSA isolates 
(OP100, B51, IP70, B53, S62 & AS3), was used with the Ion Torrent™ next generation sequencing kit; and 
carried out as described in Section 2.7. The quality assessment results are from each stage of sequencing 
is mentioned below. 
 
 
3.4.8.1 Fragmentation of the DNA 
 The initial stage of the sequencing, involved the fragmentation of the DNA and then the subsequent 
clean up of the DNA as described in Section 2.7.1a and Section 2.7.1b, respectively.  
To ensure that the fragmented DNA was within the required size after the initial step, the 
Bioanalyser® instrumentation was used to assess its average size as described in Section 2.7.1c. The results 
of this is given in Figure 3.7a-g. 
 
 Figure 3.7a is an electropherogram of the high sensitivity ladder showing the upper and lower markers. 
These markers are indicators of a successful run. The ladder also shows the size of base pairs that can be 
expected; which range from 35 bp to 10380 bp.  
 
 A 400 bp ladder was used as the expected size of the DNA once fragmented should be between 350 
– 450 bp’s. The results shown in Figures 3.7b-g that the six isolates have been fragmented near to the 
expected fragment size, indicated by the peak in the graph. The results show the following: OP100 peaks at 
481 bp; B51 peaks at 479 bp; IP70 peaks at 483 bp; B53 peaks at 478 bp; S62 peaks at 481 bp and AS3 
peaks at 488 bp. 
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Figure 3.7a: is an electropherogram of the high sensitivity 
ladder, showing the lower and upper markers. 
 
Figure 3.7b-g: The results show the following: OP100 peaks 
at 481 bp; B51 peaks at 479 bp; IP70 peaks at 483 bp; B53 
peaks at 478 bp; S62 peaks at 481 bp and AS3 peaks at 488 
bp. 
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3.4.8.2 Ligation to Adaptors  
Once the fragmented DNA size was checked; the samples were ligated to their very own specific 
barcode adaptors as described in section 2.7.1d and as shown in Table 3.3. 
 
The ligated-DNA samples were then added to the E-Gel® SizeSelect™ agarose cassette, and once 
the samples had migrated to the 400-base pair collection well, it was extracted; as described in section 2.7.1e. 
The six samples were then amplified and purified as described in 2.7.1f. The six samples were subsequently 
quantified and pooled in equal-molar concentration in to two pools, as described in section 2.7.1g; the pools 
are shown in Table 3.3. 
 
 The barcoded library samples were then analysed by the Bioanalyser® instrumentation, as described 
in section 2.7.1c. The results of this is given in Table 3.3 and Figures 3.8a-g 
 
 
	 OP100 B51 IP70 B53 S62 AS3 
Specific 
Barcode adaptor 
33	 34	 35	 36	 37	 38	
Pool Number 1	 1	 1	 2	 2	 2	
Size in Base 
pairs 
437	 451	 464	 489	 492	 495	
Molarity (pmol/l) 988.6	 289	 438.4	 182.5	 284.5	 212	
Aligned 
migration time 
(seconds) 
79.18	 80.01	 80.74	 82.16	 82.37	 82.54	
  
Table 3.3: Showing the assigned barcode adaptors, the pool number and output of the Bioanalyser®; 
which includes the size of the isolate in base pairs, its molarity and the aligned migration time. 
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(E)	
	
(F)	
	
(G)	
	
Figure 3.8a: Electropherogram showing the fluorescence intensity 
(FU) versus the size/ migration time for the ladder markers. 
 
Figures 3.8b-g: Shows the fluorescence intensity (FU) versus the 
size/ migration time for the six samples. 
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3.4.8.3 Chip loading 
The 2 pools of MRSA samples were then loaded into the ports of two Ion 316™ v2 Chip as described 
in section 2.7.3d and a representation of how successful the loading was shown in Figure 3.3 and Table 3.4  
 
 It is interesting to note from Figures 3.9a, 3.9b and Table 3.4 that 71% and 72% of wells 
were loaded in both chips. The samples that were loaded in the wells were 100% enriched with Ion Sphere 
Particles (ISP). Both pools had a greater percentage of clonal ISPs which indicate that DNA is cloned from a 
single original template, as opposed to polyclonal, which indicate that the ISPs is carrying clones from two or 
more templates. For both pools, the number of usable reads was  50%, which is again an indication of a 
good analysis. 
 
  
 
 
 
 
 
 
 
 
Figure 3.9a: A representation of the loading density for pool two which includes MRSA OP100, B51 & 
IP70, on to the Ion 316™ v2 Chip. This heat map shows that the analysis has achieved an average 
loading density of 71%. As shown on the indicator bar; red shows a good loading density and blue 
indicates a poor loading density on the specific area of the chip. 
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Figure 3.9b: A representation of the loading density for pool two which includes MRSA B53, S62 & 
AS3, on to the Ion 316™ v2 Chip. This heat map shows that the analysis has achieved an average 
loading density of 72%. As shown on the indicator bar; red shows a good loading density and blue 
indicates a poor loading density on the specific area of the chip. 
 
	 Pool One Pool two 
Usable Reads 53% 50% 
% Loaded wells  71% 72% 
% Empty wells  29% 28% 
% Enrichment 100% 100% 
% Clonal  59% 56% 
% Polyclonal  41% 44% 
	Table 3.4a: Showing the success rate of Pool One and Pool Two chip loading; which is represented 
by % usable reads, % loaded / empty wells, % enrichment and % clonal/ polyclonal.  
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3.4.8.4 Ion Torrent summary 
 Once the Ion Torrent had completed sequencing the six strains, they were made available on the Ion 
Torrent Sever via the Ion Torrent browser and downloaded, as described in section 2.7.3e. The results from 
the Ion Torrent Browser analysis report indicated that a good run was performed. The results of the run are 
shown below in Table 3.4b. The results in the table include the total number of sequence reads, average 
length of the read, the total number of contigs and the average length of the contigs. 
 
3.4.8.5 Genome Assembly  
 The CLC Bio Genomics workbench software package was used to assemble the six MRSA isolates 
using the read mapping function as described in section 2.8. The sequences were mapped to two reference 
S. aureus genomes; NCTC 8325 and MW2. NCTC 8325 was chosen because it is a laboratory reference 
genome and MRSA MW2 was chosen because it is a highly virulent strain that includes a majority of the 
virulence factors (n=40) identified in the literature. The results of the MW2 read mapping is shown below in 
table 3.4b. It was not possible to fully assemble the strains as there was not a sufficient density of cover to 
allow one to get a fully assembly. The coverage varied between 75.94% to 94.05% of the mapped read. If 
one Ion Torrent chip was used per sample, then it may have been possible to achieve a greater coverage 
and potentially assemble each strain, however this was not the case. The table shows the total number of 
MW2 mapped reads, the % of MW2 mapped reads as well as the average length of the mapped reads. 
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 OP100 B51 IP70 B53 S62 AS3 
Total 
sequence 
Reads 
841,702 755,056 715,221 739,943 791,261 661,387 
Average 
length of 
Read 
297.03 309.63 321.34 307.3 292.44 305.85 
Total No. of 
Contigs 
1,662 80 93 162 164 137 
Average 
length of 
Contig 
3,838 34,580 30,051 17,534 17,415 20,453 
No. of MW2 
mapped reads
  
756,556 710,150 641,185 624,788 600,896 584,528 
% of MW2 
mapped reads 
89.88% 94.05% 89.65% 84.44% 75.94% 88.38% 
Avg length of 
mapped reads 
298.43 311.02 323.08 312.17 298.69 309.34 
 
 
 
 
3.4.9 Selecting and acquiring the virulence factor gene seqeunces 
 A literature review was then undertaken to identify known S. aureus virulence factors and acquire 
their genomic sequences as described in section 2.9.3. Table 3.5 presents a list of virulence factors and their 
respective gene symbols that were compiled. Virulence factors refer to the properties that will enable S. 
aureus to establish itself in the host and enhance its potential to cause disease. This list includes the major 
virulence factor genes, i.e. adherence genes, cytotoxin genes, immune evasion genes, enzyme genes, super 
antigen protein genes and enterotoxin genes, as well as the genes that encode for methicillin resistance. 
This list includes a wide variety of virulence factors present for many different roles as described in Section 
1.5. 
 
Table 3.4b. This table shows the results of the ion torrent run which includes the total number 
of contigs as well as the average length of the contigs. It also shows the % of mapped reads 
including the average length of the mapped reads. 
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Gene  Description 
Methicillin resistance gene 
mecA Encodes for methicillin-resistance  
PBP2 Penicillin binding protein-2 
Cytotoxin  
hla alpha-hemolysin gene 
hlb beta-hemolysin phospholipase gene 
hlgA Gamma-hemolysin component A  
lukS-PV  Panton-Valentine leukocidin 
lukS leucocidin S component 
lukF-PV Panton-Valentine leukocidin subunit F  
Immune Evasion 
chp chemotaxis inhibitory protein CHIPS 
sbi IgG binding protein 
sak Staphylokinase  
Enzymes and other secreted proteins 
sspA serine protease; v8 protease; glutamyl endopeptidase 
sspB cysteine protease precursor 
sspC cysteine protease  
vwb von Willebrand factor-binding protein 
lip lipase 
lip1 triclylglycerol lipase 
coa staphylocoagulase 
lipA lipoic acid synthetase 
plc 1-phosphatidylinositol phosphodiesterase/ precursoer 
nuc nuclease 
nucA thermonuclease 
hysA, hysA1, hysA2 hyaluronate lyase 
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aur zinc metallo proteinase aureolysin  
Involved in Persistence 
hemB Delta-aminolevulinic acid dehydratase 
sepA multidrug resistance efflux pump 
Adherence 
cna Collagen adhesion protein 
efb fibrinogen-binding protein 
fnb fibronectin-binding protein 
ebpS elastin-binding protein 
bbp bone sialoprotein-binding protein 
eap extracellular adherence protein 
clf clumping factor 
Enterotoxins 
entE enterotoxin E 
sea enterotoxin A  
seb enterotoxin B  
seh enterotoxin H  
sek enterotoxin K 
seg enterotoxin G  
tst toxic shock syndrome 
 
 
 
 
 
 
 
Table 3.5: The S. aureus virulence factors and their respective genes. 
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3.4.10 Extracting virulence factors from published S. aureus strains 
 The Nucleotide BLAST tool (Altschul et al., 1990) was used to identify if the virulence factors, 
acquired through literature research and GenBank, were present in the published S. aureus. If the 
corresponding virulence factor gene was present, the gene sequence was extracted in FASTA format and 
GenBank format, as described in section 2.11.  A representation of the presence of virulence factors in 
Hospital-associated (Table 3.6), Community-associated (Table 3.7) and Livestock-associated (Table 3.8) S. 
aureus strains are given in Tables 3.6 to 3.8. The cut of value to determine if the virulence factor sequence 
was present in a particular strain was was set at 90% query coverage, 95% identity and an E value of <0.01, 
this data is shown in Appendix 2. BLASTn results were checked for evidence of gene duplication (more than 
one homolouge gene in a strain); however, no evidence of this was observed.  
 
3.4.11 Extracting virulence factors from novel MRSA strains 
 CLC Genomics Workbench was initially used to create a reference library of the novel strains using 
the read mapping functionality, as described in Section 2.8.2. This ensured that the novel sequences were 
annotated. A virulence factor database was then created, as described in Section 2.8.3. The virulence factors 
could then be located on the newly sequenced consensus sequence by simply searching for it using the 
name or symbol of the query virulence factor, it was also possible to use the BLASTn tool to locate them, as 
described in Section 2.8.5. A representation of the presence of virulence factors of the newly sequenced 
strains is given in Table 3.9 below. 
 
Once all of the virulence factor genes had been extracted from both the published and novel strains, a graph 
(Figure 3.10) showing the overall presence of virulence factor genes in the S. aureus strains, based on the 
percentage of sequence similarity was created. This graph shows that although the the frequency of virulence 
factor genes varies amongst the S. aureus strains, a majority of genes are shared as well. A clustered column 
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bar graph (Figure 3.11) representing the frequency of virulence factor genes in hospital-associated (HA), 
community-associated (CA) and livestock-associated (LA) was also produced. It is again evident from this 
graph that a majority of the virulence factor genes are shared amongst the HA, CA and LA strains, with a few 
exceptions. It is noticeable that the enterotoxins are not present in many strains along with the cna gene and 
lukSpV gene.
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Figure 3.10: A histogram representing the the prevalence of virulence factor genes in the 53 S. aureus strains. 	
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Table 3.6: A representation of the presence of virulence factor genes present in 24 published hospital-associated strains. The S. aureus strains are given across the top 
of the figure and the genes along the side. The black colour indicates that a gene is present in the S. aureus and the white indicates that it is absent. 
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Table 3.7: A representation of the presence of virulence factor genes present in 16 published community-associated strains. The S. aureus strains are given across the 
top of the figure and the genes along the side. The coloured block indicates that a gene is present in the S. aureus and the white indicates that it is not present.  
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aureus strains are given across the top of the 
figure and the genes along the side. The 
coloured block indicates that the gene is 
present in the S. aureus strain and the white 
indicates that it is not. 
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Figure 3.11: A clustered column bar graph representing the frequency of virulence factors amongst the hospital-associated, 
community-associated and livestock-associated published and novel S. aureus strains. 
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3. 5 Discussion 
 A number of published complete S. aureus genome sequences (n=50) were acquired for this study. S. 
aureus strains were classified as either hospital-associated (HA), community-associated (CA) or live-stock 
associated (LA), following an extensive literature review as shown in Table 3.1. For instance, S. aureus H-
EMRSA-15 has been described as a strain that appeared in 1991 and rapidly disseminated across UK hospitals 
affecting individuals who had been in the healthcare setting (O’Neil et al., 2001). This strain was therefore 
characterised as hospital-associated (HA). In contrast, S. aureus strain USA300_FPR3757 was described as 
causing sporadic outbreaks of skin and soft tissue infection in otherwise healthy individuals (Diep et al., 2007). 
This strain has therefore been designated as an epidemic community-associated (CA) S. aureus strain. Another 
isolate; S. aureus ST398 has been described as a livestock-associated (LA) because it was originally isolated 
from swine in 2004. Currently, this strain has been reported as the causative agent causing infection in humans 
working with intensively farmed animals (Schijffelen et al., 2010). Forty-seven S. aureus strains were successfully 
classified as either HA (n=24), CA (n=16) or LA (n=7). Three strains could not be classified due to the lack of 
information present in the literature. Staphylococcus aureus strains 55/2053, NRS100 & TCH60 were therefore 
omitted from further investigation. The methicillin-sensitive S. aureus (MSSA) strains were also included 
(MSSA476 & 71193) as a comparison to the MRSA strains, as they are effectively progenitor strains, for example 
71193 was the precursor to ST398 (MRSA) (Bhat et al., 2009; Uhlemann et al., 2012). The MAUVE analysis as 
well as the BLASTn analysis revealed that there were very minor differences between 71193 and ST398, with 
71193 harbouring only two additional virulence factor genes (chp & vwb) than ST398. 
 
Initial genome comparative analysis using MAUVE was carried out. Figure 3.5, an output comparing the three 
classifications was produced. Initially three classifications were expected to be different with more unique regions 
and segments, however, it was interesting as the strains were similar. The homologous regions represented by 
the coloured blocks were shared throughout the 3 sequences, with minor differences occurring within the blocks 
164	
	
indicating regions that are unique to the strain. More in-depth analysis using MAUVE observed that nucleotide 
differences did exist amongst the virulence factor genes but further analysis is required to test what the changes 
may cause phenotypically.  
 A further six novel MRSA strains were also investigated. These strains were also classified as either HA 
(n=3) or LA (n=3) according to the information that was provided by the collaborators. The presence of virulence 
factors from the published and novel strains were then examined further. It is observed that there is a minor 
difference in the presence of virulence factor genes amongst the classified strains, evidenced by Figure 3.11. 
 The presence of these genes amongst the strains was further analysed to try and suggest why the genes 
are present in some strains but not others. The first step in S. aureus colonisation is mediated by the products of 
a number of adhesion genes. One such gene, the cna gene, encodes the collagen-binding adhesion protein which 
targets collagen (Foster & Hook, 1998). Collagen-binding adhesion protein binds to collagen with a high degree 
of specificity (Rhem et al., 2000). It is therefore reasonable to suggest that the presence of the cna gene in 
livestock-associated (LA) S. aureus may contribute to the fact that it acts as a virulence factor, enhancing the 
bacteria’s chance of adhesion to the hosts cells and tissue. Although the sample size is small, this study has 
demonstrated that the cna gene is present in two LA strains that cause outbreaks in humans, however it is absent 
from the strains that are restricted to animals (ED133, ED98 & RF122), this characteristic is shown in Table 3.8. 
LA strain ST398, originally designated 71193 was isolated from healthy pig farmers and their pigs (Armand-
Lefevre et al., 2005). At the time, Armand-Lefevre et al., (2005) strongly suggested that S. aureus colonisation 
occurred in the nostrils of the pig farmers and that their daily interaction with the pigs most likely increased their 
chances of being colonised greatly with this bacterium. Whereas LA strain 08BA0216 was isolated from a human 
postoperative surgical site (Golding et al., 2012). It is suggested that that the adhesion protein was not absolutely 
necessary to cause an infection in this instance due to the presence of an open wound, nevertheless this strain 
still possessed the relevant gene to adhere to the collagen, abundantly present in the connective tissue of the 
skin. It is further noted that LA S. aureus which do not contain the cna gene have not effected humans. Strains 
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ED133 and ED98 have been implicated in an outbreak of bovine mastitis and a chicken with bacterial 
chondronecrosis, respectively (Lowder et al., 2009; Guinane et al., 2010). It is therefore suggested that these 
strains do not posses the ability to bind to collagen in humans or animals. The exception to this trend was strain 
LA LGA251 which was isolated from a milk sample (Garcia-Alvarex et al., 2011; Paterson et al., 2014). It is 
suggested however, that since this strain was isolated from a bovine bulk tank milk sample and not directly from 
the cattle, it only serves as a contaminant of the milk. This suggests that this strain may still have the potential to 
interact with human collagen, this remains to be seen.  When the novel LA strains sequenced in the study were 
examined, only LA-MRSA S62 carried the cna gene, it was not carried by either LA-MRSA B53 or LA-MRSA AS3; 
however, it is not known if these particular strains were isolated exclusively from animals, produce contamination 
or animal-to-human interaction. A conclusion cannot therefore be made due to lack of information. Typically, the 
LA-MRSA strains examined did carry a high proportion of the adherence genes that were being investigated: efb, 
ebpS, bbp, eap & clf. The exception was the fnb gene, which encodes the fibrontectin-binding protein, was absent 
from one of the sequenced strains (MRSA AS3); however, the eap gene and its subsequent extracellular 
adherence protein has the ability to bind to numerous plasma protein which includes fibronectin.  A majority of 
HA-MRSA (58%) did not carry the cna gene. It was present in strain MRSA252, an important   epidemic methicillin-
resistant S. aureus EMRSA-16 clone. However, all the other adherences genes (efb, ebpS, bbp, eap & clf)  are 
present in the HA-MRSA strains; except EMRSA and HO 50960412 that lack efb. It is not necessary for all of the 
adherence genes to be present because health-care institutions have other risk factors that can contribute to 
MRSA colonisation in humans and not just adherence. For instance, Strain Mu50 was isolated from a patient who 
underwent heart surgery.  Hiramstsu et al. (1997) suggested that the full complement of adhesion related genes 
to colonise the host are not required. The majority of CA-MRSA (81%) also do not possess the cna gene; again 
this is not the expected trend, however with the exception of the MSHR1132 strain; they do exhibit all of the other 
adherence related genes.  
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 Staphylokinase, encoded by the sak gene, promotes the establishment of S. aureus skin infections and 
increases the bacterial penetration through skin barriers (Kwienski et al., 2013). Once penetration has occurred 
through the skin barriers, staphylokinase activates plasminogen molecules to plasmin; an enzyme that degrades 
fibrin, a protein of the extra-cellular matrix (ECM) (Kwienski et al., 2013). This invasion of the host tissue results 
in the spread of the bacterium and increased infection. It is interesting to note that the majority of the highly 
virulent community-associated (CA) (88%) and the established hospital-associated (HA) (96%) including the 
newly sequenced HA S. aureus (100%) possess the sak gene. In contrast to this, all of the livestock-associated 
strains, including the newly sequenced LA strains lack the sak gene and therefore lack staphylokinase production. 
This study confirms that S. aureus from veterinary sources lack staphylokinase production and suggests that is 
may have an impact on the virulence of LA MRSA by promoting the establishment of S. aureus and causing 
increased bacterial penetration through the skin barriers (Kwienski et al., 2013).  
 
 The chemotaxis inhibitory protein virulence factor, which is encoded by the chp gene, specifically impairs 
the response of neutrophils and monocytes by reducing neutrophil recruitment towards complement activation 
(C5a) (de Haas et al., 2004). This gene is not present in the LA strains, with the exception of 71193. This is not 
the expected trend because MRSA ST398 was initially designated 71193 so the same genotypic profile was 
expected. The chp gene is also present in 62.5% of the HA strains and 50% of the CA strains including the highly 
virulent and endemic USA300 strains. This profile is an indication that there is a minor difference in the LA strains 
which differ from both HA and CA strains and suggests that the possession of different virulence genes may 
possible alter pathogenicity. 
 
 The presence of the Panton-Valentine Leuckocidin (PVL) in MRSA is associated with an increased 
virulence in humans and is typically found in CA (Sola et al., 2012) (1.5.6.3, Pg 1.8.2).  Functional PVL consists 
of two components encoded by the lukS-PV and lukF-PV genes, thus both genes are needed to establish PVL 
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as a virulence factor (Rahman et al., 1991). PVL gene lukS-PV is absent from 100% of the HA strains and the 
lukF-PV is present in 62.5% of the HA strains. Since both genes are needed to encode for the PVL toxin, this 
study confirms that none of the HA-MRSA strains have ability to produce functional PVL. The lukS-PV is present 
in 57% of the CA strains and lukF-PV is present in 69% of the CA strains. This study also confirms that the 
endemic hyper virulent USA300 strains (UA-S391_USA300, USA300-ISMMS1, USA300_FPR3737 and 
USA300_TCH1516) contain both genes and therefore have the potential to produce the PVL virulence factor, 
more examination is required to make a definitive conclusion on the production of this virulence factor. Studies 
by Blanco et al. (2011) concluded that the USA300 clones are predominant among the PVL-positive clones in 
Spain and throughout Europe and are normally implicated in severe skin and soft tissue infections (SSTIs). In the 
literature, for an isolate to be typically more pathogenic and classified as a community-associated strain, the 
presence of the PVL toxin is necessary with PVL positive genes being used as a marker (Bhatta et al., 2016). 
This study suggests that this association should no longer be applied to identify community-associated strains. 
The data also indicates that 100% of the published LA-MRSA strains encode the lukS-PV gene and only 1 strain 
(ED98) encodes the lukF-PV gene; again this would suggest that PVL is not functional in 6 out of the 7 strain. 
Surprisingly, the newly sequenced HA-MRSA and LA-MRSA strains harbour both of these genes and therefore 
the presence of PVL gene. This study concludes that livestock-associated strains possess the genes necessary 
to produce PVL but more work is required to demonstrate if it a functional gene. The conclusions drawn here 
support the findings by Peeters et al. (2015). Studies by Peeters et al. (2015) concluded that ST80 strains carried 
the Panton-Valentine leukocidin gene. 
 
 During infection, S. aureus can secrete two coagulases; Staphylococcal coagulase (coa gene) and von 
Willebrand factor binding protein (vWbp) (vwb gene), both promote coagulation by activating prothrombin, which 
in turn converts fibrinogen into fibrin and promotes clotting of the plasma or blood and enables the establishment 
of S. aureus disease (McAdow et al., 2012). The coa gene is present in all HA-MRSA strains, excluding MRSA 
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6850 which does however encode the vwb gene. The vwb gene also is present in a further 42% of all HA-MRSA 
strains. The coa gene is encoded by 100% of the CA-MRSA strains. A further 56% of the CA-MRSA also encode 
the vwb gene, including the highly virulent USA300 strains. The coa gene is encoded by 100% of the LA-MRSA 
strains, however, only the 71193 strain encodes the vwb gene. The novel sequenced strains do not encode the 
coa gene, however the trend is reverse, because excluding MRSA IP70, they all encode the vwb gene. These 
trends suggest that the presence of both the coa and vwb genes in the bacteria will determine a more virulent 
strain. This statement is supported by the fact that the highly virulent USA300 strains do encode both genes. 
 The mecA gene allows S. aureus to be resistant to β-lactam antibiotics by encoding the protein penicillin 
binding protein 2a (PBP2a). PBP2a has a low affinity for β-lactams such as methicillin, therefore allows the 
transpeptidation reactions to proceed, allowing cell wall synthesis at concentrations which would other have been 
inhibited (Lim & Strynadka, 2002; Rice, 2012). It is interesting to note that all strains that were investigated in this 
study have the presence of PBP2, this ensures that these strains are methicillin-resistant. Surprisingly, not all 
strains show the presence of the mecA gene; only 42% of HA-MRSA, 63% of CA-MRSA, 0% of LA-MRSA, 0% 
newly sequenced HA-MRSA and 100% of newly sequenced LA-MRSA encode for the mecA gene. This was not 
the expected trend but can be explained by the by the fact that in this study only one mecA gene was investigated. 
Studies have suggested a divergent mecA gene in livestock-associated LGA251 has been observed which is 
unique because it is phenotypically resistant to methicillin, however it has tested negative for the mecA gene 
(Garcia-Alvarex et al., 2011); this divergent mecAlga251 gene was not investigated in this current study, due to lack 
of time. In this study BLAST was used to help identify if the virulence factor genes were present in some or all of 
the S. aureus strains. The strains containing the virulence factor genes were only identified if they were highly 
similar. Various divergent mecA genes such as mecC were not recognised by the BLAST search, because it will 
only determine sequences that are similar. The cut of value to determine if the virulence factor sequence was 
present in a particular strain was was set at 90% query coverage, 95% identity and an E value of <0.05. mecAlga251 
has been recognised to be 70% identical to the S. aureus mecA gene (Garcia-Alvarex et al., 2011), this did not 
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therefore show up in the BLAST search. Further gene analysis is needed to confirm the presence of the mecA 
gene in all of these strains.  
 It has been shown that the presence/ absence of virulence factor genes can help predict if an organism 
will be pathogenic. However, it has also been demonstrated that the majority of these genes are present in 
the three classifications that have been given in literature (HA, CA & LA), with a minor difference within 
livestock-associated strains. It is therefore reasonable to suggest that classifications that have been given in 
literature may possibly be artificial and not universally applicable and that at a molecular level the strains are 
in fact very similar. This conclusion coincides with the findings by Bal et al. (2016) who published their paper 
a month before this thesis was submitted. Bal et al. (2016) concluded that the traditional classification of 
MRSA into hospital-associated and community-associated was no longer relevant and that genomic studies 
had has led to a better epidemiological understanding of this bacterium with the authors describing the 
‘blurring’ of these classifications (Bal et al., 2016). 
  
 
 
 
 
 
 
 
Chapter 4: 
Phylogenetic analysis of S. aureus strains 
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4.1 Introduction  
Phylogenetics is the science of classification of living organisms. A phylogenetic analysis attempts to 
group organisms, or gene sequences based on similarity and is dependent on the accurate estimates of 
evolutionary relationships (Gaucher et al., 2010). The phylogenetic trees that are produced are the inferred 
graphical representation of the evolutionary relatedness among the species. 
 
 A variety of models are used to reconstruct phylogenetic trees. The neighbour-joining tree (NJ) is 
constructed by calculating the genetic distance measured by comparing the nucleotide sequence; it is 
therefore a distance based method. NJ is the most widely used method for building phylogenetic trees, with 
the original research paper by Satiou & Nei being cited about 13,000 times since 1987 (Gascuel & Steel, 
2006). The maximum-parsimony tree (MP) is created by using the model that minimises the number of 
changes required to generate the observed variation in the sequences and chooses the tree that require the 
fewest mutations to explain the data.  Finally, the maximum-likelihood tree (ML) uses the method that first 
incorporates the Bayesian statistics to determine a model, a tree is then created which gives the highest 
likelihood of the observed data based on the selected model of evolution (Saitou & Nei, 1987; Yang & 
Rannala, 2012). 
 
In this study all three methods of phylogenetic tree reconstruction have been used to examine and 
analyse the phylogenetic relationship between the nucleotide sequences of the S. aureus virulence factor 
genes. This will help determine the relationship between the strains to see how they cluster together and 
infer how related they are. 
 
 
 
172		
4.2 Aims 
The aims of this present study were to:  
• Collate the virulence factor sequences that were extracted from the known (n=47) and newly 
assembled (n=6) S. aureus genomes into one FASTA file.  
 
• Use MUSCLE, a multiple sequence alignment software to align the collated virulence factor 
sequences. Repeating for all virulence factors (n=43) that were extracted (Edgar., 2004). 
 
• Use Phylogeny.fr for initial phylogenetic analysis and produce evolutionary trees that show similarities 
and differences in the genetic characteristics of the nucleotide sequences. The ‘One Click mode” 
pipeline was used to construct the trees within the phylogeny.fr program. No parameters were 
changed and the default settings were utilised within the software.  This included the use of MUSCLE 
3.7 to align the sequences, Gblocks 0.91b for alignment refinement by removing poorly aligned 
positions and divergent regions, PhyML 3.0 to undertake the phylogeny with the HKY85 substitution 
model which is suitable for calculating DNA substitutions such as transition and transversions and 
finally the tree rendering was undertaken using TreeDyn 198.3 (Dereeper et al., 2008). 
 
• Use MEGA, a molecular evolutionary genetics analysis software to construct Neighbour-Joining Trees 
(NJ), Maximum-Parsimony Trees (MP) and Maximum-Likelihood Trees (ML) to further compare the 
virulence factors of interest to determine if the three classifications of S. aureus (HA, CA & LA) are 
evident (Kumar et al., 1994). 
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4.3 Materials and Methods 
• The virulence factor sequences that were extracted from the known and newly assembled S. aureus 
genomes, as carried out  in Sections 2.9 and 2.11, respectively, were collated in to a single FASTA 
file. 
 
• The method for aligning the virulence factor sequences using MUSCLE, as carried out in Section 2.13. 
 
• The method for initial phylogenetic analysis using Phylogeny.fr as carried out in Section 2.14. 
 
• Use MEGA to construct construct Neighbour-Joining Trees, Maximum-Parsimony Trees and 
Maximum-Likelihood Trees as carried out in Sections 2.12.1, 2.12.2, 2.12.3, 2.12.4. 
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4.4 Results 
 The S. aureus virulence factors (n=43) that were compiled during the literature research and their 
respective genes are shown in Table 3.5. The nucleotide sequences of these virulence factors were 
extracted, if present, from the S. aureus genomes. Nucleotide BLAST was used to identify and extract the 
query virulence factor from the known S. aureus strains, as described in Section 2.11. CLC Bio was then 
used to identify and extract the query virulence factor from the novel S. aureus strains, as described in Section 
2.8. A representation of the presence of the query virulence factors for Hospital-associated, Community-
associated, Livestock-associated and the newly sequenced strains are given in Table 3.6, Table 3.7, Table 
3.8 and Table 3.9, respectively.  
 
 The extracted virulence factor gene seqeunces were then collated into a single FASTA file for each 
virulence factor. This file consists of a single-line description (the sequence name), with the first character of 
the description line preceded by a greater-than (>) symbol, followed by a text-based format for representing 
the nucleotide sequence base pairs. As an example, the mecA gene was present in n=10 Hospital-associated 
strains, n=10 Community-associated strains, n=7 Livestock-associated strains and n=3 newly sequenced 
strains. These were all collated into a single FASTA file so that comparative analysis could be done on this 
virulence factor gene. This was then carried out for all virulence factors (n=43). 
 
4.3.1 Aligning the S. aureus Sequences 
 The S. aureus sequences were subsequently aligned using MUSCLE, as described in Section 2.13. 
The output file was in FASTA format. Multiple alignment of sequences is an important step in many 
applications that will be carried out in this study; including phylogenetic tree estimations and the analysis of 
DNA polymorphisms (using DnaSP). Both are important bioinformatics applications that are used to 
understand the evolutionary process shaping genomic variation. 
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4.3.2 Phylogeny.fr 
Phylogeny.fr was then initially used to create phylogenetic trees, as described in Section 2.14. 
Phylogenetic trees were created for all of the virulence factor genes, they are given in Appendix 2. An 
example of one phylogenetic tree produced using phylogeny.fr is shown in Figure 4.1a.  
The phylogenetic tree is for the hla gene which encodes alpha-haemolysin. The virulence factors 
were chosen as it contains S. aureus strains from hospital-associated (HA), community-associated (CA), 
livestock-associated (LA) as well as the newly sequenced strains.  
 A phylogenetic analysis shown in Figure 4.1a was created using Phylogeny.fr and shows the 
relationship between alpha-hemolysin virulence factor gene that was extracted from the various S. aureus 
strains. The ‘red’ box is showing a number of livestock-associated strains that have formed a single clade. 
The 3 ‘blue’ boxes are highlighting hospital-associated strains that have clustered together to form 3 clades 
and the ‘green’ is highlighting the community-associated strains that have formed 1 clade. It is worth noting 
that not all LA strains fall in the same clade, the same is true of the HA and LA strains. 
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Figure 4.1a: A phylogenetic 
tree for the virulence factor 
alpha-hemolysin (hla) 
produced using phylogeny.fr 
showing 52 out of a total of 53 
possible strains (MSHR1132 
did not harbour the hla gene.. 
	
Figure 4.1b: A maximum-
likelihood tree for the 
virulence factor alpha-
hemolysin (hla) produced 
using MEGA. 
	
Key: 
Blue: HA-MRSA 
Red: LA-MRSA 
Green:  CA-MRSA	
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4.3.3 MEGA analysis 
A more detailed phylogenetic analysis was then undertaken using MEGA, as described in section 
2.12. Phylogenetic trees were created using the neighbour-joining method, maximum-parsimony method and 
maximum-likelihood method. In total 132 phylogenetic trees were created, however only six will be presented. 
The phylogenetic trees that will be presented are maximum-likelihood trees that are representative of the 
gene family classification.  
 
Figure 4.1b is a maximum-likelihood tree created using MEGA and shows the alpha-hemolysin 
virulence factor. A comparison between the two trees (Figure 4.1a and 4.1b) indicate that many of the clusters 
are similar, however not identical. For instance, the hospital-associated strains (HA) H-EMRSA-15 & 
H050960412 cluster together as do IP70 & MRSA252 and finally a larger clade consisting of XN108, Z172, 
Bmb9393, T0131, JKD6008 & TW20. The same is true of the community-associated (CA) clade (SA40, 
SA957 & M013) indicated by the green box. However, the notable difference can be observed in the livestock-
associated (LA) strains that have been clustered together (red box). In both figures one clade that consists 
of LA strains (B53, S62, AS3, O8B02176, ST398 & 71193) have clustered together. The other LA strains 
(LGA251, ED133, RF122 & ED98) that have clustered in Figure 4.1b but have not in Figure 4.1a with the 
exception of strain ED98. These differences concluded that MEGA maximum-likelihood trees were chosen 
over the other methods and program due to the nature of modelling. DNA sequences require a model to 
understand the largely stochastic process. Phylogeny.fr uses the HGY85 model, which can not be changed, 
whereas MEGA utilises a model that best fits the data; for alpha-hemolysin the Tamura 3-parameter model 
was used and each virulence factor gene had it own explicit model of evolution to fit to the specific dataset. 
 
Figure 4.2 is a bar graph representing the nodal support values that were achieved from a maximum-
likelihood tree for all of the virulence factor genes. These nodal support values are the bootstrap support 
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values (BP) for the splits or branches in the phylogenetic tree. The error bars represent the standard deviation 
of the nodal values and gives a general idea of how precise a measurement is from the true value. 
Phylogenetic bootstrapping is a technique for inferring confidence values on phylogenetic trees that is based 
on reconstructing many tree from minor variations of the input data, called replicates (Pattengale et al, 2010). 
High bootstrap support values for a branch is highly suggestive that the split actually occurs in the tree, 
conversely a low bootstrap support values suggests that this might not be true split. It can also suggest that 
recent expansion has occurred in the organism’s gene. A study by Pattengale et al. (2010) concluded that 
bootstrap replicates of 100 – 500 replicates is sufficient as it produces support values that correlate at better 
than 95%. For the ML analysis in this study the bootstrap was set to 500 replications, as shows in Section 
2.12.3. 
 
Figure 4.2 shows the mean nodal support values calculated from the maximum-likelihood trees of 
the S. aureus virulence factor genes. The majority of the ML trees nodal values are exceeding >50. This high 
nodal values therefore suggests that the split occurring in the trees have actually occurred. A number of 
genes are also showing low nodal values. 
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A bar graph representing the nodal support values that were acheived from a Maximum-liklihood tree for the virulence factor 
genes
Figure 4.2. A bar graph representing the mean nodal support values (achieved from 500 bootstrap replications) from maximum-likelihood trees 
that were produced for the S. aureus virulence factor genes. The error bars represent the standard deviation of the nodal support values. 
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Figure 4.3 is a maximum-likelihood phylogenetic analysis revealing the relationship of the S. aureus 
strains for the pbp2 gene which encodes penicillin-binding protein 2. The coloured boxes indicate clades that 
have formed as part of the classification that is observed in the literature. The red box indicates two livestock-
associated clades. The first clade are the LA S. aureus strains that have caused disease in humans and the 
second clade are the rest of the LA strains that have been isolated from the animals. The blue boxes indicate 
that 3 hospital-associated clades that are being observed. It is interesting to note that no community-
associated S. aureus strains were grouped in a clade, instead they are part of a larger clade that also includes 
HA and LA strains. 
 
Figure 4.4 is a maximum-likelihood phylogenetic analysis revealing the relationship of the S. aureus 
strains for the lukf-pv gene which encodes the Pantone-Valentine leucocidin subunit S and PVL toxin. This 
gene was chosen as it is a representative of a cytotoxin gene. The coloured boxes again denote the clades 
that have formed as part of the classification in the literature. The clades are well defined for this gene. 
 
 Figure 4.5 is a maximum-likelihood tree that reveals the relationship of S. aureus strains for the vwb 
genes which encodes the von Willebrand factor-binding protein. This gene was chosen because it is a 
representative secreted protein that enhances virulence. The red box shows the novel LA strains and the 
blue box show the novel HA strains. Again CA does not form its own clade but is instead clustered among 
the LA and HA strains. 
 
 Figure 4.6 is a maximum-likelihood tree that reveals the relationship of S. aureus strains for the seb 
gene that encodes enterotoxin B. This gene was chosen because it is a representative enterotoxin. The red 
box shows the LA strains that do not cause disease in humans. A single CA strain sits apart from the others 
and 2 HA clades are also present. 
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 Figure 4.7 is a maximum-likelihood tree representing the relationship for the clf gene which encodes 
clumping factor. The LA strains (red box) have formed the clades that do and do not cause disease in human. 
Again the CA strains are clustered amongst the HA and LA strains. 
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Figure 4.3: A Maximum Likelihood 
phylogenetic analysis, based on 
the General Time Reversible 
(GTR-G) evolution model. The 
relationship of HA, CA & LA S. 
aureus strains for the PBP2 gene 
which encodes Penicillin-binding 
protein 2. The numbers at the 
nodes are bootstrap percent 
probabilities values based on 500 
replications. Coloured boxes are 
consistent with strain 
classifications. 
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 Figure 4.4: A Maximum Likelihood phylogenetic analysis, based on the Tamura Nei (TN93+G) model of evolution. The relationship of HA, CA & LA S. aureus strains for the lukF-PV gene which 
encodes Panton-Valentine leucocidin subunit F. The numbers at the nodes are bootstrap percent 
probabilities values based on 500 replications. Coloured boxes are consistent with strain 
classifications. 
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Figure 4.5: A Maximum Likelihood phylogenetic analysis, based on the Tamura 3-
parameter (T92). The relationship of HA, CA & LA S. aureus strains for the vwb gene 
which encodes von Willebrand factor-binding protein. The numbers at the nodes are 
bootstrap percent probabilities values based on 500 replications Coloured boxes are 
consistent with strain classifications. 
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Figure 4.6: A Maximum Likelihood phylogenetic, based on the Hasegawa-Kisaino-Yano parameter 
(HKY). The relationship of HA, CA and LA S. aureus strains for the seb gene which encodes 
enterotoxin B. The numbers at the nodes are bootstrap percent probabilities values based on 500 
replications Coloured boxes are consistent with strain classifications. 
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Figure 4.7: A Maximum Likelihood 
phylogenetic analysis, based on the 
General Time Reversible (GTR-G) 
parameter. The relationship of HA, CA & 
LA S. aureus strains for the clf gene which 
encodes clumping factor. The numbers at 
the nodes are bootstrap percent 
probabilities values based on 500 
replications. Coloured boxes are 
consistent with strain classifications. 
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4.5 Discussion: 
 It was concluded by a comparative analysis of two phylogenetic trees (Figure 4.1a & 4.1b) created 
using two different techniques (Phylogeny.fr & MEGA) that the optimum methods of phylogeny reconstruction 
to be used in this study will be the maximum-likelihood method, using MEGA. This is further supported by 
the use of Bayesian statistical models that is incorporated within this method. It was observed in Figure 4.2 
that a large majority of ML trees produced show high nodal support values. This suggests that the splits and 
subsequent branching occurring in the trees have actually occurred. 
 Figure 4.1b is a phylogenetic tree for the virulence factor alpha-hemolysin (hla) that is found in the 
majority of the samples being observed (n = 52). The LA strains that have been clustered together are 
highlighted with a ‘red’ box and two clades are presented. The first clade (B53, S62, AS3, 08BA02176, ST398 
& 71193) consists of strains implicated with infection and diseases in humans. Subsequently, the second 
clade consists of LA strains that have not been implicated in human disease and instead have been isolates 
from either milk samples (LGA251) or bovine mastitis (ED133 & RF122). It is notable that ED98 has not 
clustered with this clade. It is suggested that ED98 has not clustered with the other LA strains because it is 
not a bovine strain or has not been implicated with humans, instead it has been isolated from a chicken with 
bacterial chondronecrosis and osteomyelitis. It is also notable that this second LA clade is part of a large 
clade that that also includes hospital-associated (HA) and community-associated (CA). This general trend 
seems to exist within all of the ML phylogenetic trees that were created for the various virulence factors. 
 Another notable trend in a majority of the ML trees, with the exception of the gene seb, is the clustering 
of HA strains H-EMRSA-15 and H050960412. This is not that surprising as it has been previously reported 
that both of these strains are predominant in the UK, and both have previously been profiled to being 99.45% 
similar to each other (Sabirova et al., 2014). This observation along with the consistently high nodal values, 
which are typically in the 90 – 99 percentile, suggests that the ML phylogenetic trees that have been produced 
are reflective of a true split. 
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 Another pattern that seems to be notable within the majority of the ML trees is the clade that consists 
of HA strains XN108, Z172, Bmb9393, T0131, JKD6008, TW20. Interestingly these HA strains are 
disseminated globally (China, Taiwan, Brazil, New Zealand & UK) and do not posses any, characteristic apart 
from the fact that they are hospital-associated. Again they are clustered in the majority of the ML trees that 
were produced. It is suggested that the possible cause for these HA strains clustering together could be the 
antibiotics that were used to treat them. If the same antibiotic has been used in different countries, it 
represents a common factor that is acting as a selective pressure being exerted on the S. aureus strain. This 
suggestion needs further investigation. Interestingly, these strains are part of a larger clade that also include 
the USA300 strains which are implicated in epidemiologically non-associated sporadic outbreaks in healthy 
individuals.  
 The final HA clade that appears in the majority of ML trees consists of strains MRSA252 & MRSA IP70. 
MRSA252 is a strain that was implicated in an outbreak at an ICU where all of the infected individuals died 
as a direct result of MRSA septicaemia. Whereas MRSA IP70, a newly sequenced strain was isolated from 
an inpatient, however no other information is available. Strains OP100 and B51 were isolated from 
outpatients, who by definition were hospitalised for less than 24 hours. These two novel strains are clustered 
with the other CA strains (MMSA476 and MW2) that have been implicated with paediatric deaths; it is 
reasonable to suggest that these strains may have been community-associated and not hospital-associated 
and further confirms this observation. 
  The green box (Figure 4.1) indicates a community-associated clade. Interestingly these three CA 
strains (SA40, SA957 and M013) are also Taiwanese clones so it is not surprising that they group together. 
It is therefore suggested that this CA clade is more likely due to a geographic relationship. 
 The maximum-likelihood tree that is of notable difference is Figure 4.4 and represents the lukF-PV 
gene. This ML tree represents an almost true split of the classifications (HA, CA & LA) of S. aureus that were 
initially to be expected before this study was undertaken. The exception was strain OP100 that is clustered 
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within a clade of CA strains. However, this coincides with the previous suggestion that because OP100 is 
from an outpatient, this strain may have been classified incorrectly. However, this observation is not 
consistent with all of the virulence factor genes. It was also previously concluded that PVL genes lukS-PV 
and lukF-PV that encodes the bi-component Panton-Valentine leucocidin (PVL) play a crucial role in the lysis 
of erythrocytes and leukocytes and are present in the novel livestock-associated strains. Two novel HA 
strains also posses both components of the PVL (B51 & OP100), again this has not been identified before.  
 
 The final ML tree presented in Figure 4.7 shows clf gene which encodes clumping factor protein.  This 
is an important adherence gene that has a dual role. Clumping factor A bind to sites on fibrinogen which 
plays a major role in blood clotting and clumping factor B is a major determinant of S. aureus nasal 
persistence and colonisation in hosts (Wertheim et al, 2008; Xiang et al, 2010). It has been observed that in 
a healthy population, approximately 20% are colonised with S. aureus and a further 30% of the population 
are intermittently colonised (Kluytmans et al, 1997). It is interesting to note that the CA strains do not cluster 
in a single clade. This observation suggests that nasal persistence of S. aureus is not strain dependent as 
the majority of both HA and CA strains have the same gene for clumping factor. That being said, it is also 
observed that LA strains do show a difference but nevertheless still possess the clumping factor protein. This 
is further supported by the origin of the LA ST398 strain. Armand-Armand-Lefevre et al (2005) observed that 
pig farming is a risk factor for increased nasal S. aureus colonisation. 
 In conclusion these observations are suggesting that although only a small sample set of virulence 
factors phylogenies were presented, the overall trend observed in the ML analysis showed consistently 
similar results. This data does show some clusters, notably in the livestock-associated strains and less so in 
the hospital-associated strains. Almost no clusters exist within the community-associated strains with the 
exception of one but it was proposed that this was likely due to a geographical relationship. It is therefore 
reasonable to suggest that the lack of clustering into HA, CA and LA clades again indicates that the 
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classifications given to these S. aureus strains by the authors of their respective papers may be artificial and 
leads to the finding presented by Bal et al. (2016) that there is a blurring of these epidemiological 
classifications. 
 It is important to mention that only one virulence factor was phylogenetically analysed at one time. The 
differentiation between the virulence factor phylogenies are also suggestive of the fact that different selective 
pressures may be acting on the genes which are therefore evolving at different rates. This needs further 
investigation. 
 
 
 
  
 
 
 
 
 
 
 
Chapter 5 
Investigating positive selection in S. aureus and divergence between populations 
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5.1 Introduction: 
The literature review discussed in Section 1.1 revealed that S. aureus is an established commensal 
organism that is relatively common as part of the human micro-flora, however it is also an opportunistic 
pathogen that can can cause disease, especially if the immune system is compromised (Sousa & Lenastre, 
2004). For this organism to become pathogenic, they must have the ability to establish infection and cause 
disease. S. aureus accomplishes this task by expressing virulence factors that will enable it to successfully 
attach and establish itself in/on the host and evade its defences. However, in order for S. aureus to survive 
in the host, it must adapt to any selective pressures such as changes to the hosts biology, the hosts immune 
system and any antibiotic therapy that may administered.  
 Genomes can undergo small changes as well as large-scale evolutionary changes. Frequent genome 
rearrangements are caused by genomic recombination events. Horizontal transfer has the ability to introduce 
new sequences into the bacterial chromosomes whereas deletions remove portions of the genomes (Darling 
et al., 2004). Substitutions of bases also readily occur. Substitutions are mutations that can exchange one 
base of the genome for another, this could result in a change of the codon that can then encode a different 
amino acid and consequently change the protein that will be produced. A synonymous substituiton is a 
change in the DNA sequence that codes for amino acids in a protein sequence, but does not change the 
encoded amino acid sequence. In comparison, a nonsynonymous substitution is a nucleotide mutation that 
alters the amino acid of a protein. Sequence alignments are therefore absolutely necessary for bioinformatics 
studies. Sequence alignments arrange the DNA nucleotide sequences to identify regions of homology among 
the strains. These regions of similarity/ dissimilarity are presented as rows and identifies nucleotide residues 
that may be conserved, not conserved (or mismatch) or not aligned.  The mismatch of the DNA sequences 
can be caused by substitutions or point mutations and the non-alignment can be caused by the insertion and/ 
or deletion of base(s) (Indels) (Edgar, 2004).  
 The genes encoding the various S. aureus virulence factors will be investigated and analysed to 
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determine if they are under positive selection by comparing the rates of synonymous versus nonsynonymous 
mutation (dN/dS or ω). DnaSP (Librado & Rozas., 2009) generated average number of nucleotide differences 
between the sequences per nonsynonymous site (dN) and also the average number of nucleotide differences 
between sequences per synonymous sites (dS). The ratio ω = dN/ dS can therefore be calculated and is a 
measure of the difference between the two sites (Yang & Bielawski, 2000). The virulence genes have different 
ω (dN/dS) values and inferences about the evolutionary mechanisms acting on the specific gene can 
therefore be made.  If ω = 1 it implies that the amino acid change is neutral and that the DNA sequence is 
evolving neutrally, if ω < 1 it implies that purifying selection is acting on the amino acid changes to filter our 
deleterious mutations and remove any non-synonymous substitutions from the population in order to 
preserve the function of the protein, only when ω > 1 does it imply that the amino acid change for the gene 
offers a selective advantage, providing evidence of diversifying or positive selection resulting is some kind of 
phenotypical outcome that is of benefit (Yang & Bielawski, 2000).  
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5.2 Aims: 
The aims of this present study were to:  
 
• To perform a genome-wide analysis on S. aureus virulence factor genes, in order to identify genes that 
are undergoing adaptive evolution.  
• Investigate divergence between populations of S. aureus  
 
 
5.3 Materials and Methods: 
 
• DnaSP analysis was carried out to determine nucleitde polymorphism from aligned DNA sequence 
data. The query virulence factor genes were loaded (Section 2.15.1). The polymorphism data was 
generated (2.15.2). The polymorphic sites data was generated (2.15.3). The synonymous and 
nonsynonymous substitutions were generated (Section 2.15.4). And the DNA divergence was also 
calculated  
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5.4 Results 
 
5.4.1 Haplotype and nucleotide diversity 
 
 
 The data that was produced from the DnaSP analysis is available in full in Appendix 1.  To determine 
the nucleotide DNA sequence variation in the S. aureus population, the proportion of nucleotide positions 
that are polymorphic can be determined.  Polymorphic or variable sites (s) were determined from the data. 
Polymorphic sites within the S. aureus DNA can be calculated by measuring the haplotype diversity (h) and 
nucleotide diversity per site (π) of the virulence factors. Haplotype diversity (h) is a measure of the probability 
that two randomly sampled alleles are different (de Jong et al., 2011). Whereas nucleotide diversity per site 
(π) is a measure of the average number of nucleotide substitutions between two populations or species and 
is used to measure the degree of polymorphism within a population (Nei & Li, 1979). Studies carried out by 
Goodall-Copestake et al (2012) estimated the genetic diversity of animal cox1 genes by calculating the h and 
π. The effect of sample size on haplotype diversity and nucleotide diversity were investigated; it was 
suggested that samples analysis of n5 individuals has shown to hinder accurate h and π comparisons 
where as sample sizes ≥25 are recommended for greater accuracy (Goodall-Copestake et al., 2012). 
  In this study the sample size of the S. aureus organisms was 52 strains with the frequency of the 
genes that are present ranging from 7 strains to 52, with the exception of the seh gene that was present in 5 
strains, suggesting that an overall good sample size is being tested. 
 A graph (Figure 5.1) was subsequently produced to show the the nucleotide diversity (π) within the 
virulence factor genes.   The graph shows that the overall nucleotide diversity of the virulence factor genes 
varies greatly. This suggests that variation does exist between populations of S. aureus, as demonstrated by 
the π of the virulence factor genes. 
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Figure 5.1: A graph representing the nucleotide diversity (π) of the S. aureus virulence factor genes. The error bars represent the standard deviation 
of the nucleotide diversity. Data was generated using DnaSP. The complete data generates is shown in Appendix 1. 
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5.4.2 Positive selection 
To examine and subsequently explain the genetic variation that was observed in the S. aureus 
virulence factors, the dN/dS (ω) ratios were calculated. The ω was calculated by using orthologous gene 
sequences that were found within in multiple S. aureus genome strains.   This ratio determines if selective 
pressure is being exerted on the gene. The summary data in Table 5.1 were extracted from Appendix 1 and 
it shows the virulence factor genes that are under positive selection including the statistical significance of 
this observation. 
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Virulence 
factor gene 
N (No. of 
sequences) 
S (No. of 
variable 
sites) 
Hd (Haplotype 
diversity 
dN dS ω (dN/dS) Tajimas D Statistical 
significance 
Fu & Li’s D Statistical 
significance 
PBP2 57 2 0.94 (+/- 0.015) 
26 202 0.12 -2.41 p<0.01 -6.11 p<0.02 
hlb 52 134 0.95 (+/- 0.019) 128 16 8 -1.39  -2.46 p<0.05 
hlgA 56 58 0.87 (+/-0.032) 13 47 0.28 -1.79  -4.49 p<0.02 
lukF-PV 34 570 0.86 (+/- 0.034) 161 123 1.31 -0.38  2.04 p<0.02 
sspA 57 411 0.86 (+/- 0.029) 219 88 2.49 -2.47 p< 0.01 -6.01 p<0.02 
sspB 57 201 0.89 (+/- 0.021) 65 142 0.46 -1.88 p<0.05 -4.87 p<0.02 
sspC 57 69 0.82 (+/- 0.035) 24 75 0.32 -2.47 P<0.01 -6.06 p<0.02 
vwb 27 134 0.55 (+/- 0.107) 78 42 1.86 -0.71  1.39 p<0.05 
lip 57 970 0.86 (+/- 0.024) 457 361 1.27 -2.63 p<0.001 -6.69 p<0.02 
lip1 56 845 0.93 (+/- 0.018) 365 143 2.55 -2.64 p<0.001 -6.49 p<0.02 
lipA 56 56 0.83 (+/- 0.033) 1 59 0.02 -2.11 p<0.05 -5.22 p<0.02 
plc  57 132 0.89 (+/- 0.022) 43 95 0.45 -0.61  -2.64 p<0.05 
plc 57 132 0.89 (+/-0.022) 43 95 0.45 -0.64  -2.64 p<0.05 
nuc 56 136 0.85 (+/- 0.032) 60 71 0.85 -2.38 p<0.01 -5.99 p<0.02 
hysA 57 1500 0.89 (+/- 0.028) 626 235 2.66 -1.66  -4.76 p<0.02 
aur 57 565 0.90 (+/- 0.021) 253 100 2.53 -1.78  -5.77 p<0.02 
sepA 55 65 0.85 (+/- 0.031) 8 59 0.14 1.75  1.66 p<0.02 
cna 22 225 0.89 (+/- 0.055) 127 206 0.61 2.01 p<0.05 1.15  
ebpS 56 335 0.89 (+/- 0.028) 253 71 3.56 -1.96 p<0.05 -5.60 p<0.02 
SCIN 57 79 0.82 (+/- 0.042) 37 37 1 -2.17 p<0.05 -5.29 p<0.02 
entE 19 374 0.54 (+/-0.136) 241 62 3.89 -2.39 p<0.01 -3.16 p<0.02 
sea 19 84 0.45 (+/-0.128) 39 84 0.46 -2.24 p<0.01 -3.37 p<0.02 
seb 14 213 0.80 (+/- 0.094) 138 68 2.03 2.59 p<0.01 1.36  
seh 5 81 0.4 (+/- 0.237) 26 55 0.47 -1.26  -1.26 p<0.02 
sek 18 34 0.82 (+/- 0.237) 30 4 7.5 1.13  1.66 p<0.02 
Table 5.1: Table showing the virulence factor genes that are under positive selection and the statistical 
significance tests. Data was generated using DnaSP. The complete data generate dis shown in Appendix 1. 
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Similar studies have previously demonstrated the role of the dN/dS. Figure 5.2a was produced from 
the dN/dS data generated for all S. aureus strains and all virulence genes. This graph shows the various 
virulence factors along the ! axis and the nonsynonymous to synonymous ratio (ω = dN/dS) along the " 
axis. This graph shows an array of results which suggests that the various virulence factor genes are either 
evolving neutrally (ω = 1), under purifying selection (ω < 1) or under positive selection (ω > 1). The data 
suggests that the vast majority of the virulence factor genes (n = 21) are undergoing positive selection, ω > 
1. Likewise, many virulence factor genes (n = 16) are also demonstrating purifying selection, ω < 1. Only a 
small minority of the genes (n = 3) are evolving neutrally (ω = 1), this is demonstrated on the graph by the 
placement of the gene being on the ! axis.  
In this study it is seen that genes under positive selection have been found in all virulence factor 
categories, and that the genes include; LukS-PV, lukF-PV, chp, sspA, vwb, lip, lip1 nucA, hysA, hysA1, aur, 
fnb, ebpS, bbp, entE, seb and tst. It is interesting to note that the dN/dS value for the mecA gene is ω = 1 
which suggests that the amino acid substitution may be largely neutral. The mecA gene, which is carried on 
a Staphylococcal Cassette Chromosome (SCCmec) is present in many strains of S. aureus that are resistant 
to methicillin; it is observed that the various strains have acquired the SCCmec by horizontal transfer that 
appears to be neutral, and not evolving (Ito & Hiramatsu, 1998; Katayma et al., 2000). Where the mecA was 
not present it is likely that divergent mecA genes such as the meclga251 or mecC are present but were not 
identified in this study. 
 
The next stage of the analysis focused on the livestock-associated strains only. This was because the 
livestock-associated S aureus strains were only recently noted and it would be interesting to investigate the 
genes that are under positive selection. Figure 5.2b is a graph representing the dN/dS ratio of all of the 
virulence factor genes present in only livestock-associated S. aureus strains. The sample size of the 
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livestock-associated strains was comparably smaller (n = 10) than all of the combined strains (n = 52). Similar 
genes as before are showing the same characteristics, for instance the hlb gene is amongst the virulence 
genes that is showing considerable positive selection (ω > 10.5). It is also interesting to note that the mecA 
gene is again evolving neutrally (ω = 1). Other genes have shown the same rate of evolution and are evolving 
under purifying selection (ω < 1) namely PBP2, hla, hlgA, spA, sspC, lipA, plc, sepA, cna, ebb and eap. The 
genes that are under purifying selection would not be expected to change. The notable difference in the clf 
gene which is under a considerable amount of positive selection in the livestock-associated S. aureus strains 
(ω > 6.03) whilst it is under purifying selection when collated with all of the other strains (ω > 0.85). The other 
notable difference is the absence of the enterotoxins from the livestock-associated strains. 
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Figure 5.2a: A graph showing the dN/dS ratio (ω) of all of the virulence factor genes 
in all of the strains. Complete data is availible in Appendix 1.	
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Figure 5.2b: A graph showing the dN/dS ratio (ω) of the virulence factor that are present 
in the livestock-associated strains. Complete data is available in Appendix 1. 
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 Figure 5.3a and Figure 5.3b were subsequently produced from the data that is presented in Appendix 
1. Figure 5.3 is a regression analysis that shows the length of the virulence factor gene sequences along the ! axis and the nucleotide diversity of the virulence factor genes along the " axis. The length of the virulence 
factor genes nucleotide sequence ranges from 330 bp (base pairs) for the sspC gene to 4872 bp for the 
hysA1 gene.  A single nucleotide polymorphism (SNP) is a variation in a single nucleotide that occurs at a 
specific position along the nucleotide sequence. Since nucleotide diversity is used to measure the degree of 
polymorphism within a population the expected trend from the regression analysis would be that the longer 
the virulence factor nucleotide sequence the greater the chance of a SNP occurring, this graph shows that 
this is statistically highly significant (P<0.001). As the graph shows, the nucleotide diversity increases as the 
length of the nucleotide sequence increases. 
 A second regressions analysis was also undertaken (Figure 5.b), to determine if there was a 
relationship between the observed dN/dS ratio of the virulence factor gene and the length of its nucleotide 
sequence. The graph produced shows the length of the virulence factor nucleotide sequences along the ! 
axis and the dN/dS ratio (ω) along the " axis. Since dN/dS ratio is the numbers of synonymous mutations 
versus the nonsynonymous mutation that are being observed on the nucleotide sequence of the virulence 
factor gene; the expected trend would be to observe a greater number of mutations occurring as the length 
of the virulence factor genes nucleotide sequence increases, however this is not the case. This graph 
suggests that this relationship does not exist, instead there is a large dN/dS clusters near the 150 bp to 1500 
bp mark (P = 0.704).
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Figure 5.3a: A regressions analysis showing the 
observed nucleotide diversity (π) vs the length of the 
virulence factor gene. The trend line is shown. 
(Slope: 0.000024; Intercept 0.017501; r2 0.292441; 
DoF 42; P=0.000151 therefore P<0.001). 	
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Figure 5.3b: A regression analysis showing the observed 
dN/dS ratio (ω) vs the length of the virulence factor gene. 
The trend line is shown. (Slope: -0.000127; Intercept 
2.271417; r2 0.003483; DoF 42; P=0.704).	
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 A second regression analyses was then undertaken of the livestock-associated strains to determine 
the significance of the data.  Figure 5.3a was then produced by the data that is presented in Appendix 2. This 
regression graph shows the length of the virulence factor nucleotide sequences along the ! axis and the 
nucleotide diversity of the virulence factor genes along the " axis. This graph suggests that there is 
correlation between the two variables. Although there a major cluster between 250 bp to 1000 bp, the graph 
does suggest that as the length of the nucleotide sequence increases there so does the nucleotide diversity, 
this is supported by the P < 0.001. The number of S. aureus sequences varied from n = 3 for the chp gene 
to a maximum of n = 10 for the hla gene. Goodall-Copestake et al. (2012) concluded that a sample size of 
≥25 is recommended for greater accuracy, this has not been the case for this analysis. Since the number of 
S. aureus sequences sample size did not exceed ≥25, it is suggested that a greater sample set is required 
to improve the accuracy of this observation. 
 
 A second regressions analysis was again undertaken (Figure 5.3.b), to determine if there was a 
relationship between the observed dN/dS ratio of the virulence factor gene and the length of its nucleotide 
sequence. The graph produced shows the length of the virulence factor nucleotide sequences along the ! 
axis and the dN/dS ratio (ω) along the " axis. This graph suggests that this relationship does not exist, 
instead there is a large dN/dS clusters near the 150 bp to 1500 bp mark, with a P value this is P = 0.145. 
This again suggests no significance. 
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Figure 5.4a: A regressions analysis showing the 
observed nucleotide diversity (π) vs the length of the 
virulence factor gene in livestock-associated strains. 
The trend line is shown. (Slope: 0.00003; Intercept 
0.018278; r2 0.248114; DoF 34; P=0.001991 
therefore P<0.001).	
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Figure 5.4b: A regressions analysis showing the 
observed nucleotide diversity (π) vs the length of the 
virulence factor gene in livestock-associated strains. 
The rend line is shown. (Slope: 0.000414; Intercept 
0.951858; r2 0.061562; DoF 34; P=0.145).	
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5.4.3 Divergence  
The next step was to investigate the divergence (Dxy) between the populations of S. aureus that 
have been classified, namely hospital-associated, community-associated and livestock-associated. The Dxy 
measure corresponds to the average number of sequence differences per nucleotide position between 
sequences sampled from two nucleotide populations, this was implemented by using DnaSP (Westram et 
al., 2016). 
 
 Figure 5.5 is a graph representing the divergence that was observed between populations of S. 
aureus. The observations suggest that the populations are not very divergent. A similar study by Jiufeng et 
al. (2013) investigated the divergence of of Clonorchis sinensis, a liver fluke species in China. The authors 
obtained 255 isolates that spanned over 17 provinces of China. Differentiation analysis revealed three 
clusters (A, B & C); however, it was concluded that there was low divergence within the populations with Dxy 
ranging from 0.4% to 0.8%, nevertheless a geographical link was observed (Jiufeng et al., 2013). 
Geographical linkage in S. aureus was  investigated further.
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Figure 5.5: A graph representing the pairwise nucleotide differences observed between two populations (Dx 
& Dy). This is used to quantify divergence within the populations. 
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Discussion 
 Bacteria need to adapt to its ever changing environment in order for it to survive and grow in the host. 
It is hypothesised that selective pressures, that are put on the bacteria, are the driving forces behind bacterial 
evolution (Lambert & Kussell, 2015). Investigating and analysing evolutionary events that occur in wild 
populations that can be possibly related to nucleotide changes is not an easy task and relies on assumptions. 
It is however possible to investigate ‘selective pressures’ in a controlled setting. For instance, Mwangi et al. 
(2007) conducted an experiment where a patient was treated with Vancomycin for three months due to 
reoccurring S. aureus infections. Samples of the bacterium were collected before and during intervals of the 
therapy, for instance the first isolate (JH1) recovered at the beginning of the treatment was fully susceptible 
to Vancomycin (MIC = 1µg/ml). The last isolate recovered at the end of the therapy (JH9) showed a decrease 
susceptibility to the chemotherapy (MIC = 8µg/ml), the bacterium ultimately developed resistance to this 
antibiotic and the treatment ultimately failed. There were only 35 point mutations identified in 31 loci between 
JH1 and JH9. The resistance patterns were correlated by observing the nucleotide substitutions. The first 
and second isolates (JH1 & JH2) only differed by six nucleotide substitutions (increasing the MIC from 1.0 to 
4.0 µg/ml); and between the second and fifth mutation (JH2 and JH5) there was a further increase in 
tolerance to Vancomycin (from 4 - 6µg/ml) caused by a single additional mutation in gene SA1249, of 
unknown function (Mwangi et al., 2007). It is interesting to note that only a few mutations can cause a 
bacterium’s tolerance to chemotherapy increase. The impact of nucleotide polymorphisms on virulence has 
also recently been demonstrated by identification of InDel’s and SNPs in the comparative analysis of two 
methicillin resistant S. aureus strains, USA300_FPR3757 and USA300-HOU-MR (Diep et al., 2006; 
Highlander et al., 2007). Highlander et al. (2007) identified an Indel in an operon (snoABCDEFG) in USA300-
HOU-MR which results in reduction in susceptibility to thrombin-induced platelet microbicidal protein 1 (tPMP-
1). It has been suggested that this allows USA300-HOU-MR to evade platelet-mediated killing in the blood 
stream and can therefore lead to a more severe disease (Highlander et al., 2007).   
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 Evolutionary analysis has been undertaken on many important human pathogens. A study by Lefebure 
& Stanhope (2007) investigated the genus Streptococcus. Analysis was carried out on 26 Streptococcus 
strains to determine levels of recombination and positive selection. This study reported that positive selection 
was observed in 11% to 34% of the core genome with the authors further concluding that positive selection 
was a much slower process on genome structure than recombination but nevertheless played an important 
role in species differentiation and host adaptation of different species to different hosts (Lefebure & Stanhope, 
2007). Another similar study by Lefebure & Stanhope (2009) investigated the genus CampylobacterIt was 
concluded that 92.5% of the non-recombinant genome of one lineage was under positive selection. Again, it 
was suggested that this may be due to the various species of bacteria in competition for resources in the 
gastrointestinal tract of animals and humans, resulting in a ‘Red Queen macroevolutionary dynamic 
Hypothesis’’ whereby each competing bacteria must constantly adapt in order to maintain its position within 
the ecosystem (Lefebure & Stanhope, 2007). Studies by Soyer et al. (2009) have shown evidence of positive 
selection that has also been noted in selected Salmonella serotypes. Salmonella causes disease in humans 
and different animal species and is another pathogen of great interest. Five Salmonella genome sequences 
were investigated that represented a broad host range and were used to identify core chromosomal genes 
that show evidence for recombination and positive selection. In total, 41 genes with confirmed or likely roles 
in virulence were found to be under positive selection, interestingly these were all located in Salmonella 
pathogenicity islands (SPIs). It was also concluded that positive selection contributes to the evolution of host 
restricted Salmonella serotypes (Soyer et al., 2009). 
 
 Positive selection was investigated in S. aureus species that are not only present in humans but also 
in a variety of different host species. These hosts will have distinctly different immune systems as well as 
different biological pressures exerted on the bacterium. In addition to this, the different hosts will also have 
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different therapeutic pressures exerted on to it which will cause S. aureus to evolve differently in the hosts if 
the organism is to thrive. It was concluded in this study that although there is a relationship between the 
nucleotide diversity (π) and length of the virulence factor gene, there is no significance between the dN/dS 
ratio of the virulence factor and its respective nucleotide significance indicating that the genes are instead 
exerted under positive selection. 
 
 The genes encoding for virulence factors were investigated and analysed to determine if they are under 
positive selection. It was observed that a majority of the genes were indeed under positive selection including 
LukS-PV, lukF-PV, chp, sspA, vwb, lip, lip1 nucA, hysA, hysA1, aur, fnb, ebpS, bbp, entE, seb and. It is also 
observed that genes PBP2, hlgA, hla, sspB, sspC, lipA, plc, nuc, cna, sea and seh are undergoing purifying 
selection. 
 
 The hlb gene was under a significant amount of positive selection as observed by the significantly high 
dN/dS ratio of 8. Beta-hemolysin which is encoded by the hlb gene functions as an exotoxin that is involved 
in the haemolytic activity on erythrocytes (Kataama et al., 2012). Recent studies have also suggested that 
the hla gene may have an important secondary role in skin colonisation with in vitro studies suggesting that 
colonisation efficiency was 50-fold greater with the presence of the gene than without it (Katayama et al., 
2012). In comparison alpha-hemolysin, a pore-forming cytotoxin encoded by the hla gene, does not have any 
secondary role and is instead involved in only erythrocyte lysis. The hla gene had a dN/dS ratio of 0.16, 
concluding that it is not under any kind of positive selection but is instead under purifying selection. This 
observation concludes that the selective pressure acting on this gene may be due to its secondary function. 
This phenomenon has altered the fitness of the S. aureus and it suggested that it is the driving force of 
evolution because it has to compete with the micro-flora of the skin if it is to colonise the host and thrive. The 
hlb gene will therefore be under continuous positive selection. This is further supported by Figure 5.2b. Again 
	
	
	 212	
the hlb was under positive selection and has a dN/dS ratio of 10.5. It is suggested that this gene may be 
needed for skin colonisation of the S. aureus to the host and it is under positive selection because it is 
competing with other micro-organisms.  Armand-Lefere et al. (2005) isolated LA-MRSA ST398 from healthy 
pig farmers and their pigs suggesting that colonisation occurred primarily in the nostrils however the 
colonisation of skin was not investigated during that study. 
 Since competing with other micro-organisms can drive selective pressure and cause evolutionary 
changes, it is not surprising that a majority of the adherence genes are under positive selection.  Figure 5.2a 
shows a cluster of adherence genes that are evolving under positive selection. For instance, adherence 
genes that encode fibrontectin-binding protein (fnb), Elastin-binding protein (ebpS) and bone- sialoprotein 
binding protein (bbp) have dN/dS ratios of 3.85, 3.56 and 2.83, respectively. This data strongly suggests that 
competition of other micro-organisms adhering to the host results in selective pressure acting on the gene.  
 Clumping factor (clf), found in a majority of the strains (n = 54), binds to different sites on the fibrinogen 
(clfA and clfB). It is observed from Figure 5.2a that the clf gene has a dN/dS ratio of 0.85, suggesting that the 
gene may be evolving away from neutrality. clf is neutral in the full data set but very positive in the LA data 
set (Figure 5.2), it is suggested host-pathogen interaction may play a role in this difference because 
interaction with host tissue plays a critical role in establishing, for example, mastitis infection (Kerro et al., 
2002). 
 Three enterotoxins, entE , seb and sek , dN/dS values of 3.88, 2.03 and 7.7, respectively, which cause 
sporadic food poisoning outbreaks are released by S. aureus strains also show considerable positive 
selection. The gastrointestinal tract is a very volatile environment to a microorganism due to competition with 
other bacteria, viruses, archaea and fungi with the human intestine being home to 1014  bacterial cells and 
thousands of strains (Kaiko & Stappenbeck, 2014). It is suggested that S. aureus has to compete in the hosts 
environment and could possibly acquire genetic information by natural genetic transformation which is the 
uptake of free DNA by bacterial cells, a type of horizontal gene transfer (Lorenz & Wackernagel, 1994). 
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 The human complement system is the first defence against bacteria, once activated it attracts 
neutrophils to the site of infections and opsonises bacteria to facilitate phagocytosis (Laarman et al., 2011). 
Staphylococcus aureus have successfully developed ways to evade the human complement system. Metallo-
protease aureolysin, encoded by the aur gene, is a complement inhibitor that prevents phagocytosis of the 
bacteria and thus ensures survival in the host. It is therefore not surprising that the aur gene has a dN/dS 
ratio of 2.53. Other genes that may be evolving due to selective pressure from the hosts defenses are both 
components of the PVL toxin, lukf-pvand luks-pv that have a dN/dS ratio of 1.3 and 2.04 respectively; and 
von Willebrand factor binding protein which is encoded by the vwb gene (dN/dS = 1.86). These secreted 
toxins and proteins will be considered foreign by the host and will be targeted by the immune response. The 
S. aureus will therefore have to to evolve and adapt if they are to survive in the host. 
 It is concluded that selective pressures act on various genes independently and that the size of the 
gene does not play a role in the rate of mutation. It is suggested that genes are therefore evolving at different 
rates as different genes are under different selective pressures. In addition to this, observations from the 
divergence studies suggest that there is very little variation amongst the hospital-associated, community-
associated and livestock associated populations, as seen in Figure 5.5. It is concluded that the three S. 
aureus populations are not significantly differentiated.   
  
 
 
 
 
 
 
 
 
 
Chapter 6: 
Population genetics of S. aureus 
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6.1 Introduction 
 Population genetics is the study of the distribution and change in frequency of alleles within a population 
and as such sits in the field of evolutionary biology; it examines the genetic variability within a population and its 
primary purpose is to understand the evolutionary forces that act upon it (Brookfield, 1996). It has been stated that 
pathogenic bacteria exist as population, with studies suggesting that members of these populations exhibit varying 
degrees of virulence (Spratt & Maiden, 1999). Many of the genes, as shown by this study, will be polymorphic and 
as such exist in a number of forms. It is important to understand that the focus of population genetics is to understand 
the population or species as a whole and not an individual strain. 
 
A software called DnaSP was implemented in this study to determine the level and distribution of genetic 
polymorphism within natural populations by comparing the respective alleles. In this study virulence factor genes 
that occur within a population of S. aureus were compared. The evolutionary forces which can include mutation, 
migration, selection and genetic drift are examined by DnaSP to determine the pattern of genetic variation that is 
being observed and is supported by a number of statistical methods and tests (Rozas et al., 2009). The ‘Neutral 
Theory’ of molecular evolution plays a central role in the analysis of genetic data. The Neutral Theory states that the 
majority of evolutionary change and most of the variation within a species at the molecular level are not caused by 
natural selection but instead driven by random drift of selectively mutant alleles that are neutral (Crow, 2000). DnaSP 
was also used to perform statistical neutrality tests on the data to determine if a DNA sequence is evolving randomly 
(neutrally) or evolving under a non-random process, i.e selection. Neutrality tests applied to the DNA sequences 
was Tajima’s D which is computed as the difference between two measures of genetic diversity i.e.  the mean 
number of pairwise differences and the number of segregating sites and Fu & Li’s D (Tajima, 1989). Another stasitcal 
test that examines the polymorphism distributions have been designed, namley the Fu and Li’s D and extends 
Tajima’s D by measuring the differences beween the number of mutations appearing only once among the 
seqeunces and the total number of mutations (Fu & Li, 1993; Rozas et al., 2009). Other statistical tests, such as the 
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Ramos-Onsins & Rozas index, R2 and the raggedness index, r were used to determine the evolutionary history of 
the species by detecting population growth (Ramos-Onsins & Rozas, 2002). 
 The use of haplotype networks to see a visual relationship between individual genotypes at the population level 
was also utilised in this study, by using a software called PopArt (Leigh & Bryant, 2015).  
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6.2 Aims 
The aims of the present study include:  
• To quantify the level of DNA polymorphism and subsequent genetic diversity in the S. aureus population. 
• To investigate the geographical relationship of the S. aureus population using haploptype networks  
• To investigate the classifications of S. aureus (hospital-associated, community-associated and livestock-
associated) at a population level and infer a relationship. 
• To investigate the diversity of synonymous and nonsynonymous mutations along the length of the gene using 
sliding window analysis. 
• Carry out demographic pairwise analysis of the S. aureus virulence factor genes to infer population growth 
events. 
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6.3 Materials and Methods 
 
• DnaSP analysis was carried out, in Section 2.15.  Intially the seqeunce alignment of the virulence factor 
was loaded, as carried out in Section 2.15.1. The polymorphism data, which included the number of variable 
sites, the haplotype diversity, nucleotide diversity and the tests of neutrailty, as carried out in Section 2.15.5 
and Section 2.15.3 
 
• Initally the virulence factor NEXUS file was generated in DnaSP, as carried out in Section 2.15.7. The 
NEXUS file was then formatted in BioEdit, as carried out in Section 2.15.8. And the method for Haplotype 
network analysis and the creation of haplotype networks using PopArt, as carried out in Section 2.16 
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6.4 Results 
6.4.1 Quantifying DNA polymorphism in the S. aureus population 
 Quantifying the level of DNA polymorphism in the S. aureus population was accomplished by measuring the 
nucleotide diversity per site (π), the number of variable sites (s), the number of haplotypes (h) and also the haplotype 
diversity (Hd) (Tajima, 1989; Rozas, 2009). This data was produced using DnaSP analysis which is available in full 
in Appendix 1. 
 
Figure 6.1a is a graph showing the number of variable sites (s) along the ! axis and the nucleotide diversity (π) 
along the " axis. This graph suggest that as the number of variable sites (s) (or polymorphic sites) between the S. 
aureus samples increases so does the nucleotide diversity (π). This demonstrates that there is overall diversity 
amongst the S. aureus population. This is further supported by Figure 6.1b which shows the number of haplotypes 
(h) along the ! axis and the nucleotide diversity per site (π) along the " axis. The extent of nucleotide diversity in 
the S. aureus population is represented in this graph. This graph suggests that the nucleotide diversity varies greatly 
within the overall population.   
 However, Figure 6.1c is a graph showing the number of variable sites (s) along the ! axis and the haplotype 
diversity (Hd) along the " axis.This graph shows the trend that as the number of variable sites increases so does 
the haplotype diversity, although there is a plateau. This is plateau is illustrative of gene maintenance in the S. 
aureus population.  Since haplotype diversity (Hd) is a measure of the probability that two randomly sampled alleles 
are different, the plateau suggests that the gene function is being maintained despite the differing number of variable 
sites (s). These differences in the number of variable sites (s) can be due to the ratio of synonymous and 
nonsynonymous nucleotide mutations being expressed; synonymous nucleotide substitutions do not alter amino 
acids sequence, in contrast nonsynonymous nucleotide mutations alter the amino acid sequence of the protein. 
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Figure 6.1a is a graph representing the relationship between the 
number of variable sites and nucleotide diversity per site of the S. 
aureus population. Figure 6.1b is a graph representing the 
relationship between the number of haplotypes and the nucleotide 
diversity. Figure 6.1c is a graph representing the relationship between 
the number of variable sites and haplotype diversity per site of the S. 
aureus populations. 
 
These graphs suggest that although there is observed diversity 
amongst the S. aureus population and its respective genes, the 
function of the gene is being maintained.  
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6.4.2 Investigating the geographical relationship of the S. aureus population  
 This study included a large number of S. aureus isolates (n=53). Table 6.1 shows the S. aureus strains that 
were used in this study along with countries that they were isolated from. The information for this table was extracted 
from Table 3.1, found in Section 3.4. It should be noted that it was not possible to determine the country of orgion 
for strain NCTC8325 so it was excluded from this study. It is obvious from Table 6.1 that the S. aureus strains from 
this study have been isolated from all over the world and are therefore a good representation of the strains that have 
been isolated (n=52). Haplotypes of virulence factor genes shared amongst the S. aureus strains were identified 
using DnaSP, as described in Section 2.15. Haplotypes can be used to compare individuals between populations in 
order to infer which populations are most closely related with each other.  
 
 Haplotype networks to infer geographic relationships were created using data for the pbp2 and scn virulence 
factor genes. These two genes were used as they were present in the majority of the strains and were therefore a 
good representation of the wider S. aureus population. Figure 6.2a and Figure 6.2b are haplotype networks created 
using PopArt, as described in Section 2.16. The areas of the circles are proportional to the number of individual 
strains harbouring the specific haplotype and the different colours represent the geographic location of the isolate, 
this is identified by the key. The numbers in the brackets adjacent to the lines linking the circles represent the 
mutational steps between the haplotypes.  It is interesting to note the that there is no set pattern of the distribution 
in haplotypes across the entire network for either the PBP2 and SCIN genes. Haplotype network analysis based on 
the PBP2 and SCIN gene show little association between the multiple countries, with the majority of the haplotypes 
being unique to the country of isolation, however SCIN Hap_9 is shared by isolates from nine different countries. It 
is important to point out that the mutational steps between the haplotypes, which are represented by the numbers 
in the brackets do not differ by a great amount, with the majority of the haplotypes only differing by 1 - 5 mutational 
steps. The exception to this is SCIN Hap_16 which differs by 60 mutational steps and PBP2 Hap_24 which differs 
by 185 mutational steps. Despite these difference in the mutational steps between the haplotypes, it is important to 
note that the virulence factor gene is still reconsiged as either a SCIN or PBP2 gene. 
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Strain Isolated 
04-02981 Koln, Germany 
08BA0216 Canada 
11819-97 Denmark 
502A USA 
6850 USA 
71193 Dominican Republic 
AS3 Belgium 
B51 UK 
B53 Belgium 
Bmb9393 Rio de Janeiro, Brazil 
COL Colindale, England 
CN1 Seoul, South Korea 
CA-347 California, USA 
ECT-R2 Ostergotland, Sweden 
ED133 France 
ED98 Ireland 
H-EMRSA-15 England 
H0 5096 0412 Suffolk 
IP70 UK 
JKD6008 New Zealand 
JKD6159 Australian  
JH9 Maryland, USA 
JH1 Maryland, USA 
LGA251 England 
M1 Denmark 
Mu50 Japan 
Mu3 Japan 
MW2 North Dakota, USA 
MSSA476 Oxford, UK 
MSHR1132 Northern Territory, Australia 
MRSA252 UK 
M013 Taiwan 
Newman UK 
N315 Japan 
NCTC8325 Not Known. 
 OP100 UK 
RF122 Ireland 
S62 Belgium 
SA40 Taiwan 
SA957 Taiwan 
ST398 (S0385) Germany 
ST228 isolate 18385 Lausanne, Switzerland 
ST228 isolate 16125 Lausanne, Switzerland 
ST228 isolate 16035 Lausanne, Switzerland 
T0131 China 
TW20 London, UK 
UA-S391_USA300 USA 
USA300-ISMMS1 USA 
USA300_FPR3737 USA 
USA300_TCH1516 San Fransisco, USA 
VC40 USA 
XN108 China 
Z172 Taiwan 
Table 6.1: A table showing the 
Staphylococcus aureus strains that 
were used in this study along with the 
countries that that they were isolated 
from. The information was extracted 
from Table 3.1. 
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A) SCIN gene  
B) PBP2 gene 
Figure 6.2a & Figure 6.2b: Are haplotype network representing the SCIN & PBP2 virulence factor 
genes, created using the TCS methodology. The areas of the circle are proportionate to the number 
of individual strains harbouring the specific haplotype and the different colours represent the country 
of origin of the isolate. The numbers in brackets represent the mutational steps between the 
haplotypes and the small black circles indicate missing haplotypes. 
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6.4.3 Investigating the relationship of the S. aureus population 
 Haplotype networks were also created for S. aureus strains that represented hospital-associated, community-
associated and livestock-associated to determine if any relationship existed between this classification in the wider 
population. Figures 6.3a-e are haplotype networks that were created for a number of S. aureus virulence factor 
genes: a) Staphylocoagulase (coa), b) PVL toxin (lukF-PV), c) von Willebrand factor-being protein (vwb), d) 
enterotoxin B (seb) and e) thermonuclease (nucA). These haplotype networks represent S. aureus virulence factor 
genes that have a variety of different functions. These particular virulence factor genes were also chosen as they 
represented virulence factor genes that were exhibiting the greatest amount of divergence between the given 
populations i.e hospital-associated, community-associated and livestock-associated; as demonstrated in Section 5, 
Figure 5.6a-e. The ‘populations’ for these virulence factor were designated as either hospital-associated, 
community-associated or livestock-associated and are shown on the haplotypes networks as green, purple and red 
circles, respectively. The areas of the circle are proportionate to the number of individual strains harbouring the 
specific haplotype. Where more then one haplotype was observed to be in the same ‘population’; the circle is divided 
into a pie diagram where the slices correspond to the proportion of the individual strains from a given population. 
Again, the numbers in the brackets represent the mutational steps between the haplotypes. 
 It is interesting to note from all of these haplotypes networks that there is a limited relationship between the 
‘populations’ defined in literature. This has been suggested because the 3 classifications do not cluster together into 
separate clades, instead the hospital-associated, community-associated and livestock-associated haplotypes are 
present across the whole population. The coa Hap_1 and Hap_8 share haplotypes that are present in both hospital-
associated (HA) and community-associated (CA) populations. This relationship is also present in vwb Hap_4, seb 
Hap_2 and lukF-PV Hap_1. The nucA Hap_3 and lukF-PV Hap_6  haplotypes are present in all three S. aureus 
populations, including livestock-associated (LA). It is also observed that the mutational steps between the 
haplotypes vary greatly. For instance, coa Hap_1 which a haplotype for both HA ad CA strains differs by only 1 
mutational step from Hap_2 which is apparantly specific to LA strains. Another example is the LA specific seb Hap_4 
and Hap_6 haplotypes which appear to be significantly different, however, they only differ by 6 mutational steps. 
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The final example is the nucA Hap_12, Hap_13, Hap_14, Hap_11 and Hap_9 haplotypes which represent individual 
HA, CA and LA strains that only differ by a few mutational steps. It is therefore reasonable to conclude  that the 
classification into the populations’ implied by the literature is artifical.  
 
Figures 6.3a: A haplotype network that was created for the Staphylocoagulase (coa) virulence factor 
gene, created using the TCS methodology. The areas of the circle are proportionate to the number of 
individual strains harbouring the specific haplotype and the different colours represent the country of 
origin of the isolate. The numbers in brackets represent the mutational steps between the haplotypes and 
the small black circles indicate missing haplotypes. 
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Figures 6.3b: A haplotype network that was created for the Thermonuclease (nucA) virulence factor gene, 
created using the TCS methodology. The areas of the circle are proportionate to the number of individual 
strains harbouring the specific haplotype and the different colours represent the country of origin of the 
isolate. The numbers in brackets represent the mutational steps between the haplotypes and the small 
black circles indicate missing haplotypes. 
 
Figures 6.3c: A haplotype network that 
was created for the Thermonuclease 
(nucA) virulence factor gene, created 
using the TCS methodology. The areas 
of the circle are proportionate to the 
number of individual strains harbouring 
the specific haplotype and the different 
colours represent the country of origin 
of the isolate. The numbers in brackets 
represent the mutational steps between 
the haplotypes and the small black 
circles indicate missing haplotypes. 
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Figures 6.3d: A haplotype network that 
was created for the enterotoxin B (seb) 
virulence factor gene, created using the 
TCS methodology. The areas of the 
circle are proportionate to the number of 
individual strains harbouring the 
specific haplotype and the different 
colours represent the country of origin 
of the isolate. The numbers in brackets 
represent the mutational steps between 
the haplotypes and the small black 
circles indicate missing haplotypes. 
 
Figures 6.3e: A haplotype network that was created for the Panton-Valentine toxin, subunit F (lukF-PV) 
virulence factor gene, created using the TCS methodology. The areas of the circle are proportionate to 
the number of individual strains harbouring the specific haplotype and the different colours represent the 
country of origin of the isolate. The numbers in brackets represent the mutational steps between the 
haplotypes and the small black circles indicate missing haplotypes. 
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6.4.4 Sliding window analysis of synonymous and nonsynonymous mutations 
 The sliding window analysis is a useful tool to uncover synonymous and nonsynonymous rate variation along 
a sequence that can detect regions under differing selection (Schmid & Yang, 2008). Llopart & Aguade (1999) have 
previously used this analysis to identify the variations in synonymous and nonsynomous within genes in the 
Drosophila species. The sliding window analysis method was used to compare the ratio of synonymous and non 
synonymous polymorphisms, for a number of virulence factor genes: a) lukF-PV, b) nucA, c) vwb, d) coa and e) seb, 
Figures 6.4a-e. The nonsynonymous mutations are highlighted in red and the synonymous or silent mutations are 
highlighted in blue. In Table 5.1 (Section 5.7) it was observed that a number of virulence factor genes were under 
positive selection, this was identified by a ratio ω >1. It is interesting to note that although lukF-PV (ω = 1.308), nucA 
(ω = 1.315), vwb (ω = 1.857), col (ω = 4.9) and seb (ω = 2.029) are all evolving under positive selection there is still 
a high level of diversity of synonymous and nonsynonymous rates being observed along the gene, as shown in 
Figures 6.4a-e. Examining these graphs illustrates the trend of mutations along the length of the gene and suggest 
that there is diversity, however it is also apparent that the majority of polymorphisms being observed in these genes 
are mostly non synonymous. Some parts of the genes are also free of any mutations (synonymous or 
nonsynonymous), this is particulary apparent in region 85 – 113, in the vwb gene and 225 – 253, in the coa genes.  
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Figure 6.4a-e: Sliding window analysis showing the ratio of synonymous and nonsynonymous polymorphism 
observed in a number of S. aureus virulence factor genes: a) lukF-PV, b) nucA, c) vwb, d) coa and d) seb. The 
nonsynonymous mutations are highlighted in red and the synonymous or silent mutations are highlighted in blue. 
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6.3.5 Pairwise comparisons of S. aureus virulence factor genes  
 The distribution of pairwise differences in a set of sequences is an important tool for molecular evolutionary 
studies (Mousset et al., 2004). DnaSP was used to generate the theoretical population growth distribution by 
measuring the number of pairwise differences between pairs of sequences (Roza, 2009). The mismatch distribution 
is a graphic way of visualising the signature of an expansion event.  A frequency graph of pairwise differences 
between alleles that exhibit unimodal properties are indicative of populations that have recently passed through a 
recent demographic expansion (Excoffier, 2003). In comparison a bimodal or multimodal distribution frequency of 
sharp peaks are found in populations that have been constant over time and are therefore considered to be 
nonsignificant (Sousa et al., 2012). Studies have also shown that a unimodal distribution for the pairwise analysis is 
suggestive of a process of expansion which is supported by neutrality tests that indicate a deviation from neutrality 
(Sodre et al., 2012). To test the goodness-of-fit for the observed distribution of frequency curves the raggedness 
index, r and Ramos-Onsins & Rozas index, R2 were also calculated, and if significant were indicative of population 
growth (Ramos-Onsins & Rozas, 2002). To determine whether the sequences also conformed to the expectations 
of neutrality of evolution, Tajima’s D statistical test was used (Tajima, 1989). Previously, The Tajima’s D test showing 
negative values has indicated deviations from neutrality and has suggested recent population expansion (Sharma 
et al., 2013).  
 
 Figure 6.5a-e shows the pairwise distribution for a number of S. aureus virulence factor genes a) lukF-PV, b) 
nucA, c) vwb, d) coa and d) seb. All the pairwise distribution analysis are showing a multimodal distribution and as 
such it is indicative that the population have not passed through a recent expansion and are instead showing that 
the populations have been constant over some time. This is supported by the the r and R2 index, shown in Table 
6.2, which support this observation. However, conflicting evidence from the both the majority of the Tajima’s D and 
Fu & Li’s D negative values deviating away from neutrality are supporting the hypothesis that the whole sample has 
recently passed through a population expansion event. This is observed for the lukF-PV, nucA, vwb, and coa genes. 
The seb gene has a Tajima’s D of 2.59 (p<0.01)  
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Figure 6.5a-e: Pairwise distributio analysis for a number of S. 
aureus virulence factor genes: a) lukF-PV, b) nucA, c) vwb, d) 
coa and d) seb. All analysis are showing a multimodal distributon 
and as such are not significant.  
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Virulence 
factor  
lukF-PV nucA vwb coa seb 
Tajima’s D -0.38234  -0.8496 -0.71047 -0.11428  2.5904 (p<0.01) 
Fu & Li’s D 2.04025 (p<0.02) 0.88805 1.39427 (p<0.05) -1.42261 1.36471 (p<0.5) 
r 0 (p<0.000) 0.927 (p<0.036) 0.253 (p<0.088) 0.205 (p<0.007) 0.01 (p<0.040) 
R2 0 (p<0.000) 0.937 (p<0.184) 0.765 (p<0.225) 0.864 (p<0.15) 0.85 (p<0.2440) 
Table 6.2: A table showing the statistical tests of neutrality and the goodness-of-fit indexes for 
population expansion for S. aureus viruelnce factors. 
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6.5 Discussion: 
 This study has suggested that the observed diversity amongst the S. aureus populations varies greatly, this 
trend is shown in Figure 6.1a-b. Furthermore, although there is genetic diversity it is shown that the virulence factor 
genes are still recognized as their respective genes and the population is being maintained, as shown in Figure 
6.1c. This diversity is also confirmed by the use of geographic haplotypes that were created for the scin and pbp2 
virulence factors that were present in the majority of S. aureus strain in this study. The haplotypes for both genes 
are promiscuously distributed and show no geographic clustering. Haplotype networks were also created for the S. 
aureus strain ‘populations’ that were defined in literature, namely hospital-associated, community-associated and 
livestock-associated. It was noted that only a limited relationship was observed with the majority of the haplotypes 
not clustering into clades or any defined pattern. There were even occurrences of the 3 classifications sharing a 
haplotype, denoted as a pie chart with the three colours in Figure 6.3b and 6.3e. This was observed in LukF-PF 
Hap_6 and nucA Hap_5 demonstrates sharing of the haploptypes between hospital-assciated, community-
associated and livestock-associated strains. This was further evidence that these classifications have become 
blurred o ver time and do not represent genuine divisions in the wider S. aureus population; this was also evidenced 
in the phylogenetic trees that also showed a mixed distribution of clades for the HA, CA and LA strains.  
 The sliding window analysis of the virulence factor genes also showed a high level of diversity along the 
nucleotide sequence. It was concluded that the five virulence factors that were analysed (LukF-PV, nucA, vwb, coa 
& seb) were under positive selection and this was further confirmed by the greater frequency of nonsynonymous 
mutations then synonymous mutations present in the sliding window analysis (Figure 6.4a-e). Recent studies by 
Agashe et al. (2016) have however suggested that synonymous mutations can also evolve under extremely strong 
positive selection, this needs further analysis as the mechanisms for this were unknown. The pairwise comparisons 
for S. aureus virulence genes showed some conflicting evidence. On the one hand, pairwise analyses were showing 
a multimodal distribution which is indicative of a population that have not passed through a recent expansion event, 
however on the other hand, the tests for neutrally, Tajima’s D and Fu & Li’s D negative values has indicated 
deviations from neutrality, which suggests a recent population expansion. If S. aureus were evolving neutrally, it 
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would mean that they are evolving randomly, however since they are evolving away from neutrality and under a 
non-random process, it is suggested that selective forces are acting on the population. This is further evidence of 
positive selection and local adaptation, and this has been demonstrated throughout this thesis and is further 
supported by the array of evidence that is presented in this chapter, including the lack of relationship in the haplotype 
networks that show notable diversity and no relationship between the hospital-associated, community-associated 
and livestock-associated. 
 
 In conclusion, because the selected S. aureus population lack a geographic structure, shown by the lack of 
clustering in the haplotypes, but a high diversity It is therefore highly suggestive that these S. aureus strains are 
under evolutionary processes acting at a local level, and the bacteria are adapting and evolving at a local level 
through positive selection. 
 
 
 
  
 
 
 
 
 
 
 
 
7.0 General discussion and future work 
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7.1 General discussion 
The aim of this study was to initially investigate the three classifications of S. aureus that been defined 
in literature, namely hospital-associated (HA), community-associated (CA) and livestock-associated (LA) and 
to determine if this classification was also recognised at a genomic level. As stated in Section 1.8, MRSA 
initially occurred only in healthcare-settings so they were subsequently defined as hospital-associated (HA). 
MRSA were then being isolated from healthy persons in the community who had no links with healthcare 
facilities, these were classified as community-associated (CA). More recently, a third group of MRSA have 
been identified. This group has emerged from a novel zoonotic reservoir; since farm animals such as pigs 
were implicated, this group were classified as livestock-associated (LA) MRSA. Fifty-three S. aureus strains 
(Table 3.1 and 3.2) have been used in this study, which includes previously sequenced and published strains 
obtained through the NCBI database. A number of novel strains were also gifted from two collaborators; Prof. 
Valerie Edward-Jones (Manchester Metropolitan University, UK) provided isolates from hospital patients and 
Dr Patrick Butaye (The Veterinary & Agrochemical Research Centre, Belgium) provided strains from a 
number of farm animals (cattle, chicken & swine) and they were subsequently sequenced using the Ion 
Torrent Next Generation sequencing protocol. A comprehensive literature review was then undertaken on 
these strains and an array of virulence factor genes which are produced by S. aureus to facilitate 
pathogenesis were identified (Table 3.5). A major emphasis in the literature has been placed on S. aureus 
classification into HA, CA and LA strains. The authors of the papers where the respective strain was studied 
almost always concluded what the classification of the strain was (i.e HA, CA OR LA). It was hypothesised 
that the presence/ absence of virulence factor genes that are expressed on the genomes of these S. aureus 
may explain the virulence that is associated with the different classes. 
 
 In Chapter three, the virulence factor genes from each isolate of S. aureus was extracted, if present, to 
determine if there was a difference in the virulence genes associated with the three classes of S. aureus. This 
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study has suggested that livestock-associated strains that cause infection to humans seem to be subtly different 
from the other strains, but overall the majority of the virulence genes are found within all strains. This study 
showed that the cna adhesin gene was present in 3 LA strains that cause outbreaks in humans, but was absent 
from the strains that are restricted to animals. It was therefore suggested that the presence of this gene may 
possibly contribute to infections in humans. The presence of the Panton-Valentine Leuckocidin (PVL) in MRSA is 
associated with an increased virulence in humans and is typically found in community-associated strains. 
Functional PVL consists of two components encoded by the lukS-PV and lukF-PV genes, thus both genes are 
needed to establish PVL as a virulence factor (Rahman et al., 1991). This study has confirmed that the USA300 
strains contain both functional genes, this has been reported before. (Highlander et al., 2007). However, this 
study has also confirmed that the novel LA strains also contain both functional genes. This study concludes that 
livestock-associated strains possess the genes necessary to produce PVL. The finding drawn here support the 
conclusions by Peeters et al. (2015) who found that livestock-associated ST80 strains carried the Panton-
Valentine leukocidin gene. It was also noted in this study that not all isolates of S. aureus encoded the mecA 
gene but all of the isolates had the presence of the PBP2A gene. This was an interesting trend because it suggests 
that all isolates of S. aureus had the presence of the penicillin binding protein 2 gene, which is needed for β-
lactam resistance; however, it also suggested the presence of divergent mecA genes that were not investigated 
in this study (Garcia-Alvarez et al. (2011). 
 
In chapter 4, a maximum-likelihood phylogenetic analysis was carried out to determine if a molecular 
relationship was observed between the classifications of S. aureus denoted in the literature (HA, CA & LA). 
It was interesting to note that there were some similarities but not enough to warrant the usage of the 
exclusive terms hospital-associated, community-associated and livestock-associated. Many of the strains 
that formed clades did so because of other reasons, for instance, three strains that have been designated 
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community-associated (SA40, SA957 & M013) were also all Taiwanese strains, and a geographical 
relationship existed between them.   
 
Another interesting relationship was between the cluster of livestock-associated strains that cause 
disease in humans (B53, S62, AS3, O8B02176, ST398 & 71193); although, not much information is known 
about the novel strains from this cluster (B53, S62 & AS3). The novel strains were isolated from the Belgium, 
however, it is not known if they are from the same farm or region of Belgium. Hospital strains (XN108, Z172, 
Bmb9393, T0131, JKD6008, TW20) that have been disseminated across the world did cluster into a clade 
that seem to show no geographical relationship, the only obvious relationship was the fact that they had all 
been isolated from hospitals. It is important to remember that many of the hospital-associated S. aureus were 
among the first group of strains that were isolated. It is therefore suggested that the use of the same 
antibiotics across the different hospitals around the world, represents a common factor that is possibly acting 
as a selective pressure on the bacteria. This was further supported by the differentiation observed between 
the phylogenetic trees that were produced.  The virulence factor genes were subjected to phylogenetic 
analysis one at a time and the subsequent trees that were produced, varied greatly. This was suggestive of 
the fact that different selective pressures may be acting on the genes which are therefore evolving at different 
times. Although it is also possible that some virulence factor genes are also gained by horizontal transfer 
(Brody et al., 2008), therefore whilst some virulence genes will differentiate between two strains, the ones 
gained by horizontal transfer will not. It was concluded that a relationship did not exist between the 
classifications of S. aureus that have been given in literature is no longer relevant. 
 
The suggestion of different selective pressures acting on different genes which are evolving at 
different times was investigated in Chapter 5.  It has been shown that S. aureus is relatively common 
commensal of the human flora; however, it can also be an opportunistic pathogen that can cause disease 
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(Sousa & Lenastre, 2004). In order for S. aureus to survive in the host, it must adapt to any selective 
pressures such as changes to the hosts biology, the hosts immune system and any antibiotic therapy that 
may be administered. A study by Kennedy et al. (2008) demonstrated that subtle nucleotide polymorphisms 
have a profound affect on the virulence of staphylococcal strains. It was observed that the highly virulent 
USA300 isolates may have resulted in a recent clonal expansion which resulted in the emergence of virulent 
isolates that were the consequence of DNA polymorphisms and not due to the acquisition of new or novel 
virulence factor genes (Kennedy et al., 2008).  This study has concluded that genes under positive selection 
have been found in the majority of the virulence factor categories, for instance; virulence genes, adhesin 
gene, enterotoxin genes, enzymes and other secreted protein genes. This include; lukS-PV, lekF-PV, chp, 
sspA, vwb, lip, lip1, nucA, hysA, hysA1, aur, fnb, ebpS, bbp, entE, seb and tst. It was further concluded that 
selective pressures act on various genes independently, with the rate of mutation not correlating with the 
length of the gene sequence. It was suggested that genes are therefore evolving at different rates because 
different genes are under different pressures. It was also observed that there was very little divergence or 
variation amongst the hospital-associated, community-associated and livestock-associated strains. This 
supports the observed lack of HA, CA and LA specific clades in the phylogenetic analyses and again 
reiterated the conclusion that the classification that has been denoted in the literature may be artificial. 
 
In Chapter 6, the population genetics of S. aureus was investigated to determine the genetic diversity 
of the population, to investigate a geographical relationship between the population and also to investigate 
the classification that has been denoted in the literature. It was concluded that the observed diversity amongst 
the S. aureus population varied greatly, however, despite this diversity the gene function was being 
maintained. A geographical linkage was also investigated, and it was concluded that haplotypes for S. aureus 
genes (pbp2 & scin) were promiscuously distributed and showed no geographic clustering. It was also further 
concluded; with the aid of haplotype networks, that the 3 classifications denoted in the literature are artificial 
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and do not represent genuine divisions, this was initially concluded in Chapter 4, based upon the phylogenetic 
analyses and Chapter 5, based upon polymorphism and divergence studies.  
In conclusion, an extensive understanding of genomic variation at the single nucleotide level is 
extremely important to determine the events that define bacterial virulence. S. aureus populations are highly 
diverse and have a broad host range. It has previously been suggested that pathogens with a broad host 
range have the greatest probability of being transmitted to humans (Taylor et al., 2001). It is obvious from 
the data that S. aureus are present in a broad range of farm animals as well as other animals that are in close 
contact to humans. It is also evident from the data that the S. aureus population is highly diverse. This study 
employs the computational aspects of biology to determine the genes that are subject to positive and 
selective pressures. It is suggested that S. aureus are under evolutionary processes acting at a local level 
and that they are adapting and evolving at a local level through positive selection, which may be dependent 
on the hosts environment. 
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7.2 Future work 
 A future aim of this study would be to evaluate a greater number of S. aureus strains that have been 
sequenced. It should be noted, that when this thesis was undertaken, all of the S. aureus strains that had 
complete assembled genome sequences published in GenBank were utilised in this study and at the time 
there were approximately 50 S. aureus strains. Undertaking a current search of S. aureus in GenBank would 
yield in excess of 116 fully sequenced strains. Also, the collaborators; Prof. Valerie Edward-Jones 
(Manchester Metropolitan University, UK) provided isolates from hospital patients and Dr Patrick Butaye (The 
Veterinary & Agrochemical Research Centre, Belgium) provided strains from a number of farm animals, did 
in fact provide many more strains that were not utilised in this study. In total, 20 strains were provided of 
which only 6 were sequenced using Ion Torrent, due to the time and financial constraints of the study. It is 
suggested that a greater number of strains are investigated in the future to confirm and further the findings 
observed. 
It should also be noted that currently only contigs were used in this study from the sequenced strains 
and that the novel strains of S. aureus were not full assembled. This was due to the fact that full coverage of 
the contigs was not observed, instead there was some gaps in the genome when compared to the existing 
published S. aureus strains. Any future works that may arise from this study should use one high sensitivity 
Ion Torrent DNA chip per isolate, and not three as has been currently done. Although it has been enough for 
the purpose of contigs, it should be noted that one high sensitivity DNA chip per sample will yield a greater 
number of contigs and that the assembly of the entire genome would be possible.  
Although a relatively high number of S. aureus virulence factor genes were identified (43) from a 
broad range of categories, it should be noted that a greater number of virulence factor genes are available 
for investigation. Figure 1.2 identified approximately 150 genes that may be involved in the virulence of S. 
aureus. Investigating a greater number of virulence factor genes across the whole genome would be a good 
step to determine if similar findings are observed. 
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This study utilised the power of computational biology to determine if the virulence factor genes are 
present or absent at a genotypic level. The genotypic properties were investigated, however, it would also be 
beneficial to investigate if the gene are expressed phenotypically. This can be determined by initially 
translating the amino acid sequences to see if the protein function was maintained. Following on from the 
DnaSP work the range of nonsynonymous mutations in the virulence genes could be investigated to 
determine any potential in the disruption of the protein structures that may lead to altered function. This would 
require analysis of 3-dimensional structures.  The auto-translation of the nucleotide sequences using 
EMBOSS translate tool (of both the reference and identified query sequence) would be initially undertaken; 
the altered amino acid sites would be identified and these would be mapped on a 3D structure of the reference 
protein to determine if they affect the functional sites (active sites/ binding sites of the protein). 
A large number of polymorphisms that were identified within the virulence factor haplotypes were 
single nucleotide polymorphisms. It would be interesting to investigate how these changes to the nucleotide 
sequence ultimately change the protein it is encoding. It was stated that the gene function was being 
maintained, this can be further investigated by utilising protein modelling to determine if the functions of the 
protein remains the same or differs. Undertaking culture based experiments to confirm if the bacterium is in 
fact producing the products of the gene, for example, is the bacterium with the collagen binding gene actually 
producing collagen.  
  
 
 
 
 
 
 
 
Bibliography 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 244	
Agashe D, Sane M, Phalnikar K, Diwan GD, Habibullah A, Martinez-Gomez NC, Sahasrabuddhe V, Polachek 
W, Wang J, Chubiz LM & Marx. Large-effect benifical synonymous mutations mediate rapid and parallel 
adaptation in a bacterium. The Society of Molecular Biology and Evolution. 2016; 33(6): 1542 - 1553. 
 
Al Laham N, Mediavilla JR, Chen L, Abdelateef N, Elamreen RA, Ginocchio CG, Pierard D, Becker K, 
Kreiswirth BN. MRSA Clonal Complex 22 Strains Harbouring Toxic Shock Syndrome (TSST-1) Are Endemic 
in the Primary Hospital in Gaza, Palestine. PLoS One. 2015; 10(3): 
 
Altman DR, Sebra R, Hand J, Attie O, Deikis G, Carpini KWD, Patel G, Rana M, Arvelakis A, Grewal P, Dutta 
J, Rose H, Shopsin B, Daefler S, Schadt E, Kasarskis A, van Bakel H, Bashir A & Huprikar S. Transmission 
of Methicillin of Methicillin-Resistant Staphylococcus aureus via Deceased Donor Liver Transplantation 
Confirmed by Whole Genome Sequencing. American Journal of Transplantation. 2014; xx: 1 - 5.   
 
Altschul SF, Gish W, Miller W, Myers EW & Lipman DJ. Basic local alignment tool. The Journal of Molecular 
Biology. 1990; 215(3): 403 - 410. 
 
Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W & Lipman DJ. Gapped BLAST and PSI-
BLAST: a new generation of protein database search programs. Nucleic Acids Research. 1997; 25: 3389 - 
3402. 
 
Amaral MM, Coelho LR, Flores RP, Souza RR, Silvia-Carvalho MC, Teixeira LA, Ferreira-Carvalho BT & 
Figueiredo MS. The predominant variant of the Brazilian epidemic clonal complex of Methicillin-Resistant 
Staphylococcus aureus has an enhanced ability to produce biofilm and adhere to and invade airway epithelial 
cells. The Journal of Infectious Diseases. 2005; 192: 801 - 810. 
 
Ammerlaan HSM, Kluytmans JAJW, Wertheim HFL, Nouwen JL and Bonten MJN. Eradication of Methicillin-
Resistant Staphylococcus aureus Carriage: A Systemic Review. Healthcare Epidemiology. 2009; 48: 922 - 
930. 
 
Andrey DO, Joussellin A, Villanueva M, Renzoni A, Monod A, Barras C, Rodriguez N & Kelley WL. Impact of 
the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in 
Staphylococcus aureus. PLoS One. 2015; DOI: 10.1371/journal.pone.0135579.  
 
Applebaum P C. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus 
aureus. Clinical Microbiology and Infection. 2006; 12(1): 16 - 23. 
 
Armand-Lefevre L, Ruimy R & Andremont A. Clonal comparison of Staphylococcus aureus isolates from 
healthy pig farmers, human controls, and pigs. Emerging Infectious Diseases. 2005; 11(5): 711 - 714. 
 
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins ATA, Feil EJ, Van den 
Elsen JMH. S. aureus IgG-binding proteins SpA and Sbi: Host specificity and mechanisms of immune 
complex formation. Molecular Immunology. 2008;  45: 1600 - 1611. 
 
Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda 
H, Cui L, Yamamoto K & Hiramatsu K. Genome and virulence determinants of high virulence community-
acquired MRSA. The Lancet. 2002; 359: 1819 - 1827. 
 
	 245	
Baba T, Bae T, Schneewind O, Takeuchi F & Hiramatso K. Genome sequence of Staphylococcus aureus 
strain Newman and comparative analysis of Staphylococci genomes: Polymorphisms and evolution of two 
major pathogenicity islands. Journal of Bacteriology. 2008; 190(1): 300 - 310. Journal of Global Antimicrobial 
Resistance. 2016; 6: 95 – 101. 
 
Bal AM, Coomb GW, Holden MTG, Lindsay JA, Nimmo GR, Tattevin P & Skov RL. Genomic insights into the 
emergence and spread of international clones of healthcare-, community- and livestock-associated 
methicillin-resistant Staphylococcus aureus: Blurring o the traditional definitions.  
 
Balaban N & Rasooly a. Staphylococcal Enterotoxins. International Journal of Food Microbiology. 2000; 
61(1): 1 - 10. 
 
Bansal AK. Bioinformatics in microbial biotechnology - a mini review. Microbial Cell Factories. 2005; 4:19; 
doi:10.1186/1475-2859-4-19. 
 
Baptiste KE, Williams K, Williams NJ, Wattret A, Clegg PD, Dawson S, Corkill JE, O’Neil T & Hart CA. 
Methicillin-resistant staphylococci in companion animals. Emerging Infectious Diseases. 2005; 11(12): 1942 
- 1944. 
 
Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G & von Eiff C. Prevalence of Genes Encoding 
Pyrogenic Toxic Superantigens and Exfoliative among Strains of Staphylococcus aureus Isolated from Blood 
and Nasal Specimens. The Journal of Clinical Microbiology. 2003; 41(4): 1434 - 1439. 
 
Ben Zakour NL, Sturdevant DE, Even S, Guinane CM, Barbey C, Alves PD, Cochet MF, Gautier M, Otto M, 
Fitzgerald JR & Loir YL. Genome-Wide Analysis of Ruminant Staphylococcus aureus Reveals Diversification 
of the Core Genome. Journal of Bacteriology. 2008; 190(19): 6302 - 6317. 
 
Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Oswell J and Sayers EW. GenBank. 
Nucleic Acids Research. 2012; 41. 
 
Bhat M, Dumortier C, Taylor BS, Miller M, Vasquez G, Yunen J, Brudney K, Sanchez JE, Rodriguez-Taveras 
C, Rojas R, Leon P & Lowy FD. Staphylococcus aureus ST398, New York City and Dominican Republic. 
Emerging Infectious Diseases. 2009; 15(2): 285 - 297. 
 
Bhatta DR, Cavaco LM, Nath G, Kumar K, Gaur A,  Gokhale S & Bhatta DR. Association of  Panton Valentine 
Leukocidin (PVL) genes with methicillin resistant Staphylococcus aureus (MRSA) in Wester Nepal: a matter 
of concern for community infection (a hospital based prospective study). BMC Infectious Diseases. 2016; 16: 
199. 
 
Bhakti S & Tranum-Jenson J. Alpha-Toxin of Staphylococcus aureus. Microbiology Reviews. 1991; 55(4): 
733 - 751. 
 
Bjerketorp J, Nilsson M, Ljungh A, Flock JI, Jacobsson K & Frykberg L. A novel von Willebrand factor binding 
protein expressed by Staphylococcus aureus. Microbiology. 2002; 148: 2037 - 2044. 
 
Bjerketorp J, Jacobsson K & Frykberg L. The von Willebrand factor-binding protein (vWbp) of Staphylococcus 
aureus is a coagulase. FEMS Microbiology Letters. 2004; 234: 309 - 314. 
	 246	
 
Blanco R, Tristan A, Ezpeleta G, Larsen AR, Bes M, Etienne J, Cisterna R & Laurent F. Molecular 
epidemiology of Panton-Valentine Leukocidin-positive Staphylococcus aureus in an autochthonous 
population. Journal of Clinical Microbiology. 2011; 49(1): 433 - 436. 
 
Boyle-Vavra S & Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of 
Panton-Valentine leukocidin. Laboratory Investigation. 2007; 87: 3- 9. 
Brody T, Yavatkar AS, Lin Y, Ross J, Kuzin A, Kundu M, Fann Y & Odenwald WF. Horizontal gene transfer 
link a human MRSA pathogen to contagious bovine mastitis bacteria. PLoS ONE. 2008; 3(8): e3074. 
 
Burlak C, Hammer CH, Robinson MA, Whitney AR, McGavin MJ, Kreiswirth BN & DeLeo FR. Global analysis 
of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules 
produced in vitro and during infection. Cellular Microbiology. 2007; 9(5): 1172 - 1190. 
 
Burnside K, Lembo A, de los Reyes M, Iliuk A, BinhTran, Connelly JE, Lin WJ, Schmidt BZ, Richardson AR, 
Fang FC, Tao WA & Rajagopal L. Regulation of Hemolysin Expression and Virulence of Staphylococcus 
aureus by a Serine/Threonine Kinase and Phosphate. PLoS. 2010; 5(6): e11071. 
 
Burman JD, Leung E, Atkins KL, O’Seaghdha MN, Lango l, Bernado P, Bagby S, Svergun DI, Foster TJ, 
Isenman DE & Van den Elsen JMH. Integration of Human Complement with Sbi, a Staphylococcal 
Immunoglobulin-binding Protein. The Journal of Biological Chemistry. 2008; 283(25): 17579 - 17593. 
 
Busier S, Smaczny C, Von Mallinckrodt C, Kraal A, Ackerman H, Brade V & Wichelhaus TA. Prevalence and 
Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease. The 
Journal of Clinical Microbiology. 2007; 45(1): 168 - 172. 
 
Casey JA,  Cosgrove SE, Stewart WF, Pollak J & Schwartz BS. A population-based study study of the 
epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 
2001 - 2010. Epidemiology and Infection. 2013; 141(6): 116 - 1179. 
 
CDC. Four paediatric deaths from community-acquired meticillin-resistant Staphylococcus aureus: 
Minnesota and North Dakota, 1997-1999.  Morbidity and Mortality Weekly Report. 1999; 48:  707 - 10. 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4832a2.htm#tab1 
 
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, 
Brown WJ, Cardo D & Fridkin SK. Infection with Vancomycin-Resistant Staphylococcus aureus containing 
the vanA resistance gene. The New England Journal of Medicine. 2003; 348(14): 1342 - 1347. 
 
Chen Y, Chatterjee SS, Porcella SF, Yu YS & Otto M. Complete Genome Sequence of a Pantón-Valentine 
Leukocidin-Negative Community-Associated Methicillin-Resistant Staphylococcus aureus Strain of 
Sequence type 72 from Korea. PLoS One. 2013:  8(8): e72803 
 
Chen FJ, Lauderdale TL, Wang LS, & Huang IW. Complete Genome Sequence of Staphylococcus aureus 
Z172, a Vancomycin-Intermediate and Daptomycin-Nonsusceptible Methicillin-Resistant Strain Isolated in 
Taiwan. Genome Announcements. 2013; 1(6): e01011–13. 
 
Chen CJ, Unger C, Hoffmann W., Lindsay JA, Huang YC & Götz F. Characterisation and Comparison of 2 
	 247	
Distinct Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus Clones of ST59 
Lineage. PLoS One. 2013; 8(9): e63210. 
 
Chu C, Yu C, Lee Y & Su Y. Genetically divergent methicillin-resistant Staphylococcus aureus and sec-
dependant mastitis of dairy goats in Taiwan. BMC Veterinary Research. 2012; 8(39): e1746-6148/8/39. 
Chua K, Seeman T, Harrison PF, Davies JK, Coutts SJ, Chen H, Haring V, Moore R, Howden BP & Stinear 
TP. Complete genome sequence of Staphylococcus aureus Strain JKD6159 a unique Australian Clone of 
ST398-IV Community Methicillin-Resistant Staphylococcus aureus. Journal of Bacteriology. 2010; 192(20): 
5556 - 5557. 
 
Cowan S T, Shaw C & Williams R E O. Type strain for Staphylococcus aureus Rosenbach. Journal of General 
Microbiology. 1954; 10: 174-176. 
 
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer A & Carmeli Y. Comparison of mortality 
associated with methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: a meta 
analysis. Clinical Infectious Disease. 2003; 36: 53 - 59. 
 
Costa MOC, Beltrame CO, Ferreira FA, Botelho AMN, Lima NCB, Souza RC, de Almeida LGP, Vasconelos 
ATR, Nicolas MF & Figueiredo AMS. Complete Genome Sequnce of a Variant of the Methicillin-Resistant 
Staphylococcus aureus ST239 Lineage, Strain BMB9393, Displaying Superior Ability to Accumulate ica-
Independant Biofilm. Genome Announcements. 2013; 1(4): e00576-13. 
 
Crombe F, Argudin MA, Vanderhaeghen W, Hermans K, Haesebrouck F & Butaye P. Transmission dynamics 
of methicillin-resistant Staphylococcus aureus in pigs. Frontiers in Microbiology. 2013; 4(57): doi: 
10.3389/fmicb.2013.00057.  
 
Cuny C, Kuemmerle J, Stanek C, Willey B, Strommenger B & Witte W. Emergence of MRSA infections in 
horses in a veterinary hospital: Strain characterisation and comparison with MRSA from humans. 
Eurosurveillance. 2006; 11(1-3): 44 - 47. 
 
Cuny C, Kock R & Witte W. Livestock associated MRSA (LA-MRSA) and its relevance for humans in 
Germany. International Journal of Medical Microbiology. 2013; 303: 331 - 337. 
 
Darling ACE, Mau B, Plattner FR & Perna NT. Mauve: Multiple Alignment of Conserved Genomic Sequence 
With Rearrangements. Genome Research. 2004; 14: 1394 - 1403. 
 
Daum L, Rodriguez JD, Worthy SA, Ismail NA, Omar S, Dreyer AW, Fourie PB, Hoosen AA, Chambers JP 
& Fischer GW. Next-generation Ion Torrent sequencing of drug resistance mutations in Mycobacterium 
tuberculosis strains. Journal of Clinical Microbiology. 2012; 50(12): 3831 - 3837. 
 
Dego KO, van Dijk JE & Nederbuigt. Factors invloed in the early pathogenesis of bovine Staphylococcus 
aureus mastitis with emphasis on bacterial adhesion and invasion. A review. Veterinary Quarterly. 2002: 
24(4): 181 - 198. 
 
de Haas CJC, Veldkamp KE, Peschel A, Weerkamp F, van Wamel JB, Heezius ECJM, Poppelier MJJGP, 
Van Kessel & van Strijp JAG. Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacteria Anti-
inflammatory Agent. The Journal of Experimental Medicine. 2004; 199(5): 687 - 695. 
	 248	
 
de Jong MA, Wahlberg N, van Eijk M, Brakheid PM & Zwaan BJ. Mitochondrial DNA signature for range-wide 
populations of Bicyclus anynana suggests a rapid expansion from recent refugia. PLoS one. 2011; 6(6); 
e21385. 
 
de Vries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R & Lynfield R. Staphylococcal toxic 
shock syndrome 2000 - 2006: Epidemiology, clinical features, and molecular characteristics. PLoS One. 
2011; 6(8): e22997. 
 
 
Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot 
M, Claverie JM & Gascuel O. phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids 
Research. 2008; 36: 465 - 469. 
 
Dereeper A, Audic S, Claverie JC & Blanc G. BLAST EXPLORER helps you building datasets for 
phylogenetic analysis. BMC Evolutionary Biology. 2010; 10:8. doi:10.1186/1471-2148-10-8 
 
Deurenberg RH & Stobberingh EE. The evolution of Staphylococcus aureus. Infection, Genetics and 
Evolution. 2008; 8: 747 - 763.               
 
Deurenberg RH, Vink C, Kalenic S, Freidrich AW, Bruggeman CA & Stobberingh EE. The molecular of 
methicillin-resistant Staphylococcus aureus.  Clinical Microbiology and Infections. 2006; 13: 222 -235. 
 
Diep A B, Gill S R, Chang R F, Phan T H, Chen J H, Davidson M G, Lin F, Lin J, Carleton H A, Mongodin E 
F, Sensabaugh G F & Perdreau-Remington F. Complete genome sequence of USA300, an epidemic clone 
of community-acquired meticillin-resistant Staphylococcus aureus. The Lancet. 2006; 367: 731 - 39. 
 
Dinges MM, Erwin PM & Schlievert PM. Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews. 
2000; 13(1): 16 - 34. 
 
Downer R, Roch F, Park WP, Mecham RP & Foster TJ. The Elastin-binding Protein of Staphylococcus aureus 
(EbpS) Is Expressed at the Cell Surface as an Integral Membrane Protein and Not as a Cell Wall-associated 
Protein. The Journal of Biological Chemistry. 2002; 277(1): 243 - 250. 
 
Drapeau GR, Boily Y & Houmard J. Purification and Properties of an Extracellular Protease of 
Staphylococcus aureus. The Journal of Biological Biochemistry. 1972; 247(20): 6720 - 6726. 
 
Duthie E S & Lorenz L L. Staphylococcal Coagulase: Mode of action and antigenicity. Journal of General 
Microbiology. 1952; 6: 95 - 107. 
 
ECDC-1. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in 
Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 
Stockholm, Sweden: ECDC; 2010. 
 
ECDC-2. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in 
Europe 2014 Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 
Stockholm, Sweden: ECDC; 2015. 
	 249	
 
Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC 
Bioinformatics. 2004; 5:113. doi:10.1186/1471-2105-5-113. 
 
Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids 
Research. 2004; 32(5): 1792 - 1797. 
 
Edgeworth J D, Yadegarfar G, Pathak S, Batra R, Cockfield J D, Wyncoll D, Beale R & Lindsay J A. An 
outbreak in an intensive care unit of a strain of Methicillin-Resistant Staphylococcus aureus Sequence Type 
239 associated with an increased rate of vascular access device-related bacteraemia. Clinical Infectious 
Diseases. 2007; 44: 493 - 501. 
 
Excoffier L. Patterns of DNA sequence diversity and genetic structure after range expansion: lessons from 
the infinite-island model. Molecular Ecology. 2004; 13: 853 – 864. 
 
Fisher JF & Mobashery S. 2007 Astellas USA Foundation Award: Host-Guest Chemistry of the 
Peptidoglycan. Journal of Medical Chemistry. 2010; 8(53): 4813 - 4829. 
 
Fitzgerald JR, Monday SR, Foster TJ, Bohach GA, Hartigan PJ, Meaney WJ, & Smyth CJ. Characterisation 
of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. 
Journal of Clinical Microbiology. 2001; 183: 63 - 70. 
 
Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR & Musser JM. Evolutionary genomics of Staphylococcus 
aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. PNAS. 
2001; 98(15): 8821 - 8826. 
 
Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougerty 
BA & Merrick JM. Whole-genome random sequencing and assembly of Haemophilus influenza. Science. 
1995; 269(5223): 496 - 512. 
 
Fleming A. On the antibacterial action of cultures of a penicillim, with special reference to their use in the 
isolation of B. influenze. The British Journal of Experimental Pathology. 1929; 10: 780 - 790. 
 
Foster T and Hook M. Surface protein adhesions of Staphylococcus aureus. Trends in Microbiology. 1998; 
6(12): 484 - 488. 
 
Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN & Pace NR. The Human Nasal Microbiota and 
Staphylococcus aureus carriage. PLoS One. 2010. 5(5) 
 
Fraunholz M, Bernhardt J, Schuldes J, Daniel R, Hecker M & Sinah B. Complete Genome Sequence of 
Staphylococcus aureus 6850, a Highly Cytotoxic and Clinically Virulent Methicillin-Sensitive Strain with 
Distant Relatedness to Prototype Strains. Genome Announcements. 2013; 1(5): e00775-13. 
 
Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D & Perdreau-Remington F. High prevalence of 
methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Annals 
of Emergency Medicine. 2003; 47(1): 196 - 203. 
 
	 250	
Fu YX & Li WE. Statistical Tests of Neutrality of Mutations. Genetics. 1993; 133: 693 - 709. 
 
García-Álvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Walpole E, Brooks K, Pickard 
DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RLR, Larsen AR, 
Skov RL, Peacock SJ, Maskell DJ & Holmes. Meticillin-resistant Staphylococcus aureus with a novel mecA 
homologue in human and bovine populations in the UK and Denmark: a descriptive study. The Lancet 
Infectious Diseases. 2011; 11(8): 595 – 603. 
 
Gaucher EA, Kratzer JT & Randall RN. Deep phylogeny - How a tree can help characterise early life on earth. 
Cold Spring Harbour Perspectives in Biology. 2010; 2: a002238. 
 
Gill SR. Staphylococcus aureus, Strain COL: Product Information Sheet for NR-45906. The following reagent 
was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution 
by BEI Resources, nIAD, NIH: Staphylococcus aureus, Strain COL, NR-45906. 
https://www.beiresources.org/ProductInformationSheet/tabid/784/Default.aspx?doc=47458.pdf. (Accessed 
May 2016). 
 
Gill SR, Fouts DE, Acrher GL, Mongodin EF, DeBoy RT, Ravel J, Paulson IT, Kolonay JF, Brinkac L, Beaman 
M, Dodson RJ, Daugherty SC, Madupu R, Angiuoli SV, Durkin AS, Haft DH, Vamathevan J, Khouri H, 
Utterback T, Lee C, Dimitrov G, Jiang L, Qin H, Weidman J, Tran, Kang K, Hance IR, Nelson KE & Fraser 
CM. Insights on evolution of virulence and resistance from the complete genome analysis of an early 
Methicillin-Resistant Staphylococcus aureus strain and a biofilm-producing Methicillin-Resistant 
Staphylococcus epidermis strain. Journal of Bacteriology. 2005; 187(7): 2426-22438. 
 
Golding GR, Bryden L, Nevett PN, McDonald RR, Wong R, Graham MR, Tyler S, Van Domselaar G, Mabon 
P, Kent H, Butaye P, Smith TC, Kadlec K, Schwarz S, Weese SJ & Mulvey MR. Whole-Genome Sequence 
of Livestock-Associated ST398 Methicillin-Resistant Staphylococcus aureus Isolated from  Humans in 
Canada. Journal of Bacteriology. 2012; 194(23): 6627 - 6628. 
 
Goodall-Copestake WP, Tarling GA & Murphy EJ. On the comparison of population-level estimates of 
haplotype and nucleotide diversity: a case study using the gene cox1 in animals. Heredity. 2012; 109: 50 - 
56. 
 
Goss CH & Muhlebach MS. Review: Staphylococcus aureus and MRSA in cystic fibrosis. Journal of Cystic 
Fibrosis. 2011; 10, 298 - 306. 
 
Gouaux E, Hobaugh M & Song L. α-Hemolysin, !-hemolysin, and leukocidin from Staphylococcus aureus: 
Distant in sequence but similar in structure. Protein Science. 1997; 6(12): 2631 - 2635. 
 
Gregory PD, Lewis RA, Curnock P and Dyke KGH. Studies of the repressor (Blal) of beta-lactase synthesis 
in Staphylococcus aureus. Molecular Microbiology. 1997; 24(5): 1025 - 1037. 
 
Grinberg A, Hittman A, Leyland M, Rogers L & Quesne BLE. Epidemiological and molecular evidence of a 
monophyletic infection with Staphylococcus aureus causing a purulent dermatitis in a dairy farmer and 
multiple cases of mastitis in his cows. Epidemiology Infection. 2004; 132: 507 - 513. 
 
Guinane CM, Ben Zakour NL, Tormo-Mas MA, Weinert LA, Lowder BV, Cartwright RA, Smyth DS, Smyth 
	 251	
CJ, Lindsay JA, Gould KA, Witney A, Hinds J, Bollback JP, Rambaut A, Pendadés JR, Fitzgerald JR: 
Evolutionary  genomics of Staphylococcus aureus reveals insight into the origin and molecular basis of 
ruminant host adaptation. Genome Biology and Evolution. 2010; 2: 454–466. 
 
Guindon S & Gascuel O. A simple, fast and accurate algorithm to estimate large phylogenies by maximum 
likelihood. Systematic Biology. 2003; 52(5): 696 - 704. 
 
Haggar A, Hussain M, Lonnies H, Herrmann M, Norrby-Teglund A & Flock JI. Extracellular Adherence Protein 
from Staphylococcus aureus Enhances Internalisation into Eukaryotic Cells. Infection and Immunity. 2003; 
71(5); 2310 - 2317. 
Hall TA. BioEDIT: a user friendly biological sequence alignment editor and analysis program for Windows 
95/98/NT.  Nucleic Acids Symposium Series. 1999; 41: 95 - 98. 
 
 
Hamed DM & Youssef AI. Clinical features of methicillin-resistant Staphylococcus aureus (MRSA) infection 
in rabbits and its zoonotic potentials. Pakistan Journal of Nutrition.  2013; 12(3): 244 - 249. 
 
Haran KP, Godden SM, Boxrud D, Jawahir S, Bender JB &  Sreevatsan S. Prevalence and characterisation 
of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, Isolated from bulk tank milk 
from Minnesota dairy farms. Journal of Clinical Microbiology. 2012; 50(3): 688 - 695. 
 
Harraghy N, Hussain M, Haggar A, Chavakis T, Sinah B, Hermann M & Flock JI. The adhesive and 
immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology. 2003; 
149: 2701 - 2707. 
 
Hernandez D, van der Mee-Marquet N, Kluytmans J, Donnio PY, Quentin R, Corvaglia AR & Francois P. 
Whole-Genome Sequence of Staphylococcus aureus ST398 Strains of Animal Origin. Genome 
Announcements. 2013; 1(5): e00689-13 
 
Herold BC, Immergluck LC, Marana MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD & Daum RS. 
Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing 
risk. The Journal of the American Medical Association. 1998; 279: 593 - 598. 
 
Highlander S K, Hulten K G, Qin X, Jiang H, Yerrapragada S, Mason E O, Shang Y, Williams T M, Fortunov 
R M, Liu Y, Igbowli O, Petrosino J, Tirumalai M, Uzam A, Fox G E, Cardenas A M, Muzny D M, Hemphill L, 
Ding Y, Dugan S, Blyth P R, Buhay C J, Dinh  H H, Hawes A C, Holder M, Kovar C L, Lee S L, Liu W, 
Nazareth L V, Wang Q, Zhou J, Kaplan S L & Weinstock G M. Subtle genetic changes enhance virulence 
virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiology. 2007; 7: 99. 
 
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T & Tenover FC. Methicillin-resistant Staphylococcus aureus 
clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy. 1997; 40: 135 
- 146. 
 
Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y & Kobayashi I. Dissemination 
in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. The 
Lancet. 1997; 350: 1670 - 1673. 
 
	 252	
Holden MTG, Feil EJ, Lindsay JA, Peacock SJ, Day NPJ, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin 
R, Barron A, Bason N, Bentley SD, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J, 
Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes 
B, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Sharp S, 
Simmonds M, Stevens K, Whitehead S, Barrell BG, Spratt BG & Parkhill J. Complete genomes of two clinical 
Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance.  Proceeding 
National Academy of Sciences USA. 2004; 101: 9786 – 9791. 
 
Holden M T G, Lindsay J A, Corton C, Quail M A, Cockfield J D, Pathak S, Batra R, Parkhil J, Bently & 
Edgeworth J D. Genome Sequence of a Recently Emerged, Highly Transmissible, Multi-Antibiotic- and 
Antiseptic-Resistant Variant of Methicillin-Resistant Staphylococcus aureus, Sequence Type 239 (TW). 
Journal of Bacteriology. 2010; 192(3): 888 - 892. 
 
Holden MTG, Hsu LY, Kurt K, Weinert LA, Mather AE, Harris SR, Strommenger B, Layer F, Witte W, de 
Lencaster H, Skov R, Westh H, Zemlickova H, Coombs G, Kearns AM, Hill RLR, Edgeworth J, Gould I, Gant 
V, Cooke J, Edwards GF, McAdam PR, Templeton KE, McCann A, Zhou Z, Castillo-Ramirez S, Feil EJ, 
Hudson LO, Enright MC, Balloux F, Aanensan DM, Spratt BG, Fitzgerald JR, Parkhill J, Achtman M, Bentley 
& Nubel U. A genomic portrait of the emergence, evolution and global spread of a methicillin-resistant 
Staphylococcus aureus pandemic. Genome Research. 2013; 23: 653 - 664. 
 
Holt DC, Holden MTG, Tong SYC, Castillo-Ramirex S, Clarke L, Quail MA, Currie BJ, Parkhill J, Bentley SD, 
Feil EJ & Giffard PM. A very early branching Staphylococcus aureus lineage lacking the carotenoid pigment 
Staphyloxanthin. Genome, Biology & Evolution. 2011; 3: 881 - 895. 
 
Howden BP, Johnson PDR, Ward PB, Stinear TP, & Davies JK. Isolates with Low-Level Vancomycin 
Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteraemia. 
Antimicrobial Agents and Chemotherapy. 2006; 50(9): 3039 - 3047. 
 
Howden BP, Seeman T, Harrison PF, McEvoy CR, Stanton JL, Rand CJ, Mason CW, Jenson SO, Firth N, 
Davies JK, Johnson PDR & Stinear TP. Complete Genome Sequence of Staphylococcus aureus Strain 
JKD6008, an ST239 Clone of Methicillin-Resistant Staphylococcus aureus with Intermediate-Level 
Vancomycin Resistance. Journal of Bacteriology. 2010; 92(21): 5848 - 5849. 
 
HPA-1. Health Protection Agency. Annual counts and rates of MRSA bacteraemia (April 2007 - March 2011). 
Available from:	https://www.gov.uk/government/statistics/mrsa-bacteraemia-annual-data. 2011. 
(Accessed 06/06/17). 
 
Hu C, Xiong N, Zhang Y, Rayner & Chen S. Functional characterisation of lipase in the pathogenesis of 
Staphylococcus aureus. Biochemical and Biophysical Research Communications. 2012; 419: 617 - 620. 
 
Hu Y, Meng J, Sei C, Hervin K, Fratamico PM & Shi X. Characterisation and comparative analysis of a second 
thermonuclease from Staphylococcal aureus. Microbiological Research. 2013; 168: 174 - 182. 
 
Huang TW, Chen FJ, Miu WC, Liao TL, Lin AC, Huang IW, Wu KM, Tsai SF, Chen YT & Lauderdale TL. 
Complete genome sequence of Staphylococcus aureus M013, a pvl-positive, ST59-SCCmec type V strain 
isolated in Taiwan. Journal of Bacteriology. 2012; 194(5): 1256 - 1257. 
	 253	
 
Ito T & Hiramastu. Acquisition of Methicillin Resistance and Progression of Multi-antibiotic Resistance in 
Methicillin-Resistant Staphylococcus aureus. Yonsei Medical Journal. 1998; 39(6): 526 - 533. 
Ito Y, Yoh MF, Toda K, Shimazaki M, Nakamura T & Morita E. Staphylococcal scalded-skin syndrome in an 
adult due to methicillin-resistant Staphylococcus aureus. Journal of Infectious Chemotherapy. 2002; 8: 256 - 
261. 
 
James CW, Gurk-Turner C. Cross-reactivity of beta-lactam antibiotics. BUMC Proceedings. 2001; 14: 106 - 
107. 
 
Jamrozy DM, Fielder MD, Butaye P & Coldham NG. Comparative Genotypic and Phenotypic Characterisation 
of Methicillin-Resistant Staphylococcus aureus ST398 Isolated from Animals and Humans. PLoS One. 2010; 
7(70). 
 
Jevons MP. Celbenin-resistant Staphylococci. British Journals of Medicine.  1961; 1:124 - 125. 
 
Jiufeng S, Huang Y, Huang H, Liang P, Wang X, Mao Q, Men J, Chen W, Deng C, Zhou X, Lv X, Zhou J, 
Zhang F, Li R, Tian Y, Lei H, Liang C, Hu C, Li X & Yu X. Low divergence of Clonorchis Siensis in China 
based on multi-locus analysis. PloS One. 2013; 8(6): e67006. 
 
Jongerius I, Puister M, Wu J, Ruyken M, Van Strijp JAG & Rooijakkers SHM. Staphylococcal Complement 
Inhibitor Modulates Phagocyte Responses by Dimerisation of Convertases. The Journal of Immunology. 
2009; 184: 420 - 425. 
 
Jongeries I, Kohl J, Pandey MK, Ruyken M, Van Kessel KPM, Van Strijp JAG & Rooijakers SHM. 
Staphylococcal complement evasion by various convertase-blocking molecules. The Journal of Experimental 
Medicine. 2007; 204(10): 2461 - 2471. 
 
Kafala B & Sasarman A. Cloning and sequence analysis of the hemB gene of Staphylococcus aureus. 
Canadian Journal of Microbiology. 1994; 40(8): 651 - 657. 
 
Kaiko GE & Stappenbeck TS. Host-microbe interactions shaping gastrointestinal environment. Trends in 
Immunology. 2014; 35(11): 538 - 548. 
 
Kanehisa M. The KEGG database. Novartis Foundation Symposia. 2002; 247: 91 – 101. 
 
Kaplan NM. Use of thermonuclear testing to identify Staphylococcus aureus by direct examination of blood 
cultures. East Mediterranean Health Journal. 2003; 9(1/2): 185 - 190. 
 
Katyama Y & Hiramatsu K. A new class of genetic element, Staphylococcus cassette chromosome mec, 
encodes methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2000; 
44(6): 1549 - 1555. 
 
Katayama Y, Baba T, Fukuda M & Hiramatsu K. Beta-Hemolysin Promotes Skin Colonisation by 
Staphylococcus aureus. The Journal of Bacteriology. 2013; 195(6): 1194 - 1203. 
 
Kazmierczak Z, Gorski A & Dabrowska. Facing Antibiotic Resistance: Staphylococcus aureus Phages as a 
	 254	
medical tool. Viruses. 2014. 6, 2551 - 2570. 
 
Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, Mediavilla JR, Byrne KA, Parkins 
LD, Tenover FC, Kreiswirth BN, Musser JM & DeLeo RF. Epidemic community-associated methicillin-
resistant Staphylococcus aureus: Recent clonal expansion and diversification. Preceding’s for the National 
Academy of Science. 2008; 105(4): 1327 – 1332. 
 
Khawcharoenporn T, Tice AD, Grandinetti A & Chow D. Risk factors for community-associated methicillin-
resistant Staphylococcus aureus cellulitis - and the value of recognition. Hawaii Medical Journal. 2010; 69: 
232 - 236. 
 
Kim SH, Chun HS, Han MH, Park NY & Suk K. A Novel Variant of Staphylokinase Gene from Staphylococcus 
aureus ATTC 29213. Thrombosis Research. 1997; 87(4): 387 - 395. 
 
Kimman T, Hoek M & de Jong MCM. Assessing and controlling health risks from animal husbandry. NJAS 
Wageningen of Life Sciences. 2013; 66: 7 - 14. 
 
Klein E, Smith DL & Laxminarayan R. Hospitalisations and deaths caused by methicillin-resistant 
Staphylococcus aureus, United States, 1999 - 2005. Emerging Infectious Diseases. 2007; 13(12): 1840 - 
1846. 
 
Kluytmans J, Van Belkum A and Verbrugh H. Nasal Carriage of Staphylococcus aureus: Epidemiology, 
Underlying Mechanisms, and Associated Risks. The Journal of Clinical Microbiology Reviews. 1997; 10(3): 
505 - 520.  
 
Kock R, Harlizius J, Bressan N, Laerberg R, Wieler LH, Witte W, Deurenberg RH, Voss A, Becker K & 
Friedrich AW. Prevalence and Molecular characteristics of methicillin-resistant Staphylococcus aureus 
(MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. European Journal 
of Clinical Microbiology & Infectious Disease. 2009; 28: 1375-1382. 
 
Krawczyk-Balska A & Bielecki J. Listeria monocytogenes listeriolysin O and phosphatidylinositol-specific 
phospholipase C affect adherence to epithelial cells. Canadian Journal of Microbiology. 2005; 51(9): 745 - 
751. 
 
Kreisel KM, Stine OC, Johnson JK, Perencevich EN, Sardell MD, Lesse AJ, Gordin FM, Climo MW & 
Roughmann MC. USA300 Methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe 
sepsis: Is USA300 MRSA associated with more severe infections? Diagnostic Microbiology and Infectious 
Disease. 2011; 70(3): 285 - 290. 
 
Kreiswirth BN, Lofdahl S, Betley MJ, O’Reilly M, Schlieret PM, Bergdoll MS & Novick RP. The toxic shock 
syndrome exotoxin structural gene us not detectably transmitted by a prophage. Nature. 1983; 20: 709 - 712. 
 
Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A, Low DE & Novick RP. Evidence for 
a clonal origin of methicillin-resistance in Staphylococcus aureus. SCIENCE. 1993; 259: 227 - 230. 
 
Kumar S, Tamura K & Nei M. MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers. 
Computer Application in Bioscience. 1994; 10(2): 189 - 191. 
	 255	
 
Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki KI, Nagai Y, Lian T, 
Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, 
Sawano T, Inoue RI, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, 
Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H & Hiramatsu K. 
Whole genome sequencing of methicillin-resistant Staphylococcus aureus. The Lancet. 2001; 357(9264): 
1225 - 1240. 
 
Kwiecinski J, Jacobson G, Karlsson M, Zhu X, Wang W, Bremell T Josefsson E & Jin T. Staphylokinase 
Promotes the Establishment of Staphylococcus aureus Skin Infections While Decreasing Disease Severity. 
The Journals of Infectious Diseases. 2013; 208: 990 - 998. 
 
Kwok AYC, Su S, Reynolds RP, Bay SJ, Av-Gay Y, Dovichi NJ & Chow AW. Species identification and 
phylogenetic relationships based on partial HSP60 gene sequences within the genus Staphylococcus. 
International Journal of Systemic Bacteriology. 1999; 49, 1181-1192.  
 
Laarman AJ, Ruyken M, Malone CL, van Strijp JAG, Horswill AR & Rooijakkers SHM. Staphylococcus aureus 
Metalloprotease Aureolysin Cleaves Complement C3 to Meidate Immune Evasion. The Journal of 
Immunology. 2011;186: 6445 - 6453. 
 
Lambert G & Kussell E. Quantifying selective pressure driving bacterial evolution using lineage analysis. 
Physical Reviews. 2015; 5(1). 
 
Larner-Sevensson H, Worning P, Bartels MD, Hansen LH, Boye K & Westh H. Complete Genome of 
Staphylococcus aureus Strain M1, a Unique t024-ST8-IVa Danish Methicillin-Resistant S. aureus Clone. 
Genome Announcements. 2013; 1(3): e00336-13. 
 
Lee SS, Kim YJ, Chung DR, Jung KS & Kim JS. Invasive Infection Caused by a Community-Associated 
Methicillin-Resistant Staphylococcus aureus Strain Not Carrying Panton-Valentine Leukocidin in South 
Korea. The Journal of Clinical Microbiology. 2010; 48(1): 311 - 313. 
 
Lee BY, Singh A, David MZ, Bartsch SM, Slayton RB, Huang SS, Zimmer SM, Potter MA, Macal CM, 
Lauderdale DS, Miller LG & Daum RS. The economic burden of community-associated methicillin-resistant 
Staphylococcus aureus (CA-MRSA). Clinical Microbiology and Infection. 2013; 19(6): 528 - 536. 
 
Lefebure T & Stanhope MJ. Evolution of the core and pan-genome of Streptococcus: positive selection, 
recombination, and genome composition. Genome Biology. 2007; 8:R71. 
 
Lefebure T & Stanhope MJ. Pervasive, genome-wide positive selection leading to functional divergence in 
the bacterial genus Campylobacter. Genome Research. 2009; 19: 1224 - 1232. 
 
Leigh JW & Bryant D. POPART: full-feature software for haplotype network construction. Methods in Ecology 
and Evolution. 2015; 6: 1110 - 1116. 
 
Lim D & Strynadka NCJ. Structural basis for the β-lactam resistance of the PBP2a from methicillin-resistant 
Staphylococcus aureus. Natural Structural Biology. 2002; 9(11): 870 - 876. 
 
	 256	
Lin D & Strynadka NC. Structural basis for the beta lactic resistance of PBP2a from methicillin-resistant 
Staphylococcus aureus. Natural Structure and Molecular Biology. 2002; 9(11): 870 - 876. 
 
Lindqvist M, Isakasson B, Grub C, Jonassen TO & Hallgren A. Detection and characterisation of SCCmec 
remnants in multiresistant methicillin-susceptible Staphylococcus aureus causing a clonal outbreak in a 
Swedish county. European Journal of Clinical Microbial Infectious Diseases. 2012; 31: 141 - 147. 
 
Lister J. On the Antiseptic Principle in the Practice of Surgery. British Medical Journal. 1867; 21; 2(351): 246-
248 
 
Li M, Cheung GYC, Hu J, Wang D, Joo, HS, DeLeo FR & Otto M. Comparative Analysis of Virulence and 
Toxin Expression of Global Community-Associated Methicillin-Resistant Staphylococcus aureus Strains. The 
Journal of Infectious Diseases. 2010; 202: 1866 – 1876. 
 
Li Y, Cao B, Zhang Y, Zhou J, Yang B & Wang L. Complete genome sequence of Staphylococcus aureus 
T0131, an ST239-MRSA-SCCmec Type III clone isolated in China. Journal of Bacteriology. 2011; 193(13): 
3411 - 3412. 
 
Librado P & Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. 
Bioinformatics. 2009; 25(11): 1451 - 1452. 
 
Lipovy B, Brychta P, Chaloupkova Z & Suchanek I. Staphylococcal scalded skin syndrome in the Czech 
Republic an epidemiological study. Burns. 2012; 38: 296 - 300. 
 
Llopart A & Aguade M. Synonymous rates RpII215 gene of Drosophila: Variation among species and across 
the coding region. Genetics. 1999; 152: 269 – 280. 
 
Lorenz MG & Wackernagel W. Bacterial gene transfer by natural genetic transformation in the environment. 
Microbiological Reviews. 1994; 58(3): 563 - 602. 
 
Lowder BV, Guinane CM, Zakour NB, Weinert LA, Conway-Morris A, Cartwright RA, Simpson AJ, Rambout 
A, Nubel U & Fitzgerald JR. Recent human-to-poultry host jump, adaptation and pandemic spread of 
Staphylococcus aureus. Proceedings of the National Academy of Sciences. 2009; 106(46): 19545 - 19550.  
 
Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. The Journal of Clinical 
Investigation. 2003; 111(9): 1265 - 1273. 
 
Markis G, Wright JD, Ingham E & Holland KT. The hyaluronate lyase of Staphylococcus aureus - a virulence 
factor? Microbiology. 2004; 150: 2005 - 2013. 
 
Martin JF, Ullan RV & Garcia-Estrada C. Regulation and compartmentalisation of beta-lactam biosynthesis. 
Microbial Biotechnology. 2010; 3(3): 285 - 299. 
 
McAdow M, Missiakas DN & Schneewind O. Staphylococcus aureus Secretes Coagulase and von Willebrand 
Factor Binding Protein to Modify the Coagulation Cascade and Establish Host Infections. Journal of Innate 
Immunity. 2012; 4: 141 - 148. 
 
	 257	
McCarthy AJ & Lindsay JA. The distribution of plasmids that carry virulence and resistance genes in 
Staphylococcus aureus is lineage associated. BMC Microbiology. 2012; 12: 104 
 
McDonald M, Dougall A, Holt D, Huygens F, Oppedisano F, Gifford PM, Inman-Barber J, Stephens AJ, 
Towers R, Carapetis JR & Currie BJ. Use of a Single-Nucleotide Polymorphism Genotyping System To 
Demonstrate the Unique Epidemiology of Methicillin-Resistant Staphylococcus aureus in Remote Aboriginal 
Communities. Journal of Clinical Microbiology. 2006; 44(10): 3720 - 3727. 
 
McGavin MJ, Arsic B & Nickerson NN. Evolutionary blueprint for host- and niche-adaptation in 
Staphylococcus aureus clonal complex CC30. Frontiers in Cellular and Infection Microbiology. 2012; 2(48). 
 
McGavin MJ, Zahradka C, Rice K & Scott EJ. Modification of the Staphylococcus aureus Fibronectin Binding 
Phenotype by V8 Protease. Infection and Immunity. 1997; 65(7): 2621 - 2628. 
 
McNamee PT, Symth JA & Smyth JA. Bacterial chondronecrosis with osteomyelitis (‘femoral head necrosis’) 
of broiler chickens: A review. Avian Pathology. 2000; 29: 253 - 270. 
 
Meroueh SO. Bencze KZ, Hesek D, Lee M, Fisher JF, Stemmler TL & Mobashery S. Three-dimensional 
structure of the bacterial cell wall peptidoglycan. PNAS. 2006; 103(12): 4404 - 4409. 
 
Molne L, Verdrengh MA & Tarkowski A. Role of Neutrophil Leukocytes in Cutaneous Infection Caused by 
Staphylococcus aureus. Infection and Immunity. 2000; 68(11): 6162 - 6167. 
 
Monaco M, Pedroni P, Sanchini A, Bonomini A, Indelicato A & Pantosti A. Livestock-associated methicillin-
resistant Staphylococcus aureus responsible for human colonisation and infection in an area of Italy with high 
density of pig farming. BMC Infectious Diseases. 2013; 13: 258. 
 
Mongodin E, Bajolet O, Cutrona J, Bonnet N, Dupuit F, Puchelle E & de Bentzmann S. Fibronectin-Binding 
Proteins of Staphylococcus aureus Are Involved in Adherence to Human Airway Epithelium. Infection and 
Immunity. 2002; 70(2): 620 - 630. 
 
Mosesson MW. Fibrinogen and fibrin structure and functions. Journal of Thrombosis and Haemostasis. 2005; 
3: 1984 - 1904. 
 
Mousset S, Derome N & Veuille M. A test of neutrality and constant population size based on the mismatch 
distribution. Molecular Biology and Evolution. 2004; 21(4): 724 – 731. 
 
Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia 
ED, & Tomasz A. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-
genome sequencing. Proceedings of the National Academy of Sciences. 2007; 104(22): 9451 - 9456. 
 
NCBI. (2015). Available from: http://www.ncbi.nlm.nih.gov/genbank/statistics. [Accessed: 7th December 
2015]. 
 
Nei M & Li WH. Mathematical model for studying genetic variation in terms of restriction endonucleases. 
PNAS. 1979; 76(10): 5629 - 5273. 
 
	 258	
Newsom S W B. Ogston’s coccus. Journal of hospital Infection. 2008; 70: 369-372. 
 
Nichols RL & Florman S. Clinical presentations of soft-tissue infections and surgical site infections. Clinical 
Infectious Diseases. 2001; 33(2): 84 - 93. 
 
Nubel U, Dordel J, Kurt K, Strommenger B, Westh H, Shukla SK, Zemlickova H, Lebois R, Wirth T, Jombart 
T, Balloux F & Witte W. A TimeScale for Evolution, Population Expansion, and Spatial Spred of an Emerging 
Clone of Methicillin-Resistant Staphylococcus aureus. PLoS One. 2010; 6(4): e1000855. 
 
Ogsten A. Report upon Micro-organisms in surgical Diseases.  British Medical Journals. 1881; 1(1054): 
369.b2-375. 
 
O’Neill GL, Murchan S, Gil-Setas A & Aucken HM. Identification and Characterisation of the Phage Variants 
of a Strain of Epidemic Methicillin-Resistant Staphylococcus aureus (EMRSA-15). Journal of Clinical 
Microbiology. 2001; 39(4): 1540 - 1548. 
 
ONS-1. Office for national statistics. Deaths involving Staphylococcus aureus and MRSA, England & Wales, 
1993 - 2006. Available from: 
http://webarchive.nationalarchives.gov.uk/20160107063144/http://www.ons.gov.uk/ons/dcp1
71778_324558.pdf. (Accessed 06/06/17). 
 
Ortega E, Abriouel H, Lucas R & Galvez A. Multiple Roles of Staphylococcus aureus Enterotoxins: 
Pathogenicity, Super-antigenic Activity, and Correlation to Antibiotic Resistance. Toxins. 2010; 2: 2117 - 
2131. 
  
Palma M, Shannon O, Quezada HO, Berg A & Flock JI. Extracellular Fibrinogen-binding Protein, EFB, from 
Staphylococcus aureus Blocks Platelet Aggregation Due to Its Binding to the α-Chain. The Journal of 
Biological Chemistry. 2001; 276(34): 31691 - 31697. 
 
Pantosti A. Methicillin-resistant Staphylococcus aureus associated with animals and its relevance to human 
health. Frontiers in Microbiology. 2012; 3(127): doi.10.3389/fmicb.2012.00127. 
 
Parker D, Narechania A, Sebra R, Deikus G, LaRussa S, Ryan C, Smith H, Prince A, Mathema B, Ratner 
AJ, Kreiswirth B & Planet PJ. Genome Sequence of Bacterial Interference Strain of Staphylococcus aureus 
502A. Genome Announcements. 2014; 2(2): e00284-14. 
 
Parkhill J & Wren BW. Bacterial epidemiology and biology - lessons from genome sequencing. Genome 
Biology. 2011; 12: 230. 
 
Paterson GK, Harrison EM & Holmes MA. The emergence of mecC methicillin-resistant Staphylococcus 
aureus. Trends in Microbiology. 2014; 22(1): 42 - 47. 
 
Pattengale ND, Alipour M, Bibinda-Emonds OR, Moret BM & Stamatakis A. How many bootstraps replicates 
are necessary? Journal of Computational Biology. 2010; 17(3): 337 - 354. 
 
Patti JM, Jonsson H, Guss B, Switalski LM, Wiberg K, Lindberg M & Hook M. Molecular Characterisation and 
	 259	
Expression of a Gene Encoding a Staphylococcus aureus Collagen Adhesion. The Journal of Biological 
Chemistry. 1992; 267(7); 4766 - 4722 
 
Peeters LEJ, Argudin MA, Azadikhah S, Butaye P. Antimicrobial resistance and population structure of 
Staphylococcus aureus recovered from pig farms. Veterinary Microbiology. 2015; 180: 151 – 156. 
 
Peetermans M, Vanassche T, Liesenbroghs L, Claes J, Velde GV, Kwiecinksi J, Jin T, De Geest B, Hoylaert 
MF & Verhamme P. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin 
infections. BMC Microbiology. 2014; 14: 310. 
 
Petkau A, Stuart-Edwards M, Stothard P, and Van Domselaar G. Interactive microbial genome visualisation 
with GView. Bioinformatics 2010: 26; 3125-3126. 
 
Pereira LB. Impetigo - review. Anais Brasileiros de Dermatologia. 2014; 89(2): 293 - 299. 
 
Persson L, Johnansson C and Ryden. Antibodies to Staphylococcus aureus Bone Sialoprotein-Binding 
Protein Indicate Infectious Osteomyelitis. Clinical and Vaccine Immunology. 2009; 16(6): 949 - 952. 
 
Pinchuk IV, Beswick EJ & Reyes VE. Staphylococcal Enterotoxins. Toxins. 2012; 2, 2177-2197. 
 
Plata K, Rosato AE, Wegrzyn G. Staphylococcus aureus as an infectious agent: overview of biochemistry 
and molecular genetics of its pathogenicity. Acta Biochemical Polonica. 2009; 56(4), 597-612. 
 
Popart-1. PopART. 2016. Available at: http://popart.otago.ac.nz. (Accessed 9th January 2016). 
 
Prasad GS, Radhakrishnan R, Mitchell DT, Earhart CA, Dinges MM, Cook WJ, Schlieret PM & Ohlendorf 
HH. Refined Structures of there crystal form of toxic shock syndrome toxin-1 and of a tetramutant with 
reduced activity. Protein Science. 1997; 6: 1220 - 1227. 
 
Ragle BE & Wardenburg JB. Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against 
Staphylococcus aureus Pneumonia. Infection and Immunity. 2009; 77(7): 2712 - 2718. 
 
Rahman A, Izaki K, Kato I & Kamio Y. Nucleotide sequence of leukocidin S-component gene (lukS) from 
methicillin resistant Staphylococcus aureus. Biochemical and Biophysical Research Communication. 1991; 
181(1): 138 - 144. 
 
Ramos-Onsins SE & Rozas J. Statistical properties of new neutrality tests against population growth. 
Molecular Biology & Evolution. 2002; 19(12): 2092 – 2100. 
 
Rangarajan ES & Shankar V. Sugar non-specific endonucleases. FEMS Microbiology Reviews. 2001; 25(5): 
583 - 613. 
 
Rasooly R & Hernlem BJ. Quantative Analysis of Staphylococcus Enterotoxin A by Differential Expression of 
IFN-Ɣ in Splenocyte and CD4+ T-Cells. Sensors. 2014; 14: 8869 - 8876. 
 
Rhem MN, Lech EM, Patti JM, McDevitt D, Hook M, Jones DB & Wilhelmus KR. The Collagen-Binding 
	 260	
Adhesion is a Virulence Factor in Staphylococcus aureus Keratitis. Infection and Immunity. 2000; 68(6): 3776 
- 3779. 
 
Rice K, Peralta R, Bast D, de Azavedo J & McGavin MJ. Description of Staphylococcus Serine Protease 
(ssp) Operon in Staphylococcus aureus and Non-polar Inactivation of sspA-Encoded Serine Protease. 
Infection and Immunity. 2001; 69(1): 159 - 169. 
 
Rice LB. Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycoepetides and 
fluoroquinolones. Symposium on Antimicrobial Therapy. 2012; 87(2): 198 - 208. 
 
Rollof J, Vinge E, Nilsson-Ehle P & Braconier JH. Aggregation of human granulocytes by Staphylococcus 
aureus lipase. Journal of Medical Microbiology. 1992; 36: 52 - 55. 
 
Rooijakkers SHM, Milder FJ, Bardoel BW, Ruyken M, Van Strijp JAG & Gros P. Staphylococcal Complement 
Inhibitor: Structure and Active Sites. The Journal of Immunology. 2007; 179(5): 2989 - 2998. 
 
Rodgers JD, McCullagh JJ, McNamee PT, Smyth JA & Ball HJ. Comparison of Staphylococcus aureus 
recovered from personnel in a poultry hatchry and in broiler parent farms with those isolated from skeletal 
disease in broilers. Veterinary Microbiology. 1999; 69: 189 - 198.  
 
Rolinson GN. Forty years of beta-lactam research. Journal of Antimicrobial Chemotherapy. 1998; 41: 589 - 
603. 
 
Rollof J & Normak S. in vivo Processing of Staphylococcus aureus Lipase. Journal of Bacteriology. 1992; 
174(6): 1844 - 1847. 
 
Rosenstein R & Götz F. Staphylococcal lipases: Biochemical and Molecular characterisation. Biochimie. 
2000; 82: 1005 - 1014. 
 
Rothberg JM & Laemon JH. The development and impact of 454 sequencing. Nature Biotechnology. 2008; 
26(10): 1117 - 1124. 
Rozas J & Rozas R. DnaSP, DNA sequence polymorphism: an interactive program for estimating population 
genetics parameters from DNA sequence data. Computational Applications Bioscience. 1995; 11(6): 621 - 
625.  
 
Rozas J, Sanchez-DelBarrio JC, Messeguer X & Rozas R. DnaSP, DNA polymorphism analyses by the 
coalescent and other methods. Bioinformatics. 2003; 19(18): 2496 - 2497. 
 
Rozas, J. DNA Sequence Polymorphism Analysis using DnaSP. Pp. 337-350.In Posada, D. 
(ed.) Bioinformatics for DNA Sequence Analysis; Methods in Molecular Biology Series . 2009; 
Vol. 537. Humana Press, NJ, USA. 
 
Ryden C, Yacoub AI, Maxe I, Heingard D, Oldsberg A, Franzen A, Ljunch A and Rubin K. Specific binding of 
bone sialoprotein to Staphylococcus aureus isolated from patients with osteomyelitis. The European Journal 
of Biochemistry. 1989; 184: 331 - 336.  
 
Sabat A, Kosowska K, Poulsen K, Kasprowicz A, Sekowska A, van den Burg B, Travis J & Potempa J. Two 
	 261	
Allelic Forms of the Aurolysin Gene (aur) within Staphylococcus aureus. Infection and Immunity. 2000; 68(2): 
973 - 976. 
 
Sabat A, Melles DC, Martirosian G, Grundmann H, van Beckum A and Hryiewicz. Distribution of the Serine-
Aspartate Repeat Protein-Encoding sdr Genes among Nasal-Carriage and Invasive Staphylococcus aureus 
Strains. The Journal of Clinical Microbiology. 2006; 44(3): 1135 - 1138. 
 
Sabirova, J. S., Xavier, B. B., Hernalsteens, J.-P., De Greve, H., Ieven, M., Goossens, H., & Malhotra-Kumar, 
S. Complete Genome Sequences of Two Prolific Biofilm-Forming Staphylococcus aureus Isolates Belonging 
to USA300 and EMRSA-15 Clonal Lineages. Genome Announcements. 2014; 2(3): e00610–14. 
Schijffelen MJ, Boel CHE, van Strijp JAG & Fluit AD. Whole genome analysis of a livestock-associated 
methicillin-resistant Staphylococcus aureus ST398 isolate from a case of human endocarditis. BMC 
Genomics. 2010; 11: 376. 
 
Saitou N & Nei M. The Neighbour-Joining method: A new method of reconstructing phylogenetic trees. 
Molecular Biology & Evolution. 1987; 4(4): 406 - 425. 
 
Sanger F, Nicklen S & Coulson AR. DNA sequencing with chain-terminating inhibitors. Proceedings of the 
National Academy of Science USA. 1977; 74(12): 5463 - 5467. 
 
Sass P, Berscheid A, Jansen A, Oedenkoven M, Szekat C, Strittmatter A,Gottschalk G & Bierbaum G. 
Genome sequence of Staphylococcus aureus VC40, a Vancomycin- and Daptomycin-resistant strain, to 
study the genetics of development of resistance to currently applied last-resort antibiotics. Journal of 
Bacteriology. 2012; 194(8): 2107 - 2108. 
 
Schaaff F, Reipert A & Bierbaum. An Elevated Mutation Frequency Favours Development of Vancomycin 
Resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2002; 46(11): 3540 - 3548. 
 
Schmid K & Yang Z. The trouble with sliding windows and the selective pressure in BRCA1. PLoS ONE. 
2008; 3(11): e3746.  
 
Shannon O, Uekotter A & Flock JI. The Neutralising Effects of Hyperimmune Antibodies Against Fibrinogen-
Binding Protein, Efb, from Staphylococcus aureus. Scandinavian Journal of Immunology. 2005; 63: 184 - 
190. 
 
Sheng-Yun L, Fang-Yu C, Ching-Chung Cheng, Keong-Diong L & Yhu-Chering H. Methicillin-resistant 
Staphylococcus aureus nasal colonisation among adult patients visiting emergency department in a medical 
centre in Taiwan. PLoS One. 2011; 6(6): e18620. 
 
Shi D, Ishii S, Sato T, Yamasaki H, Matsunaga M, Higuchi W, Takano T, Yabe S, Tanaka K & Yamamoto T. 
Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: Molecular characterisation 
and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus. 
Paediatrics International. 2011; 53: 211 - 217. 
 
Shinji H, Yosizawa Y, Tajima A, Iwase T, Sugimoto S, Seki K & Mizunoe. Role of Fibronectin-Binding proteins 
A and B in In Vitro Cellular Infections by Staphylococcus aureus. Infection and Immunity. 2011; 79(6): 2215 
- 2223. 
	 262	
 
Shopsin B, Gomez M, Waddington M, Riehman M & Kreiswirth BN. Use of Coagulase Gene (coa) Repeat 
Region Nucleotide Sequences for Typing of Methicillin-Resistant Staphylococcus aureus Strain. Journal of 
Clinical Microbiology. 2000; 38(9): 3453 - 3456. 
 
Sieradzki K, Leski T, Dick J, Borio L & Tomasz. Evolution of a Vancomycin-intermediate Staphylococcus 
aureus Strain In Vivio: Multiple Changes in the Antibiotic Resistance Phenotypes of a Single Lineage of 
Methicillin-Resistant S. aureus under the Impact of Antibiotics Administered for Chemotherapy. The Journal 
of Clinical Chemotherapy. 2003; 41(4): 1687 - 1693. 
 
Sifri CD, Baresch-Bernal A, Calderwood SB & Von Eiff C. Virulence of Staphylococcus aureus Small Colony 
Variants in the Caenorhabsitis elegans Infection Model. Infection and Immunity. 2006; 74(2): 1091 -  1096. 
 
Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band 
JD, White E & Jarvis WR. Emergence of Vancomycin resistance in Staphylococcus aureus. The New England 
Journal of Medicine. 1999; 340(7): 493 - 501.  
 
Smith EJ, Visai L, Kerrigan SW, Speziale P & Foster TJ. The sbi Protein is a Multifunctional Immune Evasion 
Factor of Staphylococcus aureus. Infection and Immunity. 2011; 79(9): 3801 - 3809. 
 
Smith K A. Louis Pasteur, the father of immunology? Frontiers in Immunology. 2012; 68(3): 1-10. 
 
Sodre D, Rodriguis-Filho LFS, Souza RFC, Rego PS, Schneider H, Sampaio I & Vallinoto M. Inclusion of 
South American samples reveals new population structuring of the blacktip shark (Carcharhinus limbatus) in 
the western Atlantic. Genetics and Molecular Biology. 2012; 35(4): 752 – 760.  
 
Sola C, Paganini H, Egea AL, Moyano AJ, Garnero A, Kevric I, Culasso C, Vindel A, Study Group of CA-
MRSA in Children, Argentina-2007, Lopardo H & Bocco JL. Spread of epidemic MRSA-ST5-IV clone 
encoding PVL as a major cause of community onset Staphylococcal infectious in Argentinean children. PLoS 
One. 2012; 7(1): e30487. 
 
Solar GD, Giraldo R, Ruiz-Echevarria MJ, Espinosa M & Diaz-Orejas. Replication and control of circular 
bacterial plasmids. Microbiology and Molecular Biology Reviews.1998; 62(2): 434 – 464. 
 
Sousa MA & de Lencastre H. Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant 
Staphylococcus aureus clones. FEMS Immunology and Medical Microbiology. 2004; 40: 101 - 111. 
 
Soyer Y, Orsi RH, Rodriguez-Rivera LD, Sun Q & Wiedmann M. Genome wide evolutionary analyses reveal 
serotype specific patterns of positive selection in selected Salmonella serotypes. BMC Evolutionary Biology. 
2009; 9:264: dos.10.1186/1471-2148-9-264. 
 
Spaan AN, Vrieling M, Wallet P, Badiou C, Reyes-Robles T, Ohneck EA, Benito Y, de Haas, CJC, Day CJ, 
Jennings MP, Lina G, Vandenesh F, van Kessel KPM, Torres VJ, van Strijp JAG & Henry. The staphylococcal 
toxins !-hemolysin AB and CB differently target phagocytes by implying specific chemokine receptors. 
Nature Communication. 2014; 5: 5438. 
 
Stegger M, Price LB, Larsen AR, Gillece JD, Waters AE, Skov R & Anderson PS. Genome sequence of 
	 263	
Staphylococcus aureus 11819-97, an ST80-IV European community-acquired methicillin-resistant isolate. 
Journal of Bacteriology. 2012; 194(6): 1625-1626. 
 
Stegger M, Driebe EM, Roe C, Lemmar D, Bowers JR, Engethaler DM, Keim P & Anderson PS. Genome 
Sequence of Staphylococcus aureus Strain CA-347, a USA600 Methicillin-Resistant Isolate. Genome 
Announcements. 2013; 1(4): e00517-13. 
 
Sun J, Deng & Yan. Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological 
exploitations. Biochemical and Biophysical Research Communications. 2014; 453: 254 - 267. 
 
Sung JML, Lloyd DH & Lindsay. Staphylococcus aureus host specificity: comparative genomics of human 
versus animal isolates by multi-strain microarray. Microbiology. 2008; 154: 1949 - 1959. 
 
Suzuki H, Lefebure T, Bitar PP & Stanhope MJ. Comparative genomic analysis of the genus Staphylococcus 
including Staphylococcus aureus ands its newly described sister species Staphylococcus simiae. BMC 
Central. 2012: 13(38): doi: 10.1186/1471-2164-13-38. 
 
Sydnor ERM & Perl TM. Hospital epidemiology and infection control in acute-care settings. Clinical 
Microbiology Reviews. 2011; 24(1): 141 - 173. 
 
Tang J, Zhou R, Shi X, Kang M, Wang H & Chen H. Two thermostable nucleases coexisted in Staphylococcus 
aureus: evidence from mutagenesis and in vitro expression. FEMS Microbiology Letter. 2008; 284: 176 - 183. 
 
Tamer K, Stecher G, Peterson D, Filipski A & Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis 
Version 6.0. Molecular Biology and Evolution. 2013; 30(12): 2725 - 2729. 
 
Tajima F. Statistical Method for Testing the Neutral Mutation Hypothesis by DNA Polymorphism. Genetics. 
1989; 123: 585 - 595. 
 
Taubes G. The bacteria fight back. SCIENCE.  2008; 321: 356 - 361. 
 
Taylor LH, Lathan SP & Woolhouse MEJ. Risk factors for human disease emergence. The Royal Society. 
2001; 256: 983 – 989. 
 
Tung HS, Guss B, Hellman U, Persson L, Rubin K & Ryden C. A bone sialprotein-binding protein from 
Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochemical Journal. 2000; 345: 611 - 
619. 
 
Uhlemann AC, Porcella SF, Trivedi S, Sullivan SB, Hafer C, Kennedy AD, Barbian KD, McCarthy AJ, Street 
C, Hirschberg DL, Lipkin WI, Lindsay JA, DeLeo FR & Lowy FD. Identification of a Highly Transmissible 
Animal-Independant Staphylococcus aureus ST398 Clone with Distinct Genomic and Cell Adhesion 
Properties. The American Society for Microbiology. 2012; 3(2): e00027-12. 
 
Vann JM & Proctor RA. Ingestion of Staphylococcus aureus by Bovine Endothelial Cells Results in Time- 
and Inoculum-Dependant Damage to Endothelial Cell Monolayers. Infection and Immunity. 1987; 55(9): 2155 
- 2163. 
 
	 264	
van Cleef BA, Verkade EJM, Wulf MW, Buiting AG, Voss A, Huijasdens XW, van Pelt W, Mulders MN  & 
Kluytmans JA. Prevalence of Livestock-Associated MRSA in Communities with High Pig-Densities in The 
netherlands. PLoS One. 2010; 5(2). 
 
van Duijkeren E, Jansen MD, Flemming SC, de Heeling H, Wagenaar JA, Schoormans AHW, van Nes A & 
Fluit AdC. Methicillin-resistant Staphylococcus aureus in pigs with exudative epidermitis. Emerging Infectious 
Diseases. 2007; 13(9): 1408 - 1410. 
 
van Rijen MML, Bosch T, Verkade EJM, Schouls L & Kluytmans JAJW. Livestock-Associated MRSA Carriage 
in Patients with ought Direct Contact with Livestock. PLoS One. 2014; 9(6). 
 
Van Wamel WJB, Rooijakkers SHM, Ruyken M, Van Kessel KPM, & Van Strijp JAG. The Innate Modulators 
Staphylococcal Complement Inhibitor Protein of Staphylococcus aureus Are Located on β-Hemolysin-
Converting Bacteriophages. The Journal of Bacteriology. 2006; 188(4): 1310 - 1315. 
 
Vaudaux P, Francois P, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Proctor RA, McNamara PJ, Peters 
G & Von Eiff C. Increased Expression of Clumping Factor and Fibronectin-binding proteins by hemB Mutants 
of Staphylococcus aureus Expressing Small Colony Variants. Infection and Immunity. 2002; 70(10): 5428 - 
5437. 
 
Vautor E, Cockfield J, Le Marcechal C, Le Loir Y, Chevalier M, Robinson DA, Thiery R & Lindsay J. 
Differences in virulence between Staphylococcus aureus isolates causing gangrenous mastitis versus 
subclinical mastitis in a dairy sheep flock. Veterinary Research. 2009; 40(56): DOI. 10.1051/vetres/2009039. 
 
Vazquez V, Liang X, Horndhal JK, Ganesh VK, Smeds E, Foster TJ & Hook M. Fibrinogen Is a Ligand for 
the Staphylococcus aureus Microbial Surface components Recognising Adhesive Matrix Molecules 
(MSCRAMM) Bone Sialoprotein-binding Protein (Bbp). The Journal of Biological Chemistry. 2011; 286(34): 
29797 - 29805. 
 
Ventola C.L. The antibiotic resistance crisis Part 2: Management Strategies and New Agents. Pharmacy and 
Therapeutics. 2015; 20(5):344 – 352. 
 
Vogel V, Falquet L, Calderon-Copete SP, Basset P & Blanc DS. Short term evolution of a highly transmissible 
methicillin-resistant Staphylococcus aureus clone (ST228) in a tertiary care hospital. PLoS One. 2012; 7(12): 
e38969. 
 
Von Eiff C, Heilmann C, Proctor RA, Waltz C, Peters G & Gotz F. A Site-Directed Staphylococcus aureus 
hemB Mutant Is a Small-Colony Variant Which Persists Intracellularly. The Journal of Bacteriology. 1997; 
179(15): 4706 - 4712. 
 
Wann ER, Gurusiddappa S & Hook M. The Fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus 
Is a Bifunctional Protein That Also Binds to Fibrinogen. The Journal of Biological Chemistry. 2000; 
275(18);:13863 - 13871. 
 
Wakeley J. The variance of pairwise Nucleotide Difference in two populations with migration. Theoretical 
Population Biology. 1994; 49(2): 39 - 57. 
 
	 265	
Weese JS, Rousseau J, Willey BM, Archambault M, McGeer A & Low DE. Methicillin-resistant 
Staphylococcus aureus in horses at a veterinary teaching hospital: Frequency, characterisation, and 
association with clinical disease. Journal of Veterinary Internal Medicine. 2006; 20: 182 - 186. 
 
Weese JS. Methicillin-resistant Staphylococcus aureus in animals. Oxford Journals. 2010; 51(3): 233 - 244. 
Westram AM, Panova M, Galindo J & Butlin RK. Targeted requencing reveals geographical patterns of 
differentiation for loci implicated in parallel evolution. Molecular Ecology. 2016. In Press: 
http://dx.doi.org/10.1111/mec.13640. 
 
WHO-1. World Health Organization Europe. Hospital acquired infections; The European context. Available 
from: http://www.who.int/patientsafety/events/05/apsd/EURO_Initiatives_on_blood_safety_Hafner.pdf. 
2012. (Accessed 01/06/12). 
 
WHO-2. World Health Organization. A global priority list of antibiotic-resistant bacteria to guide research, 
discovery, and development of new antibiotics:	http://www.who.int/medicines/publications/global-priority-list-
antibiotic-resistant-bacteria/en/. 2017. (Accessed 06/06/17). 
 
Wielders CLC, Fluit AC, Brisse S, Verhoef J & Schmitz FJ. mecA Gene is Widely Disseminated in 
Staphylococcus aureus population. The Journal of Clinical Microbiology. 2002; 40(11): 3970 - 3975. 
 
Wilke MS, Lovering AL & Strynadka NCJ. β-Lactam antibiotic resistance: a current structural perspective. 
Current Opinion in Microbiology. 2005; 8: 525 - 533. 
 
Wei Z, Schnupf P, Poussin MA, Zenewicz LA, Shen H & Goldfine H. Characterisation of Listeria 
monocytogenes Expressing Anthrolysin O and Phosphatidylinositol-Specific Phospholipase C from Bacillus 
anthracis. Infection and Immunity. 2005; 73(10): 6639 - 6646. 
 
Wertheim HFL, Walsh E, Choudhurry R, Melles DC, Boelens HAM, Miajlovic H, Verburgh HA, Foster T & van 
Belkum A. Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonisation of Human. PLoS 
One. 2008; 5(1). 
 
Williams REO. Healthy Carriage of Staphylococcus aureus: Its Prevalence and Importance. Microbiology and 
Molecular Biology Reviews. 1963; 27(1): 56 - 71.  
 
Wilson L G. The early recognition of streptococci as causes of disease. Medical History. 1987; 31: 403-414. 
 
Xiang H, Feng Y, Wang J, Liu B, Chen Y, Liu L, Deng X & Yang M. Crystal Structures Reveal the Multi-ligand 
Binding Mechanism of Staphylococcus aureus clfB. PloS One.2010; 8(6). 
 
Xiong N, Hu C, Zhang Y & Chen S. Interaction of sortase A and lipase 2 in the inhibition of Staphylococcus 
aureus biofilm formation. Archives of Microbiology. 2009; 191: 879 - 884. 
 
Xue H, Lu H & Zhao X. Sequence Diversities of Serine-Asparate Repeat Genes among Staphylococcus 
aureus Isolates from Different Hosts Presumably by Horizontal Gene Transfer. PLoS One. 2011; 
6(5):e20332. 
 
Yadav PK, Singh G, Singh, S, Gautam B & Saad EI. Potential therapeutic drug target identification in 
	 266	
Community Acquired-Methicillin Resistant Staphylococcus aureus (CA-MRSA) using computational analysis. 
Bioinformation. 2012; 8(14): 664-672. 
 
Yang Z & Bielawski JP. Statistical methods for detecting molecular adaptation. Trends in Ecology & Evolution. 
2000; 15(12): 496 - 503. 
 
Yang Z & Rannala B. Molecular phylogenetics: Principles and practise. Nature reviews.  2012; 13: 303 - 314. 
 
Zhang X, Hu Q, Yuan W, Shang W, Cheng H, Yuan J, Zhu J, Hu Z, Li S, Chen W, Hu X & Rao X. First report 
of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in mainland China. 
Diagnostic Microbiology and Infectious Disease. 2013; 77:64 - 68. 
 
Zhang HZ, Hackbarth CJ, Chansky KM & Chambers HF. A proteolytic transmembrane signalling pathway 
and resistance to beta-lactams in Staphylococci. Science. 2001; 291: 1962 - 1965. 
 
Zhang X, Xu X, Yuan W, Hu Q, Shang W, Hu, X, Tong Y & Rao X. Complete Genome Sequence of 
Staphylococcus aureus XN108, an ST239-MRSA-SCCmec III Strain with Intermediate Vancomycin 
Resistance Isolated in Mainland China. Genome Announcements. 2014; 2(4): e00449–14. 
	 (L) 
Length of 
Sequence 
N (No. of 
Sequences) 
S (No. 
of 
Variable 
sites 
h (No. of 
Haplotypes) 
Hd 
(Haplotype 
diversity) 
SD of 
Haplotype 
diversity 
π 
(Nucleotide 
diversity) 
SD of 
Nucleotide 
diversity 
k (Avg no. of 
nucleotide 
difference) 
Tajimas D Statistical 
Significance 
Fu & Li’s 
D 
Statistical 
Significance 
dn 
(Replacement 
changes) 
ds 
(Synonymous 
changes) 
ω (dn/ds) Ka SD Ks SD 
mecA 2007 26 2 3 0.428 
0.095 
0.00024 
0.0006 
0.48615 -0.15513  -0.68907  1 1 1 0.000245538 0.00029547 0.000184615 0.000640513 
PBP2 2187 57 232 25 0.944 0.015 0.00769 0.00286 16.73496 -2.41322 p<0.01 -6.1118 p<0.02 26 202 0.128712871 0.002178446 0.002943435 0.031456078 0.08315089 
hla 960 56 79 15 0.868 0.028 0.02137 0.00296 20.5188 0.056949  0.94103  11 70 0.157142857 0.004062857 0.003358898 0.093564416 0.10243034 
hlb 995 52 134 29 0.948 0.019 0.0243 0.00424 19.97285 -1.39415  -2.45919 p<0.05 128 16 8 0.028095249 0.030307735 0.011451056 0.011060187 
hlgA 930 56 58 19 0.868 0.032 0.00684 0.00114 6.35 -1.79359  -4.49654 p<0.02 13 47 0.276595745 0.001355 0.001558075 0.026948117 0.029635237 
LukSPV 949 17 268 7 0.809 0.068 0.1102 0.02538 103.47794 0.81837  0.46684  188 92 2.043478261 0.112825735 0.121985566 0.236900735 0.253508508 
lukS 1057 53 251 19 0.866 0.035 0.04894 0.00876 51.38679 -63385  -0.93617  229 21 10.9047619 0.059494122 0.068582124 0.02568418 0.026634222 
lukF-PV 1011 34 570 9 0.856 0.034 0.16055 0.02883 149.95009 -0.38234  2.04025 p<0.02 161 123 1.308943089 0.150054902 0.229543728 0.593016756 0.46379684 
chp 451 28 8 5 0.481 0.108 0.0028 0.00076 1.2619 -1.19239  -0.54024  6 2 3 0.002622222 0.003462406 0.003793915 0.006892478 
sbi 1314 57 255 18 0.902 0.02 0.03859 0.00488 48.20175 -0.79584  -1.4108  64 157 0.407643312 0.023576629 0.019564748 0.108159211 0.111625841 
sak 491 41 9 9 0.815 0.038 0.0036 0.00032 1.77073 -0.46005  -1.16204  9 0 9 0.004669024 0.00334164 0 0 
sspA 1087 57 411 17 0.857 0.029 0.04314 0.01652 31.44862 -2.46653  p< 0.01 -6.01246 p<0.02 219 88 2.488636364 0.051335088 0.144144723 0.085016729 0.211448419 
sspB 1555 57 201 18 0.898 0.021 0.01832 0.00444 21.63409 -1.86734 p<0.05 -4.87137 p<0.02 65 142 0.457746479 0.007220739 0.011927683 0.071325 0.116519437 
sspC 330 57 69 13 0.823 0.035 0.01408 0.00629 4.64599 -2.47292 P<0.01 -6.0626 p<0.02 24 75 0.32 0.006732644 0.021610558 0.053919799 0.148814427 
vwb 512 27 134 6 0.547 0.107 0.06312 0.01937 29.72934 -0.71047  1.39427 p<0.05 78 42 1.857142857 0.061724501 0.085825083 0.116790883 0.150017703 
lip 2100 57 970 22 0.895 0.024 0.03093 0.01393 62.32331 -2.62849 p<0.001 -6.68815 p<0.02 457 361 1.265927978 0.025712782 0.091913042 0.104507331 0.271810229 
lip1 2143 56 845 21 0.926 0.018 0.04453 0.01958 56.24156 -2.64339 p<0.001 -6.48876 p<0.02 365 143 2.552447552 0.059937727 0.185391967 0.088118182 0.265171001 
coa 2349 51 367 21 0.911 0.023 0.11623 0.00698 104.83843 -0.11428  -1.42261  198 40 4.95 0.130320627 0.067478835 0.115796235 0.071819499 
lipA 918 56 56 15 0.832 0.033 0.00549 0.00163 5.03701 -2.10997 p<0.05 -5.21607 p<0.02 1 59 0.016949153 0.00005 0.000259892 0.026146818 0.048110514 
plc 987 57 132 20 0.893 0.022 0.02638 0.00179 26.00689 -0.61081  -2.64197 p<0.05 43 95 0.452631579 0.009644925 0.005997359 0.095161905 0.057472722 
plc 987 57 132 20 0.892 0.022 0.02615 0.00184 25.78321 -0.63594  -2.64197 p<0.05 43 95 0.452631579 0.009626065 0.005966283 0.096446805 0.057435175 
nuc 687 56 136 18 0.851 0.032 0.01551 0.00567 10.37403 -2.37667 p<0.01 -5.99137 p<0.02 60 71 0.845070423 0.008314221 0.020460035 0.049946688 0.110560148 
nucA 690 57 272 16 0.641 0.07303 0.0945 0.02796 50.08709 -0.8496  0.88805  121 92 1.315217391 0.122866165 0.246672777 0.235605451 0.385913198 
hysA 2528 57 1500 28 0.898 0.028 0.09215 0.01609 211.86028 -1.66335  -4.75547 p<0.02 626 235 2.663829787 0.109446366 0.167450506 0.135715539 0.231318698 
hysA1 4872 57 2884 42 0.977 0.012 0.23432 0.00777 1111.61529 0.26073  -0.45342  419 349 1.200573066 0.272862531 0.139884799 0.390797431 0.164870006 
hysA2 2436 57 680 25 0.902 0.026 0.07658 0.00315 183.56078 0.29673  -0.47924  259 283 0.915194346 0.055963534 0.024159787 0.185718922 0.086187476 
aur 1558 57 565 18 0.901 0.021 0.08186 0.01848 70.07018 -1.77995  -5.77113 p<0.02 253 100 2.53 0.100618296 0.194420703 0.155057393 0.330170276 
hemB 4296 57 1603 38 0.977 0.009 0.0865 0.01886 262.87845 -1.29973  0.64854  722 976 0.739754098 0.099063409 0.157451314 0.13095119 0.161847954 
sepA 474 55 65 14 0.853 0.031 0.04711 0.00588 22.04579 1.74923  1.65977 p<0.02 8 59 0.13559322 0.005990572 0.006430586 0.265850976 0.293161811 
cna 3554 22 225 13 0.892 0.055 0.04778 0.00303 94.97835 2.01082 p<0.05 1.15284  127 206 0.616504854 0.041912121 0.035334277 0.075595671 0.046459595 
efb 498 54 96 12 0.838 0.03 0.03996 0.00659 19.90077 -0.35967  0.05541  32 65 0.492307692 0.016903215 0.018462957 0.151025437 0.171726808 
fnb 3252 55 1168 31 0.963 0.013 0.17129 0.03249 245.28283 -1.20642  -1.46986  177 46 3.847826087 0.251516229 0.349209622 0.345513939 0.4613624 
ebpS 1471 56 335 21 0.894 0.028 0.02499 0.00628 35.43247 -1.95648 p<0.05 -5.60148 p<0.02 253 71 3.563380282 0.025553831 0.040772489 0.032687597 0.047225734 
bbp 4302 57 1604 38 0.977 0.009 0.08631 0.01884 262.97494 -1.29888  0.64854  721 255 2.82745098 0.098827381 0.15730697 0.130908584 0.161439527 
eap 435 55 26 15 0.842 0.033 0.01481 0.01481 5.99933 0.0541  0.00312  7 24 0.291666667 0.005684444 0.004132987 0.048569966 0.037354995 
clf 3258 56 503 30 0.965 0.011 0.06763 0.00316 143.17078 0.32648  0.05801  389 455 0.854945055 0.075674545 0.040644596 0.050043312 0.028239989 
SCIN 345 57 79 16 0.818 0.042 0.01931 0.00594 6.66103 -2.1727 p<0.05 -5.29299 p<0.02 37 37 1 0.014079073 0.02470169 0.045222431 0.100294579 
entE 791 19 374 7 0.544 0.136 0.0716 0.0388 53.33918 -2.39421 p<0.01 -3.16397 p<0.02 241 62 3.887096774 0.092631579 0.190466238 0.100051462 0.17933361 
sea 780 19 84 4 0.45 0.128 0.01436 0.00921 11.11696 -2.24588 p<0.01 -3.37062 p<0.02 39 84 0.464285714 0.008961404 0.018856668 0.040578363 0.093724416 
seb 826 14 213 7 0.802 0.094 0.13588 0.01238 107.48352 2.5904 p<0.01 1.36471 p<0.5 138 68 2.029411765 0.138303297 0.119123102 0.290992308 0.249186388 
seh 726 5 81 2 0.4 0.237 0.04807 0.0008134 32.4 -126452  -1.26452 p<0.02 26 55 0.472727273 0.02092 0.027007604 0.22348 0.288511439 
sek 730 18 34 5 0.824 0.045 0.01735 0.00219 12.64706 1.13049  1.65638 p<0.02 30 4 7.5 0.019051634 0.01246854 0.011477124 0.011477124 
seg 777 24 40 6 0.583 0.101 0.01056 0.00262 8.19203 -0.9755  -2.20829  25 41 0.609756098 0.007194565 0.008263361 0.024244565 0.026700738 
tst 705 7 17 4 0.714 0.181 0.00959 0.00342 6.7619 -0.14193  0.21786  11 6 1.833333333 0.00817619 0.007906826 0.015371429 0.015368609 
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Appendix 2: 
 
The following outputs show the results of the BLASTn Search. The BLASTn tool was used to identify if 
virulence factor genes were present in some or all of the S. aureus strains. The cut off value was set at 
90% coverage, 85% identity and an E value of <0.01. 
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